Powrót do strony głownej << Powrót do listy zbiorów wartości

Zbiór wartości Substancja czynna wg klasyfikacji WHO ATC 2024‑07‑01

2.16.840.1.113883.3.4424.13.11.321

Data obowiązywania

obowiązuje od 2024‑07‑01

Status

Draft

Etykieta wersji

1.3.2

Nazwa

SubstancjaCzynnaATC

Nazwa wyświetlana

Substancja czynna wg klasyfikacji WHO ATC

Opis

Zbiór wartości służy do określenia kodu substancji czynnej wg klasyfikacji WHO ATC

Żródłowy system kodowania

2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification

Poziom/ Typ	Kod	Nazwa wyświetlana	System kodowania
0‑L	A	PRZEWÓD POKARMOWY I METABOLIZM	WHO Anatomical Therapeutic Chemical classification
0‑L	A01	PREPARATY STOMATOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	A01A	PREPARATY STOMATOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA	Preparaty zapobiegające próchnicy	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA01	sodu fluorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA02	sodu monofluorofosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA03	olaflur	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA04	cyny(II) fluorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA51	sodu fluorek, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB	Leki przeciwinfekcyjne i antyseptyki do stosowania w jamie ustnej	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB02	wodoru nadtlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB03	chloroheksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB04	amfoterycyna B	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB05	polinoksylina	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB06	domifen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB07	oksychinolina	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB08	neomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB09	mikonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB10	natamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB11	różne	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB12	heksetydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB13	tetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB14	benzoksoniowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB15	tibezoniowy jodek	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB16	mepartrycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB17	metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB18	klotrimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB19	sodu peroksoboran	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB21	chlortetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB22	doksycyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB23	minocyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB24	oktenidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB25	oksytetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB53	chlorheksydyna i cetylopirydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC	Kortykosteroidy do stosowania miejscowego w jamie ustnej	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC01	triamcynolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC02	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC03	hydrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC04	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC54	prednizolon, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD	Inne leki do stosowania miejscowego w jamie ustnej	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD01	epinefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD02	benzydamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD05	kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD06	adrenalon	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD07	amleksanoks	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD08	bekaplermin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD11	różne	WHO Anatomical Therapeutic Chemical classification
0‑L	A02	LEKI STOSOWANE W ZABURZENIACH WYDZIELANIA SOKU ŻOŁĄDKOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	A02A	LEKI ZOBOJĘTNIAJĄCE SOK ŻOŁĄDKOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA	Związki magnezu	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA01	magnezu węglan	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA02	magnezu tlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA03	magnezu nadtlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA04	magnezu wodorotlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA05	magnezu krzemian	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA10	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB	Związki glinu	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB01	glinu wodorotlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB02	algeldrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB03	glinu fosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB04	glinu węglan zasadowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB05	glinu acetooctan	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB06	aloglutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB07	glinu glicynian	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB10	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC	Związki wapnia	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC01	wapnia węglan	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC02	wapnia krzemian	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC10	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD	Połączenia i kompleksy glinu, wpania i magnezu	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD01	połączenia soli	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD02	magaldrat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD03	almagat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD04	hydrotalcyt	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD05	almasylat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF	Leki zobojętniające sok żółądkowy z lekami przeciw wzdęciom	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF01	magaldrat i leki przeciw wzdęciom	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF02	połączenia soli i leki przeciw wzdęciom	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AG	Leki zobojętniające sok żołądkowy z lekami przeciwskurczowymi	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AH	Leki zobojętniające sok żołądkowy z sodu wodorowęglanem	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AX	Leki zobojętniające sok żołądkowy, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A02B	LEKI STOSOWANE W CHOROBIE WRZODOWEJ I REFLUKSIE ŻOŁĄDKOWO-PRZEŁYKOWYM	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA	Antagoniści receptora H2	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA01	cymetydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA02	ranitydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA03	famotydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA04	nizatydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA05	niperotydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA06	roksatydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA07	ranitydyna z bizmutu cytrynianem	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA08	lafutydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA51	cymetydyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA53	famotydyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB	Prostaglandyny	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB01	mizoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB02	enprostil	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC	Inhibitory pompy protonowej	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC01	omeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC02	pantoprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC03	lanzoprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC04	rabeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC05	ezomeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC06	dekslanzoprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC07	deksrabeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC08	wonoprazan	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC09	tegoprazan	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC51	omeprazol, kombinacje	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC53	lanzoprazol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC54	rabeprazol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD	Połączenia stosowane w eradykacji Helicobacter pylori	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD01	omeprazol, amoksycylina i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD02	lanzoprazol, tetracyklina i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD03	lanzoprazol, amoksycylina i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD04	pantoprazol, amoksycylina i klarytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD05	omeprazol, amoksycylina i klarytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD06	ezomeprazol, amoksycylina i klarytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD07	lanzoprazol, amoksycylina i klarytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD08	bizmutu(III) cytrynian zasadowy, tetracyklina i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD09	lanzoprazol, klarytromycyna i tinidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD10	lanzoprazol, amoksycylina i lewofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD11	pantoprazol, amoksycylina, klarytromycyna i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD12	rabeprazol, amoksycylina i klarytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD13	rabeprazol, amoksycylina i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD14	wonoprazan, amoksycylina i klarytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD15	wonoprazan, amoksycylina i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD16	omeprazol, amoksycylina i rifabutyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD17	wonoprazan i amoksycylina	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX	Inne leki stosowane w chorobie wrzodowej i refluksie żołądkowo-przełykowym	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX01	karbenoksolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX02	sukralfat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX03	pirenzepina	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX04	metiosulfoniowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX05	bizmutu(III) cytrynian zasadowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX06	proglumid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX07	gefarnat	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX08	sulglikotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX09	acetoksolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX10	zolimidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX11	troksypid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX12	bizmutu(III) azotan zasadowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX13	kwas algi	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX14	rebamipid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX15	teprenon	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX16	irsogladyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX51	karbenoksolon, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX71	karbenoksolon, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX77	gefarnat, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	A02X	INNE LEKI STOSOWANE W ZABURZENIACH WYDZIELANIA SOKU ŻOŁĄDKOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	A03	LEKI STOSOWANE W CZYNNOŚCIOWYCH ZABURZENIACH PRZEWODU POKARMOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	A03A	LEKI STOSOWANE W CZYNNOŚCIOWYCH ZABURZENIACH PRZEWODU POKARMOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA	Syntetyczne leki cholinolityczne, estry trzeciorzędowych amin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA01	oksyfencyklimina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA03	kamilofin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA04	mebeweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA05	trimebutyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA06	rocyweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA07	dicykloweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA08	diheksyweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA09	difemeryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA30	piperidolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB	Syntetyczne leki cholinolityczne, czwartorzędowe związki amoniowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB01	benzylon	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB02	glikopironiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB03	oksyfenonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB04	pentienat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB05	propantelina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB06	otyloniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB07	metantelina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB08	tridiheksetyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB09	izopropamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB10	heksocyklium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB11	poldyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB12	mepenzolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB13	bewonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB14	pipenzolat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB15	difemanil	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB16	(2-benzohydryloksyetylo)dietylometyloamoniowy jodek	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB17	tiemoniowy jodek	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB18	prifiniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB19	timepidiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB21	fenpiweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB53	oksyfenonium, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC	Syntetyczne leki przeciwskurczowe, amidy z trzeciorzędowymi aminami	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC02	dimetyloaminopropionylofenotiazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC04	nikofetamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC05	tyropramid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD	Papaweryna i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD01	papaweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD02	drotaweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD30	moksaweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE	Antagoniści receptorów serotonich	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE01	alosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE03	cylansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX	Inne leki stosowane w czynnościowych zaburzeniach przewodu pokarmowego	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX01	fenpipran	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX02	diizopromina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX03	chlorbenzoksamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX04	pinaweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX05	fenoweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX06	idanpramina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX07	proksazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX08	alweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX09	trepibuton	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX10	izometepten	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX11	karoweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX12	floroglucynol	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX13	silikony	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX14	waletamat	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX15	olejek eteryczny miętowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX30	trimetylodifenylopropylamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX58	alweryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A03B	ALKALOIDY POKRZYKU WILCZA JAGODA I POCHODNE, BEZ DODATKÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA	Alkaloidy pokrzyku wilcza jagoda, aminy trzeciorzędowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA01	atropina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA03	hioscyjamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA04	wszystkie alkaloidy pokrzyku wilcza jagoda	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB	Alkaloidy pokrzyku wilcza jagoda półsyntetyczne, czwartorzędowe związki amoniowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB01	hioscyny butylobromek	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB02	metyloatropina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB03	metyloskopolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB04	fentonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB05	cymetropiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB06	homatropiny metylobromek	WHO Anatomical Therapeutic Chemical classification
0‑L	A03C	LEKI PRZECIWSKURCZOWE W POŁĄCZENIU Z PSYCHOLEPTYKAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA	Syntetyczne leki cholinolityczne w połączeniu z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA01	izopropamid i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA02	klidynium i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA03	oksyfencyklimina i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA04	otyloniowy bromek i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA05	glikopironiowy bromek i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA06	bewonium i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA07	ambutonium i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA08	difemanil i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA09	pipenzolat i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA30	emepronium i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA34	propantelina i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB	Alkaloidy pokrzyku wilcza jagoda i pochodne w połączeniu z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB01	metyloskopolamina i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB02	wszystkie alkaloidy pokrzyku wilcza jagoda i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB03	atropina i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB04	homatropiny metylobromek i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB31	hioscyjamina i psycholeptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CC	Inne leki przeciwskurczowe w połączeniu z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	A03D	LEKI PRZECIWSKURCZOWE W POŁĄCZENIU Z LEKAMI PRZECIWBÓLOWYMI	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA	Syntetyczne leki cholinolityczne w połączeniu z lekami przeciwbólowymi	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA01	tropenzilon i leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA02	pitofenon i leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA03	bewonium i leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA04	cyklonium i leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA05	kamylofina i leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA06	trospium i leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA07	tiemoniowy jodek i leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB	Alkaloidy pokrzyku wilcza jagoda i pochodne w połączeniu z lekami przeciwbólowymi	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB04	skopolaminy butylobromek i leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DC	Inne leki przeciwskurczowe w połączeniu z lekami przeciwbólowymi	WHO Anatomical Therapeutic Chemical classification
0‑L	A03E	LEKI PRZECIWSKURCZOWE I LEKI CHOLINOLITYCZNE W POŁĄCZENIU Z INNYMI LEKAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	A03EA	Leki przeciwskurczowe, psycholeptyki i leki przeciwbólowe w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	A03ED	Leki przeciwskurczowe w połączeniu z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	A03F	LEKI POBUDZAJĄCE PERYSTALTYKĘ	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA	Leki pobudzające perystaltykę	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA01	metoklopramid	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA02	cyzapryd	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA03	domperydon	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA04	bromopryd	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA05	alizapryd	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA06	klebopryd	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA07	itopryd	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA08	cynitapryd	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA09	mozapryd	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA10	akotiamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A04	LEKI PRZECIWWYMIOTNE I PRZECIW NUDNOŚCIOM	WHO Anatomical Therapeutic Chemical classification
0‑L	A04A	LEKI PRZECIWWYMIOTNE I PRZECIW NUDNOŚCIOM	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA	Antagoniści receptorów serotonich 5-HT3	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA01	ondansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA02	granisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA03	tropisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA04	dolasetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA05	palonosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA55	palonosetron, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD	Inne leki przeciwwymiotne	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD01	skopolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD02	ceru(IV) szczawian	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD04	chlorobutanol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD05	metopimazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD10	dronabinol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD11	nabilon	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD12	aprepitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD13	kazopitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD14	rolapitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD51	skopolamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD54	chlorobutanol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A05	LEKI STOSOWANE W CHOROBACH DRÓG ŻÓŁCIOWYCH I WĄTROBY	WHO Anatomical Therapeutic Chemical classification
0‑L	A05A	LEKI STOSOWANE W CHOROBACH DRÓG ŻÓŁCIOWYCH	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA	Kwasy żółciowe i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA01	kwas chenodeoksycholowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA02	kwas ursodeoksycholowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA03	kwas cholowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA04	kwas obetycholowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA05	ursodoksykoltauryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB	Leki stosowane w chorobach dróg żółciowych	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB01	nikotynylu metyloamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX	Inne leki stosowane w chorobach dróg żółciowych	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX01	piprozolina	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX02	hymekromon	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX03	cyklobutyrol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX04	chlorek maraliksybatu	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX05	odewiksybat	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX06	elafibranor	WHO Anatomical Therapeutic Chemical classification
0‑L	A05B	LEKI STOSOWANE W CHOROBACH WĄTROBY, LEKI LIPOTROPOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA	Leki stosowane w chorobach wątroby	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA01	argininy glutaminian	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA03	sylimaryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA04	cytiolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA05	epomediol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA06	ornityny oksyglukuronian	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA07	tidiacyk z argininą	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA08	kwas glicyryzy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA09	metadoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA10	fosfolipidy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05C	LEKI STOSOWANE W CHOROBACH DRÓG ŻÓŁCIOWYCH I LEKI LIPOTROPOWE W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	A06	LEKI PRZECZYSZCZAJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	A06A	LEKI PRZECZYSZCZAJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA	Leki zmiękczające masy kałowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA01	parafina ciekła	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA02	sodu dokuzynian	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA51	parafina ciekła, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB	Kontaktowe leki przeczyszczające	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB01	oksyfenizatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB02	bisakodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB03	dantron	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB04	fenoloftaleina	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB05	olej rycy	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB06	sennozydy	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB07	kora szakłaku amerykańskiego	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB08	sodu pikosiarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB09	bisoksatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB20	kontaktowe leki przeczyszczające w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB30	kontaktowe leki przeczyszczające w połączeniu z alkaloidami pokrzyku wilcza jagoda	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB52	bisakodyl, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB53	dantron, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB56	sennozydy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB57	kora szakłaku amerykańskiego, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB58	pikosiarczan sodu, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC	Leki przeczyszczające zwiększające objętość mas kałowych	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC01	nasienie płesznika	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC02	etuloza	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC03	ziele zatwaru	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC05	nasienie lnu	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC06	metyloceluloza	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC07	pszenica (włókna)	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC08	polikarobofil wapniowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC51	nasienie płesznika, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC53	ziele zatwaru, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC55	nasienie lnu, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD	Osmotyczne leki przeczyszczające	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD01	magnezu węglan	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD02	magnezu tlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD03	magnezu nadtlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD04	magnezu siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD10	sole mineralne w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD11	laktuloza	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD12	laktytol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD13	sodu siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD14	pentaerytrytyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD15	makrogol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD16	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD17	sodu fosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD18	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD19	magnezu cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD21	sodu winian	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD61	laktuloza, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD65	makrogol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG	Wlewki doodbytnicze	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG01	sodu fosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG02	bisakodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG03	dantron, włącznie z połączeniami	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG04	glicerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG06	oleje	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG07	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG10	sodu dokuzynian, włącznie z połączeniami	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG11	sodu laurylosiarczan, włącznie z połączeniami	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH	Antagoniści obwodowych receptorów opioidowych	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH01	metylonaltreksonu bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH02	alwimopan	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH03	naloksegol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH04	nalokson	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH05	naldemedyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX	Inne leki przeczyszczające	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX01	glicerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX02	leki wytwarzające dwutlenek węgla	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX03	lubiproston	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX04	linaklotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX05	prukalopryd	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX06	tegaserod	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX07	plekanatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX08	tenapanor	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX09	elobiksybat	WHO Anatomical Therapeutic Chemical classification
0‑L	A07	LEKI PRZECIWBIEGUNKOWE, PRZECIWZAPALNE/PRZECIWINFEKCYJNE, STOSOWANE W CHOROBACH PRZEWODU POKARMOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	A07A	LEKI PRZECIWINFEKCYJNE STOSOWANE W CHOROBACH PRZEWODU POKARMOWGO	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA	Antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA01	neomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA02	nystatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA03	natamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA04	streptomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA05	polimiksyna B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA06	paromomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA07	amfoterycyna B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA08	kanamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA09	wankomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA10	kolistyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA11	ryfaksymina	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA12	fidaksomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA13	ryfamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA51	neomycyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA54	streptomycyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB	Sulfonamidy	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB02	ftalilosulfatiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB03	sulfaguanidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB04	sukcynylosulfatiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC	Pochodne imidazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC01	mikonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX	Inne leki przeciwinfekcyjne stosowane w chorobach przewodu pokarmowgo	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX01	broksychinolina	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX02	acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX03	nifuroksazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX04	nifurzyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A07B	ADSORBENTY	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA	Preparaty węgla	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA01	węgiel aktywny	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA51	węgiel aktywny, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BB	Związki bizmutu	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC	Inne adsorbenty	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC01	pektyny	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC02	kaolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC03	krospowidon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC04	atapulgit	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC05	diosmektyt	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC54	atapulgit, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07C	ELEKTROLITY Z WĘGLOWODANAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	A07CA	Doustne sole nawadniające	WHO Anatomical Therapeutic Chemical classification
0‑L	A07D	LEKI HAMUJĄCE PERYSTALTYKĘ JELIT	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA	Leki hamujące perystaltykę jelit	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA01	difenoksylat	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA02	opium	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA03	loperamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA04	difenoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA05	loperamidu tlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA06	eluksadolina	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA52	morfina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA53	loperamid, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07E	LEKI PRZECIWZAPALNE STOSOWANE W CHOROBACH PRZEWODU POKARMOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA	Kortykosteroidy o działaniu miejscowym	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA01	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA02	hydrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA03	prednizon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA04	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA05	tiksokortol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA06	budezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA07	beklometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB	Leki przeciwalergiczne, z wyłączeniem kortykosteroidów	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB01	kwas kromoglika	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC	Kwas aminosalicylowy i leki podobne	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC01	sulfasalazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC02	mesalazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC03	olsalazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC04	balsalazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A07F	LEKI PRZYWRACAJĄCE PRAWIDŁOWĄ FLORĘ JELITOWĄ, HAMUJĄCE BIEGUNKĘ	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA	Leki przywracające prawidłową florę jelitową, hamujące biegunkę	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA01	bakterie wytwarzające kwas mlekowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA02	saccharomyces boulardii	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA03	Escherichia coli	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA51	bakterie wytwarzające kwas mlekowy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07X	INNE LEKI PRZECIWBIEGUNKOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA	Inne leki przeciwbiegunkowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA01	taniny białczan	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA02	ceratonia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA03	związki wapnia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA04	racekadotryl	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA06	krofelemer	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA51	białczan taniny, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A08	LEKI PRZECIW OTYŁOŚCI Z WYŁĄCZENIEM PRODUKTÓW DIETETYCZNYCH	WHO Anatomical Therapeutic Chemical classification
0‑L	A08A	LEKI PRZECIW OTYŁOŚCI Z WYŁĄCZENIEM PRODUKTÓW DIETETYCZNYCH	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA	Leki przeciw otyłości działające ośrodkowo	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA01	fentermina	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA02	fenfluramina	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA03	amfepramon	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA04	deksfenfluramina	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA05	mazindol	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA06	etylamfetamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA07	katyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA08	klobenzoreks	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA09	mefenoreks	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA10	sybutramina	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA11	lorkaseryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA12	setmelanotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA51	fentermina i topiramat	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA56	efedryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA62	bupropion i naltrekson	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB	Leki przeciw otyłości działające obwodowo	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB01	orlistat	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AX	Inne leki przeciw otyłości	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AX01	rymonabant	WHO Anatomical Therapeutic Chemical classification
0‑L	A09	LEKI POPRAWIAJĄCE TRAWIENIE, WŁĄCZNIE Z ENZYMAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	A09A	LEKI POPRAWIAJĄCE TRAWIENIE, WŁĄCZNIE Z ENZYMAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA	Enzymy	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA01	diastaza	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA02	połączenia enzymów (lipaza, proteaza itp.)	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA03	pepsyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA04	tylaktaza	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB	Leki zawierające kwasy	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB01	kwasu glutaminowego chlorowodorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB02	betainy chlorowodorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB03	kwas solny	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB04	kwas cytry	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC	Enzymy i leki zawierające kwasy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC01	pepsyna i leki zawierające kwasy	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC02	mieszanina enzymów i leki zawierające kwasy	WHO Anatomical Therapeutic Chemical classification
0‑L	A10	LEKI STOSOWANE W CUKRZYCY	WHO Anatomical Therapeutic Chemical classification
0‑L	A10A	INSULINY I ANALOGI	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB	Insuliny i analogi krótko działające, do wstrzykiwań	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB01	insulina ludzka	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB02	insulina wołowa	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB03	insulina wieprzowa	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB04	insulina lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB05	insulina aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB06	insulina glulizynowa	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC	Insuliny i analogi o średnim czasie działania, do wstrzykiwań	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC01	insulina ludzka	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC02	insulin wołowa	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC03	insulina wieprzowa	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC04	insulina lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD	Insuliny i analogi o średnim lub długim czasie działania w połączeniu z krótko działającymi, do wstrzykiwań	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD01	insulina ludzka	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD02	insulina wołowa	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD03	insulina wieprzowa	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD04	insulina lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD05	insulina aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD06	insulina degludec i insulina aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE	Insuliny i analogi długo działąjące, do wstrzykiwań	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE01	insulina ludzka	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE02	insulina wołowa	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE03	insulina wieprzowa	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE04	insulina glargina	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE05	insulina detemir	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE06	insulina degludek	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE07	ikodek insuliny	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE54	insulina glargina i liksysenatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE56	insulina degludek i liraglutyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF	Insuliny i analogi, do inhalacji	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF01	insulina ludzka	WHO Anatomical Therapeutic Chemical classification
0‑L	A10B	LEKI HIPOGLIKEMIZUJĄCE, Z WYŁĄCZENIEM INSULIN	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA	Biguanidy	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA01	fenformina	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA02	metformina	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA03	buformina	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB	Pochodne sulfonylomocznika	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB01	glibenklamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB02	chloropropamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB03	tolbutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB04	glibornurid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB05	tolazamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB06	karbutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB07	glipizyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB08	glikwidon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB09	gliklazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB10	metaheksamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB11	glizoksepid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB12	glimepiryd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BB31	acetoheksamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BC	Sulfonamidy (heterocykliczne)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BC01	glimidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD	Połączenia doustnych leków hipoglikemizujących	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD01	fenformina i pochodne sulfonylomocznika	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD02	metformina i pochodne sulfonylomocznika	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD03	metformina i rozyglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD04	glimepiryd i rozyglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD05	metformina i pioglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD06	glimepiryd i pioglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD07	metformina i sytagliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD08	metformina i wildagliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD09	pioglitazon i alogliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD10	metformina i saksagliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD11	metformina i linagliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD12	pioglitazon i sytagliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD13	metformina i alogliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD14	metformina i repaglinid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD15	metformina i dapagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD16	metformina i kanagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD17	metformina i akarboza	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD18	metformina i gemigliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD19	linagliptyna i empagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD20	metformina i empagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD21	saksagliptyna i dapagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD22	metformina i ewogliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD23	metformina i ertugliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD24	sytagliptyna i ertugliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD25	metformina, saksagliptyna i dapagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD26	metformina i lobeglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD27	metformina, linagliptyna i empagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD28	metformina i teneliligliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BD29	sitagliptyna i dapagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF	Inhibitory alfa-glukozydazy	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF01	akarboza	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF02	miglitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BF03	wogliboza	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG	Pochodne tiazolidynodionu	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG01	troglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG02	rozyglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG03	pioglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BG04	lobeglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH	Inhibitory dipeptydylopeptydazy 4 (DPP-4)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH01	sytagliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH02	wildagliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH03	saksagliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH04	alogliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH05	linagliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH06	gemigliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH07	ewogliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH08	teneligliptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH51	sytagliptyna i symwastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BH52	gemigliptyna i rozuwastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ	Analogi glukagonopodobnego peptydu 1 (GLP-1)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ01	eksenatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ02	liraglutyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ03	liksysenatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ04	albiglutyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ05	dulaglutyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ06	semaglutyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BJ07	beinaglutyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK	Inhibitory kotransportera glukozowo-sodowego 2 (SGLT2)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK01	dapagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK02	kanagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK03	empagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK04	ertugliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK05	ipragliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK06	sotagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK07	luzeogliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BK08	beksagliflozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX	Inne doustne leki hipoglikemizujące, z wyłączeniem insulin	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX01	guma guar	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX02	repaglinid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX03	nateglinid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX05	pramlintyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX06	benfluoreks	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX08	mitiglinid	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX15	imeglimina	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX16	tyrzepatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX17	karfloglitazar	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BX18	dorzagliatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A10X	INNE LEKI STOSOWANE W CUKRZYCY	WHO Anatomical Therapeutic Chemical classification
0‑L	A10XA	Inhibitory reduktazy aldozy	WHO Anatomical Therapeutic Chemical classification
0‑L	A10XA01	tolrestat	WHO Anatomical Therapeutic Chemical classification
0‑L	A10XX	Inne leki stosowane w cukrzycy	WHO Anatomical Therapeutic Chemical classification
0‑L	A10XX01	teplizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	A11	Witaminy	WHO Anatomical Therapeutic Chemical classification
0‑L	A11A	PREPARATY WIELOWITAMINOWE, POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA	Preparaty wielowitaminowe ze związkami mineralnymi	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA01	preparaty wielowitaminowe i żelazo	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA02	preparaty wielowitaminowe i wapń	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA03	preparaty wielowitaminowe i inne związki mineralne, włącznie z połączeniami	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AA04	preparaty wielowitaminowe i pierwiastki śladowe	WHO Anatomical Therapeutic Chemical classification
0‑L	A11AB	preparaty wielowitaminowe, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A11B	PREPARATY WIELOWITAMINOWE, BEZ DODATKÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	A11BA	Preparaty wielowitaminowe, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	A11C	WITAMINA A I D, WŁĄCZNIE Z POŁĄCZENIAMI OBYDWU WITAMIN	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CA	Witamina A, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CA01	retynol (witamina A)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CA02	betakaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CB	Witamina A i D w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC	Witamina D i analogi	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC01	ergokalcyferol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC02	dihydrotachysterol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC03	alfakalcydol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC04	kalcytriol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC05	cholekalcyferol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC06	kalcyfediol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A11CC55	cholekalcyferol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A11D	WITAMINA B1, BEZ DODATKÓW I W POŁĄCZENIU Z WITAMINĄ B6 I B12	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA	Witamina B1, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA01	tiamina (witamina B1)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA02	sulbutiamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DA03	benfotiamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A11DB	Witamian B1 w połączeniu z witaminą B6 i/lub witaminą B12	WHO Anatomical Therapeutic Chemical classification
0‑L	A11E	KOMPLEKS WITAMIN GRUPY B, WŁĄCZENIE Z POŁĄCZENIAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EA	Kompleks witamin grupy B, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EB	Kompleks witamin grupy B z witaminą C	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EC	Kompleks witamin grupy B ze związkami mineralnymi	WHO Anatomical Therapeutic Chemical classification
0‑L	A11ED	Kompleks witamin grupy B ze steroidami anabolicznymi	WHO Anatomical Therapeutic Chemical classification
0‑L	A11EX	Kompleks witamin grupy B, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A11G	KWAS ASKORBOWY (WITAMINA C), WŁĄCZNIE Z POŁĄCZENIAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GA	Kwas askorbowy (witamina C), bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GA01	kwas askorbowy (witamina C)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GB	kwas askorbowy (witamina C), połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A11GB01	kwas askorbowy (witamina C) i wapń	WHO Anatomical Therapeutic Chemical classification
0‑L	A11H	PREPARATY INNYCH WITAMIN BEZ DODATKÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA	Preparaty innych witamin bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA01	nikotynamid	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA02	pirydoksyna (witamina B6)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA03	tokoferol (witamina E)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA04	ryboflawina (witamina B2)	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA05	biotyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA06	pirydoksalu fosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA07	inozytol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA08	tokofersolan	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA30	dekspantenol	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA31	wapnia pantotenian	WHO Anatomical Therapeutic Chemical classification
0‑L	A11HA32	pantetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A11J	PREPARATY INNYCH WITAMIN, POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	A11JA	Połączenia witamin	WHO Anatomical Therapeutic Chemical classification
0‑L	A11JB	Witaminy ze związkami mineralnymi	WHO Anatomical Therapeutic Chemical classification
0‑L	A11JC	Witaminy, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A12	ZWIĄZKI MINERALNE	WHO Anatomical Therapeutic Chemical classification
0‑L	A12A	WAPŃ	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA	Wapń	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA01	wapnia fosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA02	wapnia glubionian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA03	wapnia glukonian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA04	wapnia węglan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA05	wapnia mleczan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA06	wapnia laktoglukonian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA07	wapnia chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA08	wapnia glicerofosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA09	kompleks lizyny z wapnia cytrynianem	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA10	wapnia glukoheptonian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA11	wapnia pangamanian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA13	wapnia cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA20	wapń (różne sole w połączeniu)	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AA30	wapnia lewulinian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12AX	Wapń, połączenia z witaminą D i/lub innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	A12B	POTAS	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA	Potas	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA01	potasu chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA02	potasu cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA03	potasu wodorowinian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA04	potasu wodorowęglan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA05	potasu glukonian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA30	potas (różne sole w połączeniu)	WHO Anatomical Therapeutic Chemical classification
0‑L	A12BA51	potasu chlorek, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A12C	INNE ZWIĄZKI MINERALNE	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CA	Sód	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CA01	sodu chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CA02	sodu siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB	Cynk	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB01	cynku siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB02	cynku glukonian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CB03	kompleks białkowy cynku	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC	Magnez	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC01	magnezu chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC02	magnezu siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC03	magnezu glukonian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC04	magnezu cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC05	magnezu asparaginian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC06	magnezu mleczan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC07	magnezu lewulinian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC08	magnezu pidolan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC09	magnezu orotan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC10	magnezu tlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CC30	magnez (różne sole w połączeniu)	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD	Fluor	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD01	sodu fluorek	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD02	sodu monofluorofosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CD51	fluor, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CE	Selen	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CE01	sodu selenian	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CE02	sodu selenin	WHO Anatomical Therapeutic Chemical classification
0‑L	A12CX	Preparaty innych związków mineralnych	WHO Anatomical Therapeutic Chemical classification
0‑L	A13	LEKI WZMACNIAJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	A13A	LEKI WZMACNIAJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	A14	LEKI ANABOLICZNE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	A14A	STEROIDY ANABOLICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA	Pochodne androstanu	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA01	androstanolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA02	stanozolol	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA03	metandienon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA04	metenolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA05	oksymetolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA06	kwinbolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA07	prasteron	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA08	oksandrolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AA09	noretandrolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB	Pochodne estrenu	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB01	nandrolon	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB02	etyloestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	A14AB03	oksabolonu cypionian	WHO Anatomical Therapeutic Chemical classification
0‑L	A14B	INNE LEKI ANABOLICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	A15	LEKI POPRAWIAJĄCE APETYT	WHO Anatomical Therapeutic Chemical classification
0‑L	A16	INNE LEKI DZIAŁAJĄCE NA PRZEWÓD POKARMOWY I METABOLIZM	WHO Anatomical Therapeutic Chemical classification
0‑L	A16A	INNE LEKI DZIAŁAJĄCE NA PRZEWÓD POKARMOWY I METABOLIZM	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA	Aminokwasy i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA01	lewokarnityna	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA02	ademetionina	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA03	glutamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA04	merkaptamina	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA05	kwas karglumi	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA06	betaina	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AA07	metreleptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB	Enzymy	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB01	algluceraza	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB02	imigluceraza	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB03	agalzydaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB04	agalzydaza beta	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB05	laronidaza	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB06	sakrozydaza	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB07	alglukozydaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB08	galsulfaza	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB09	idursulfaza	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB10	welagluceraza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB11	taligluceraza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB12	elosulfaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB13	asfotaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB14	sebelipaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB15	welmanaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB16	idursulfaza beta	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB17	cerliponaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB18	westronidaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB19	pegwaliaza	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB20	pegunigalzydaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB21	atidarsagen autotemcel	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB22	awalglukozydaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB23	cypaglukozydaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB24	pegzilarginaza	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB25	olipudaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB26	eladokagen eksuparwowek	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AB27	pabinafusp alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX	Różne leki działające na przewód pokarmowy i metabolizm	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX01	kwas tiokty	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX02	anetolotrition	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX03	sodu fenylomaślan	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX04	nityzynon	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX05	cynku octan	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX06	miglustat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX07	sapropteryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX08	teduglutyd	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX09	glicerolu fenylomaślan	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX10	eliglustat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX11	sodu benzoesan	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX12	trientyna	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX13	urydyny trioctan	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX14	migalastat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX15	telotristat	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX16	giwosyran	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX17	triheptanoina	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX18	lumasiran	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX19	fosdenopteryna	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX20	lonafarnib	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX21	eliwaldogen autotemcel	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX22	kwas tiomolibdenowy	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX23	leryglitazon	WHO Anatomical Therapeutic Chemical classification
0‑L	A16AX30	benzoesan sodu i fenylooctan sodu	WHO Anatomical Therapeutic Chemical classification
0‑L	B	KREW I UKŁAD KRWIOTWÓRCZY	WHO Anatomical Therapeutic Chemical classification
0‑L	B01	LEKI PRZECIWZAKRZEPOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	B01A	LEKI PRZECIWZAKRZEPOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA	Antagoniści witaminy K	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA01	dikumarol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA02	fenindion	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA03	warfaryna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA04	fenprokumon	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA07	acenokumarol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA08	etylu biskumoctan	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA09	kloryndion	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA10	difenadion	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA11	tioklomarol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AA12	fluindion	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB	Grupa heparyn	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB01	heparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB02	antytrombina III	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB04	dalteparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB05	enoksaparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB06	nadroparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB07	parnaparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB08	rewiparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB09	danaparoid	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB10	tynazaparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB11	sulodeksyd	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB12	bemiparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AB51	heparyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC	Leki hamujące agregację płytek z wyłączeniem heparyny	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC01	ditazol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC02	klorykromen	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC03	pikotamid	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC04	klopidogrel	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC05	tyklopidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC06	kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC07	dipirydamol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC08	karbazalat wapniowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC09	epoprostenol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC10	indobufen	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC11	iloprost	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC13	abcyksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC15	aloksypryn	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC16	eptyfibatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC17	tyrofiban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC18	triflusal	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC19	beraprost	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC21	treprostynil	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC22	prasugrel	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC23	cylostazol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC24	tykagrelol	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC25	kangrelor	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC26	worapaksar	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC27	seleksypag	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC28	limaprost	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AC56	kwas acetylosalicylowy, połączenia z inhibitorami pompy protonowej	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD	Enzymy	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD01	streptokinaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD02	alteplaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD03	anistreplaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD04	urokinaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD05	fibrynolizyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD06	brinaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD07	reteplaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD08	saruplaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD09	ankrod	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD10	drotrekogina alfa (aktywowana)	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD11	tenekteplaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD12	białko C	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AD13	apadamtaza alfa i cinaksadamtaza alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE	Bezpośrednie inhibitory trombiny	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE01	dezyrudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE02	lepirudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE03	argatroban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE04	melagatran	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE05	ksymelagatran	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE06	biwalirudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AE07	dabigatran eteksylat	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF	Bezpośrednie inhibitory czynnika Xa	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF01	rywaroksaban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF02	apiksaban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF03	edoksaban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF04	betriksaban	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AF51	rywaroksaban i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX	Inne leki przeciwzakrzepowe	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX01	defibrotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX04	dermatanu siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX05	fondaparynuks	WHO Anatomical Therapeutic Chemical classification
0‑L	B01AX07	kaplacyzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	B02	LEKI PRZECIWKRWOTOCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	B02A	LEKI PRZECIWFIBRYNOLITYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA	Aminokwasy	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA01	kwas aminokapro	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA02	kwas traneksamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AA03	kwas aminometylobenzoesowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB	Inhibitory proteinazy	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB01	aprotynina	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB02	alfa1-antytrypsyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB04	kamostat	WHO Anatomical Therapeutic Chemical classification
0‑L	B02AB05	ulinastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B02B	WITAMINA K I INNE LEKI HEMOSTATYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BA	Witamina K	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BA01	fitomenadion	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BA02	menadion	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BB	Fibrynogen	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BB01	fibrynogen, ludzki	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC	Leki hemostatyczne do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC01	gąbka żelatynowa absorbująca	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC02	utleniona celuloza	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC03	ester hydroksymetylowy kwasu tetragalakturonowego	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC05	adrenalon	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC06	trombina	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC07	kolagen	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC08	wapnia alginian	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC09	epinefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BC30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD	Czynniki krzepnięcia krwi	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD01	czynnik krzepnięcia IX, II, VII i X w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD02	czynnik krzepnięcia VIII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD03	zespół czynników krzepnięcia przeciw inhibitorowi czynnika VIII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD04	czynnik krzepnięcia IX	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD05	czynnik krzepnięcia VII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD06	czynnik von Willebranda i czynnik krzepnięcia VIII w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD07	czynnik krzepnięcia XIII	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD08	czynnik krzepnięcia VIIa	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD10	czynnik von Willebranda	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD11	katrydekakog	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD13	czynnik krzepnięcia X	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD14	susoktokog alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD15	waloktokogen roksaparwowek	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD16	etranakogen dezaparwowek	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BD30	trombina	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX	Inne leki hemostatyczne działające ogólnie	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX01	etamsylat	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX02	karbazochrom	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX03	batroksobin	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX04	romiplostym	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX05	eltrombopag	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX06	emicyzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX07	luzutrombopag	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX08	awatrombopag	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX09	fostamatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	B02BX10	koncyzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	B03	LEKI STOSOWANE W NIEDOKRWISTOŚCI	WHO Anatomical Therapeutic Chemical classification
0‑L	B03A	PREPARATY ŻELAZA	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA	Związki żelaza dwuwartościowego, preparaty doustne	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA01	żelaza(II) glicynosiarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA02	żelaza(II) fumaran	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA03	żelaza(II) glukonian	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA04	żelaza(II) węglan	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA05	żelaza(II) chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA06	żelaza(II) bursztynian	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA07	żelaza(II) siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA08	żelaza(II) winian	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA09	żelaza(II) asparaginian	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA10	żelaza(II) askorbinian	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA11	żelaza(II) jodek	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AA12	żelaza(II) sodu cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB	Związki żelaza trójwartościowego, preparaty doustne	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB01	żelaza(III) sodu cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB02	żelaza(III) tlenek z sacharozą	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB03	sodu feredenian	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB04	żelaza(III) wodorotlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB05	kompleksy żelaza(III) tlenku z polimaltozą	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB07	kompleks chondroityny siarczanu i żelaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB08	żelazo(III) z acetylowaną transferyną	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB09	żelaza(III) proteinianobursztynian	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AB10	żelaza(III) maltol	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AC	Żelazo, preparaty pozajelitowe	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD	Żelazo w połączeniu z kwasem foliowym	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD01	kompleks aminokwasów żelaza i kwas foliowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD02	fumaran żelazawy i kwas foliowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD03	siarczan żelazawy i kwas foliowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD04	kompleksy polimaltozy tlenku żelaza i kwas foliowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AD05	glukonian żelazawy i kwas foliowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE	Żelazo w innych połączeniach	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE01	żelazo, witamina B12 i kwas foliowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE02	żelazo, preparaty wielowitaminowe i kwas foliowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE03	żelazo i preparaty wielowitaminowe	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE04	żelazo, preparaty wielowitaminowe i związki mineralne	WHO Anatomical Therapeutic Chemical classification
0‑L	B03AE10	różne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B03B	WITAMINA B12 I KWAS FOLIOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA	Witamina B12 (cyjanokobalamina i analogi)	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA01	cyjanokobalamina	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA02	kompleks cyjanokobalaminy z taniną	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA03	hydroksokobalamina	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA04	kobamamid	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA05	mekobalamina	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA51	cyjanokobalamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BA53	hydroksokobalamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BB	Kwas foliowy i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BB01	kwas foliowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B03BB51	kwas foliowy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B03X	INNE LEKI STOSOWANE W NIEDOKRWISTOŚCI	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA	Inne leki stosowane w niedokrwistości	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA01	erytropoetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA02	darbepoetyna alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA03	glikol metoksypolietyle-epoetyna beta	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA04	peginezatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA05	roksadustat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA06	luspatercept	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA07	daprodustat	WHO Anatomical Therapeutic Chemical classification
0‑L	B03XA08	wadadustat	WHO Anatomical Therapeutic Chemical classification
0‑L	B05	PREPARATY KRWIOZASTĘPCZE I ROZTWORY DO WLEWÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	B05A	KREW I PREPARATY KRWIOPOCHODNE	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA	Preparaty krwiozastępcze i frakcje białkowe osocza	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA01	albumina	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA02	inne frakcje białkowe osocza	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA03	fluorowęglowe substytuty krwi	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA05	dekstran	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA06	preparaty żelatyny	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA07	hydroksyetyloskrobia	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA08	hemoglobiny krosfumaryl	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA09	hemoglobiny rafimer	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AA10	hemoglobiny glutamer (bydlęcy)	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX	Inne produkty krwiopochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX01	erytrocyty	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX02	trombocyty	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX03	osocze krwi	WHO Anatomical Therapeutic Chemical classification
0‑L	B05AX04	komórki macierzyste z krwi pępowinowej	WHO Anatomical Therapeutic Chemical classification
0‑L	B05B	Roztwory do wlewów dożylnych	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA	Roztwory do żywienia pozajelitowego	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA01	aminokwasy	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA02	emulsje tłuszczowe	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA03	węglowodany	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA04	hydrolizaty białkowe	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BA10	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB	Roztwory wpływające na równowagę elektrolitową	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB01	elektrolity	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB02	elektrolity z węglowodanami	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB03	trometamol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BB04	elektrolity w połączeniu z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BC	Roztwory wywołujące diurezę osmotyczną	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BC01	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05BC02	mocznik	WHO Anatomical Therapeutic Chemical classification
0‑L	B05C	ROZTWORY DO IRYGACJI	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA	Leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA01	cetylopirydynium	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA02	chloroheksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA03	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA04	sulfametizol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA05	taurolidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA06	kwas migdałowy	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA07	noksytiolina	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA08	etakrydyny mleczan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA09	neomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CA10	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB	Roztwory soli	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB01	sodu chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB02	sodu cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB03	magnezu cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB04	sodu wodorowęglan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CB10	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX	Inne roztwory do irygacji	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX01	glukoza	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX02	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX03	glicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX04	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05CX10	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B05D	ROZTWORY DO DIALIZY OTRZEWNOWEJ	WHO Anatomical Therapeutic Chemical classification
0‑L	B05DA	Roztwory izotoniczne	WHO Anatomical Therapeutic Chemical classification
0‑L	B05DB	Roztwory hipertoniczne	WHO Anatomical Therapeutic Chemical classification
0‑L	B05X	Dożylne roztwory uzupełniające	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA	roztwory elektrolitów	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA01	potasu chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA02	sodu wodorowęglan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA03	sodu chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA04	amo chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA05	magnezu siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA06	potasu fosforan, włącznie z połączeniami z innymi solami potasu	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA07	wapnia chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA08	sodu octan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA09	sodu fosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA10	magnezu fosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA11	magnezu chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA12	cynku chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA13	kwas solny	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA14	sodu glicerofosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA15	potasu mleczan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA16	roztwory kardioplegiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA17	potasu octan	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA18	siarczan cynku	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA19	glukonian wapnia	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA20	selenit sodu	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA30	połączenia elektrolitów	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XA31	elektrolity w połączeniu z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB	Aminokwasy	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB01	argininy chlorowodorek	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB02	alanyloglutamina	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XB03	lizyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XC	Witaminy	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XX	Inne dożylne roztwory uzupełniające	WHO Anatomical Therapeutic Chemical classification
0‑L	B05XX02	trometamol	WHO Anatomical Therapeutic Chemical classification
0‑L	B05Z	ROZTWORY DO HEMODIALIZY I HEMOFILTRACJI	WHO Anatomical Therapeutic Chemical classification
0‑L	B05ZA	Roztwory do hemodializy, koncentraty	WHO Anatomical Therapeutic Chemical classification
0‑L	B05ZB	Roztwory do hemofiltracji	WHO Anatomical Therapeutic Chemical classification
0‑L	B06	INNE LEKI HEMATOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	B06A	INNE LEKI HEMATOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA	Enzymy	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA02	fibrynolizyna i deoksyrybonukleaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA03	hialuronidaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA04	chymotrypsyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA07	trypsyna	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA10	deoksyrybonukleaza	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AA55	streptokinaza, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AB	Produkty zawierające hem	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AB01	hemina	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC	Leki stosowane w dziedzicznym obrzęku naczynioruchowym	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC01	inhibitor C1, pochodzący z osocza	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC02	ikatybant	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC03	ekalantyd	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC04	konestat alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC05	lanadelumab	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AC06	berotralstat	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AX	Inne czynniki hematologiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AX01	kryzanlizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AX02	betibeglogene autotemcel	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AX03	wokselotor	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AX04	mitapwat	WHO Anatomical Therapeutic Chemical classification
0‑L	B06AX05	autotemcel eksagamglogenu	WHO Anatomical Therapeutic Chemical classification
0‑L	C	UKŁAD SERCOWO-NACZYNIOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	C01	Leki nasercowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C01A	Glikozydy nasercowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA	Glikozydy naparstnicy	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA01	acetylodigitoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA02	acetylodigoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA03	liście naparstnicy	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA04	digitoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA05	digoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA06	lanatozyd C	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA07	deslanozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA08	metylodigoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA09	gitoformat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AA52	acetylodigoksyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AB	Glikozydy cebuli morskiej	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AB01	proscylarydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AB51	proscylarydyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AC	Glikozydy strofantusa	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AC01	strofantyna G	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AC03	cymaryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AX	Inne glikozydy nasercowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C01AX02	peruwozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C01B	LEKI PRZECIWARYTMICZNE, KLASA I i III	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA	Leki przeciwarytmiczne, klasa Ia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA01	chinidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA02	prokainamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA03	dyzopiramid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA04	sparteina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA05	ajmalina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA08	prajmalina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA12	lorajmina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA13	hydrochinidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA51	chinidyna, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BA71	chinidyna, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB	Leki przeciwarytmiczne, klasa Ib	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB01	lidokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB02	meksyletyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB03	tokainid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BB04	apryndyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC	Leki przeciwarytmiczne, klasa Ic	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC03	propafenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC04	flekainid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC07	lorkainid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC08	enkainid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BC09	etacyzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD	Leki przeciwarytmiczne, klasa III	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD01	amiodaron	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD02	bretyliowy tozylan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD03	bunaftyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD04	dofetylid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD05	ibutylid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD06	tedysamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BD07	dronedaron	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG	Inne leki przeciwarytmiczne, klasa I i III	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG01	moracyzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG07	cybenzolina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01BG11	wernakalant	WHO Anatomical Therapeutic Chemical classification
0‑L	C01C	LEKI POBUDZAJĄCE PRACĘ SERCA Z WYŁĄCZENIEM GLIKOZYDÓW NASERCOWYCH	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA	Leki adrenergiczne i dopaminergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA01	etylefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA02	izoprenalina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA03	norepinefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA04	dopamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA05	norfenefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA06	fenylefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA07	dobutamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA08	oksedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA09	metaraminol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA10	metoksamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA11	mefentermina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA12	dimetofryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA13	prenalterol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA14	dopeksamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA15	gepefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA16	ibopamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA17	midodryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA18	oktopamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA19	fenoldopam	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA21	kafedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA22	arbutamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA23	teodrenalina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA24	epinefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA25	amezyniowy metylosiarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA26	efedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA27	droksydopa	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA28	centachina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CA51	etylefryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE	Inhibitory fosfodiesterazy	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE01	amrynon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE02	milrynon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE03	enoksymon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CE04	bukladezyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX	Inne leki pobudzające pracę serca	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX06	angiotensynamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX07	ksamoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX08	lewosymendan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX09	angiotensyna II	WHO Anatomical Therapeutic Chemical classification
0‑L	C01CX10	omekamtyw mekarbyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C01D	LEKI ROZSZERZAJĄCE NACZYNIA STOSOWANE W CHOROBACH SERCA	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA	Organiczne azotany	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA02	glicerolu triazotan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA04	metylopropylopropanodiolu diazotan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA05	pentaerytrytylu tetraazotan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA07	propatyloazotan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA08	izosorbidu diazotan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA09	trolnitrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA13	erytrytylu tetraazotan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA14	izosorbidu monoazotan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA20	organiczne azotany w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA38	tenitramina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA52	glicerolu triazotan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA54	metylopropylopropanodiolu diazotan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA55	pentaerytrytylu tetraazotan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA57	propatyloazotan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA58	izosorbidu diazotan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA59	trolnitrat, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA63	erytrytylu tetraazotan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DA70	organiczne azotany w połączeniu z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DB	Pochodne chinolonu rozszerzające naczynia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DB01	flosechina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX	Inne leki rozszerzające naczynia stosowane w chorobach serca	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX01	itraminy tozylan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX02	prenylamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX03	oksyfedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX04	benzjodaron	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX05	karbokromen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX06	heksobendyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX07	etafenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX08	heptaminol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX09	imolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX10	dilazep	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX11	trapidyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX12	molsydomina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX13	efloksat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX14	cynepazet	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX15	klorydalol	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX16	nikorandyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX18	linsydomina	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX19	nezyrytyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX21	serelaksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX22	werycyguat	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX51	itraminy tozylan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX52	prenylamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX53	oksyfedryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01DX54	benzjodaron, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C01E	INNE LEKI NASERCOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EA	Prostaglandyny	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EA01	alprostadyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB	Inne leki nasercowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB02	kamfora	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB03	indometacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB04	glikozydy głogu	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB05	kreatynolofosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB06	fosfokreatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB07	fruktozo-1,6-bisfosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB09	ubidekarenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB10	adenozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB11	tyracyzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB13	akadezyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB15	trimetazydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB16	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB17	iwabradyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB18	ranolazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB21	regadenozon	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB22	meldonium	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB23	kwas tiazotowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EB24	mawacamten	WHO Anatomical Therapeutic Chemical classification
0‑L	C01EX	Inne połączenia leków nasercowych	WHO Anatomical Therapeutic Chemical classification
0‑L	C02	LEKI PRZECIWNADCIŚNIENIOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	C02A	LEKI PRZECIWADRENERGICZNE O DZIAŁANIU OŚRODKOWYM	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA	Alkaloidy rauwolfii	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA01	rescynamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA02	rezerpina	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA03	połączenia alkaloidów rauwolfii	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA04	alkaloidy rauwolfii, korzeń	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA05	dezerpidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA06	metozerpidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA07	bietazerpina	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA52	rezerpina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA53	połączenia alkaloidów rauwolfii, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AA57	bietazerpina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AB	Metylodopa	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AB01	metylodopa (lewoskrętna)	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AB02	metylodopa (racemiczna)	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC	Agoniści receptora imidazolowego	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC01	klonidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC02	guanfacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC04	tolonidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC05	moksonidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02AC06	rylmenidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02B	LEKI PRZECIWADRENERGICZNE BLOKUJĄCE ZWOJE NERWOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BA	Pochodne sulfoniowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BA01	trimetafan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BB	Aminy drugo- i trzeciorzędowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BB01	mekamylamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C02BC	Bis-czwartorzędowe związki amoniowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C02C	LEKI PRZECIWADRENERGICZNE O DZIAŁANIU OBWODOWYM	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA	Antagoniści receptora alfa-adrenergicznego	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA01	prazosyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA02	indoramina	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA03	trimazosyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA04	doksazosyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CA06	urapidyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC	Pochodne guanidyny	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC01	betanidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC02	guanetydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC03	guanoksan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC04	debryzochina	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC05	guanoklor	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC06	guanazodyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02CC07	guanoksabenz	WHO Anatomical Therapeutic Chemical classification
0‑L	C02D	LEKI DZIAŁAJĄCE NA MIĘŚNIE GŁADKIE TĘTNICZEK	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DA	Pochodne tiazydowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DA01	diazoksyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB	Pochodne hydrazynoftalazyny	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB01	dihydralazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB02	hydralazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB03	endralazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DB04	kadralazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DC	Pochodne pirymidyny	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DC01	minoksydyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DD	Pochodne nitroprusydku	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DD01	nitroprusydek	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DG	Pochodne guanidyny	WHO Anatomical Therapeutic Chemical classification
0‑L	C02DG01	pinacydyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C02K	INNE LEKI PRZECIWNADCIŚNIENIOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KA	Alkaloidy, z wyłączeniem alkaloidów rauwolfii	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KA01	ciemiężyca	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KB	Inhibitory hydroksylazy tyrozynowej	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KB01	metyrozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KC	Inhibitory MAO	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KC01	pargilina	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KD	Antagoniści serotoniny	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KD01	ketanseryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KN	Inne leki antyhipertensyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KN01	aprocytentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX	Leki przeciwnadciśnieniowe stosowane w tętniczym nadciśnieniu płucnym	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX01	bozentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX02	ambryzentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX03	sytaksentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX04	macitentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX05	riocyguat	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX52	ambryzentan i tadalafil	WHO Anatomical Therapeutic Chemical classification
0‑L	C02KX54	macytentan i tadalafil	WHO Anatomical Therapeutic Chemical classification
0‑L	C02L	LEKI PRZECIWNADCIŚNIENIOWE I DIURETYKI W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA	Alkaloidy rauwolfii i diuretyki w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA01	rezerpina i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA02	rescynamina i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA03	dezerpidyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA04	metozerpidyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA07	bietazerpina i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA08	alkaloidy rauwolfii i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA09	syrosyngopina i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA50	połączenie alkaloidów rauwolfii i diuretyków włącznie z innymi połączeniami	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA51	rezerpina i diuretyki, połączenia z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA52	rescynamina i diuretyki, połączenia z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LA71	rezerpina i diuretyki, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LB	Metylodopa i diuretyki w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LB01	metylodopa (lewoskrętna) i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC	Agoniści receptora imidazolowego w połączeniu z diuretykami	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC01	klonidyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC05	moksonidyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LC51	klonidyna i diuretyki, połączenia z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LE	Antagoniści receptora alfa-adrenergicznego i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LE01	prazosyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LF	Pochodne guanidyny i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LF01	guanetydyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG	Pochodne hydrazynoftalazyny i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG01	dihydralazyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG02	hydralazyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG03	pikodralazyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG51	dihydralazyna i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LG73	pikodralazyna i diuretyki, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LK	Alkaloidy, z wyłączeniem alkaloidów rauwolfii, w połączeniach z diuretykami	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LK01	ciemiężyca i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LL	inhibitory MAO i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LL01	pargilina i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LN	Antagoniści serotoniny i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LX	Inne leki przeciwnadciśnieniowe i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02LX01	pinacydyl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C02N	POŁĄCZENIA LEKÓW PRZECIWNADCIŚNIENIOWYCH Z GRUPY ATC C02	WHO Anatomical Therapeutic Chemical classification
0‑L	C03	DIURETYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	C03A	DIURETYKI O UMIARKOWANYM DZIAŁANIU, TIAZYDY	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA	Tiazydy, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA01	bendroflumetiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA02	hydroflumetiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA03	hydrochlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA04	chlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA05	politiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA06	trichlorometiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA07	cyklopentiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA08	metyklotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA09	cyklotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AA13	mebutyzyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB	Tiazydy i potas w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB01	bendroflumetiazyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB02	hydroflumetiazyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB03	hydrochlorotiazyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB04	chlorotiazyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB05	politiazyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB06	trichlorometiazyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB07	cyklopentiazyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB08	metyklotiazyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AB09	cyklotiazyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AH	Tiazydy, połączenia z psycholeptykami i/lub z lekami przeciwbólowymi	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AH01	chlorotiazyd, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AH02	hydroflumetiazyd, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AX	Tiazydy, połączenia z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	C03AX01	hydrochlorotiazyd, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C03B	DIURETYKI O UMIARKOWANYM DZIAŁANIU, Z WYŁĄCZENIEM TIAZYDÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA	Sulfonamidy, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA02	kwinetazon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA03	klopamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA04	chlorotalidon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA05	mefruzyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA07	klofenamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA08	metolazon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA09	metykran	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA10	ksypamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA11	indapamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA12	kloreksolon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA13	fenkwizon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BA82	kloreksolon, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB	Sulfonamidy i potas w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB02	kwinetazon i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB03	klopamid i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB04	chlortalidon i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB05	mefruzyd i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BB07	klofenamid i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BC	Diuretyki zawierające rtęć	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BC01	mersalil	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BD	Pochodne ksantyny	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BD01	teobromina	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BK	Sulfonamidy, połączenia z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BX	Inne diuretyki o umiarkowanym działaniu	WHO Anatomical Therapeutic Chemical classification
0‑L	C03BX03	cykletanina	WHO Anatomical Therapeutic Chemical classification
0‑L	C03C	DIURETYKI O SILNYM DZIAŁANIU	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA	Sulfonamidy, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA01	furosemid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA02	bumetanid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA03	piretanid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CA04	torasemid	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CB	Sulfonamidy i potas w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CB01	furosemid i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CB02	bumetanid i potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CC	pochodne kwasu aryloksyoctowego	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CC01	kwas etakry	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CC02	kwas tienylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CD	Pochodne pirazolonu	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CD01	muzolimina	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CX	Inne diuretyki o silnym działaniu	WHO Anatomical Therapeutic Chemical classification
0‑L	C03CX01	etozolina	WHO Anatomical Therapeutic Chemical classification
0‑L	C03D	ANTAGONIŚCI ALDOSTERONU I INNE DIURETYKI OSZCZĘDZAJĄCE POTAS	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA	Antagoniści aldosteronu	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA01	spironolakton	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA02	potasu kanrenoinian	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA03	kanrenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA04	eplerenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DA05	finerenon	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DB	Inne diuretyki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DB01	amiloryd	WHO Anatomical Therapeutic Chemical classification
0‑L	C03DB02	triamteren	WHO Anatomical Therapeutic Chemical classification
0‑L	C03E	DIURETYKI I LEKI OSZCZĘDZAJĄCE POTAS W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA	Diuretyki o umiarkowanym działaniu i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA01	hydrochlorotiazyd i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA02	trichlorometiazyd i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA03	epityzyd i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA04	altyzyd i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA05	mebutyzyd i leki oszczędzjące potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA06	chlortalidon i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA07	cyklopentiazyd i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA12	metolazon i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA13	bendroflumetiazyd i związki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EA14	butyzyd i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EB	Diuretyki o silnym działaniu i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EB01	furosemid i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03EB02	bumetanid i leki oszczędzające potas	WHO Anatomical Therapeutic Chemical classification
0‑L	C03X	INNE DIURETYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	C03XA	Inhibitory wazopresyny	WHO Anatomical Therapeutic Chemical classification
0‑L	C03XA01	tolwaptan	WHO Anatomical Therapeutic Chemical classification
0‑L	C03XA02	koniwaptan	WHO Anatomical Therapeutic Chemical classification
0‑L	C04	LEKI ROZSZERZAJĄCE NACZYNIA OBWODOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	C04A	LEKI ROZSZERZAJĄCE NACZYNIA OBWODOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA	Pochodne 2-amino-1-fenyloetanolu	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA01	izoksupryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA02	bufenina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AA31	bametan	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AB	Pochodne imidazoliny	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AB01	fentolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AB02	tolazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC	Kwas nikoty i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC01	kwas nikoty	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC02	alkohol nikotynylowy (pirydylokarbinol)	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC03	nikotynian inozytolu	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AC07	cyklonikat	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD	Pochodne puryny	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD01	pentyfilina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD02	nikotynian ksantynolu	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD03	pentoksyfilina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AD04	nikotynian etofiliny	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE	Alkaloidy sporyszu	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE01	ergoloidu mezylany	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE02	nicergolina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE04	dihydroergokrystyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE51	ergoloidu mezylany, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AE54	dihydroergokrystyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AF	Enzymy	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AF01	kalidynogenaza	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX	Inne leki rozszerzające naczynia obwodowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX01	cyklandelat	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX02	fenoksybenzamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX07	winkamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX10	moksysylit	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX11	bencyklan	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX17	winburnina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX19	suloktydyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX20	buflomedil	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX21	naftydrofuryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX23	butalamina	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX24	wisnadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX26	cetiedyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX27	cynepazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX28	ifenprodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX30	azapetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX32	fasudyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C04AX33	klazosentan	WHO Anatomical Therapeutic Chemical classification
0‑L	C05	LEKI DZIAŁAJĄCE OSŁANIAJĄCO NA NACZYNIA KRWIONOŚNE	WHO Anatomical Therapeutic Chemical classification
0‑L	C05A	LEKI STOSOWANE W LECZENIU HEMOROIDÓW I SZCZELINY ODBYTU DO STOSOWANIA MIEJSCOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA	Kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA01	hydrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA04	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA05	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA06	fluorometolon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA08	fluokortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA09	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA10	fluocynolonu acetonid	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA11	fluocynonid	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AA12	triamcynolon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AB	Antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD	Leki miejscowo znieczulające	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD01	lidokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD02	tetrakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD03	benzokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD04	cynchokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD05	prokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD06	oksetakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AD07	pramokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AE	Leki zmniejszające napięcie mięśni	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AE01	glicerolu triazotan	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AE02	izosorbidu diazotan	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AE03	diltiazem	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX	Inne leki stosowane w leczeniu hemoroidów i szczeliny odbytu do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX01	preparaty glinu	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX02	preparaty bizmutu, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX03	inne preparaty, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX04	preparaty cynku	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX05	tribenozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C05AX06	fenylefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	C05B	LEKI STOSOWANE W LECZENIU ŻYLAKÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA	Heparyna lub heparynoidy do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA01	organo-heparynoid	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA02	sodu apolan	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA03	heparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA04	sodu pentozanu polisiarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA51	heparynoid, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BA53	heparyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB	Leki obliterujące naczynia do wstrzykiwań domiejscowych	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB01	monoetanoloaminy oleinian	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB02	polidokanol	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB03	cukier inwertowany	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB04	sodu tetradecylu siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB05	fenol	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BB56	glukoza, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BX	Inne leki obliterujące naczynia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BX01	wapnia dobezylan	WHO Anatomical Therapeutic Chemical classification
0‑L	C05BX51	wapnia dobezylan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05C	LEKI WZMACNIAJĄCE NACZYNIA WŁOSOWATE	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA	Bioflawonoidy	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA01	rutozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA02	monokserutyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA03	diosmina	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA04	trokserutyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA05	hidrosmina	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA51	rutozyd, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA53	diosmina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CA54	trokserutyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX	Inne leki wzmacniające naczynia włosowate	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX01	tribenozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX02	naftazon	WHO Anatomical Therapeutic Chemical classification
0‑L	C05CX03	nasienie kasztanowca	WHO Anatomical Therapeutic Chemical classification
0‑L	C05X	INNE ŚRODKI WAZOPROTEKCYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	C05XX	Inne środki wazoprotekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	C05XX01	beperminogen perplazmid	WHO Anatomical Therapeutic Chemical classification
0‑L	C07	BETA-ADRENOLITYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	C07A	BETA-ADRENOLITYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA	Beta-adrenolityki, nieselektywne	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA01	alprenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA02	oksprenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA03	pindolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA05	propranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA06	tymolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA07	sotalol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA12	nadolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA14	mepindolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA15	karteolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA16	tertatolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA17	bopindolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA19	bupranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA23	penbutolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AA27	kloranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB	Beta-adrenolityki, selektywne	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB01	praktolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB02	metoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB03	atenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB04	acebutolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB05	betaksolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB06	bewantolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB07	bisoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB08	celiprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB09	esmolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB10	epanolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB11	esatenolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB12	nebiwolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB13	talinolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AB14	landiolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AG	Alfa- i beta-adrenolityki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AG01	labetalol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07AG02	karwedylol	WHO Anatomical Therapeutic Chemical classification
0‑L	C07B	BETA-ADRENOLITYKI I TIAZYDY	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA	Beta-adrenolityki nieselektywne i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA02	oksprenolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA05	propranolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA06	tymolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA07	sotalol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA12	nadolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BA68	metypranolol i tiazydy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB	Beta-adrenolityki selektywne i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB02	metoprolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB03	atenolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB04	acebutolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB06	bewantolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB07	bisoprolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB12	nebiwolol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BB52	metoprolol i tiazydy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BG	Alfa- i beta-adrenolityki i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07BG01	labetalol i tiazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07C	BETA-ADRENOLITYKI I INNE DIURETYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA	Beta-adrenolityki nieselektywne i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA02	oksprenolol i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA03	pindolol i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA17	bopindolol i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CA23	penbutolol i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB	Beta-adrenolityki selektywne i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB02	metoprolol i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB03	atenolol i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CB53	atenolol i inne diuretyki, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CG	Alfa- i beta-adrenolityki i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07CG01	labetalol i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07D	BETA-ADRENOLITYKI, TIAZYDY I INNE DIURETYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DA	Beta-adrenolityki nieselektywne, tiazydy i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DA06	tymolol, tiazydy i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DB	Beta-adrenolityki selektywne, tiazydy i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07DB01	atenolol, tiazydy i inne diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C07E	BETA-ADRENOLITYKI I LEKI ROZSZERZAJĄCE NACZYNIA OBWODOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	C07EA	Beta-adrenolityki nieselektywne i leki rozszerzajace naczynia obwodowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C07EB	Beta-adrenolityki selektywne i leki rozszerzajace naczynia obwodowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C07F	BETA-ADRENOLITYKI, INNE POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB	Beta-adrenolityki i blokery kanału wapniowego	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB02	metoprolol i felodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB03	atenolol i nifedypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB07	bisoprolol i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB12	nebiwolol i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FB13	metoprolol i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX	Beta-adrenolityki, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX01	propranolol i inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX02	sotalol i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX03	metoprolol i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX04	bisoprolol i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX05	metoprolol i iwabradyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C07FX06	karwedylol i iwabradyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C08	BLOKERY KANAŁU WAPNIOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	C08C	SELEKTYWNE BLOKERY KANAŁU WAPNIOWEGO O DOMINUJĄCYM DZIAŁANIU NACZYNIOWYM	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA	Pochodne dihydropirydyny	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA01	amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA02	felodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA03	izradypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA04	nikardypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA05	nifedypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA06	nimodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA07	nizoldypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA08	nitrendypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA09	lacydypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA10	nilwadypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA11	manidypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA12	barnidypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA13	lerkanidypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA14	cylnidypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA15	benidypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA16	klewidypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA17	lewamlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA51	amlodypina i celekoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CA55	nifedypina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CX	Inne selektywne blokery kanału wapniowego o dominującym działaniu naczyniowym	WHO Anatomical Therapeutic Chemical classification
0‑L	C08CX01	mibefradyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C08D	SELEKTYWNE BLOKERY KANAŁU WAPNIOWEGO O BEZPOŚREDNIM DZIAŁANIU NASERCOWYM	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA	Pochodne fenyloalkiloaminy	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA01	werapamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA02	gallopamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DA51	werapamil, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DB	Pochodne benzotiazepiny	WHO Anatomical Therapeutic Chemical classification
0‑L	C08DB01	diltiazem	WHO Anatomical Therapeutic Chemical classification
0‑L	C08E	NIESELEKTYWNE BLOKERY KANAŁU WAPNIOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EA	Pochodne fenyloalkiloaminy	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EA01	fendylina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EA02	beprydyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EX	Inne nieselektywne blokery kanału wapniowego	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EX01	lidoflazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C08EX02	perheksylina	WHO Anatomical Therapeutic Chemical classification
0‑L	C08G	BLOKERY KANAŁU WAPNIOWEGO I DIURETYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	C08GA	Blokery kanału wapniowego i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C08GA01	nifedypina i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C08GA02	amlodypina i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09	LEKI DZIAŁAJĄCE NA UKŁAD RENINA-ANGIOTENSYNA	WHO Anatomical Therapeutic Chemical classification
0‑L	C09A	INHIBITORY KONWERTAZY ANGIOTENSYNY (ACE), BEZ DODATKÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA	Inhibitory konwertazy angiotensyny (ACE), bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA01	kaptopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA02	enalapryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA03	lizynopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA04	peryndopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA05	ramipryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA06	chinapryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA07	benazepryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA08	cylazapryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA09	fozynopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA10	trandolapryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA11	spirapryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA12	delapryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA13	moeksypryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA14	temokapryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA15	zofenopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09AA16	imidapryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09B	INHIBITORY KONWERTAZY ANGIOTENSYNY (ACE), POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA	Inhibitory konwertazy angiotensyny (ACE) i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA01	kaptopryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA02	enalapryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA03	lizynopryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA04	peryndopryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA05	ramipryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA06	chinapryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA07	benazepryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA08	cylazapryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA09	fozynopryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA12	delapryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA13	moeksypryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BA15	zofenopryl i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB	INHIBITORY KONWERTAZY ANGIOTENSYNY (ACE) I BLOKERY KANAŁU WAPNIOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB02	enalapryl i lerkanidypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB03	lizynopryl i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB04	peryndopryl i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB05	ramipryl i felodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB06	enalapryl i nitrendypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB07	ramipryl i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB10	trandolapryl i werapamil	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB12	delapryl i manidypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BB13	benazepryl i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX	Inhibitory konwertazy angiotensyny (ACE), inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX01	peryndopryl, amlodypina i indapamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX02	peryndopryl i bisoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX03	ramipryl, amlodypina i hydrochlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX04	peryndopryl, bisoprolol i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX05	ramipryl i bisoprolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX06	peryndopryl, bisoprolol, amlodypina i indapamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C09BX07	zofenopril i nebiwolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C09C	ANTAGONIŚCI RECEPTORA ANGIOTENSYNY II, BEZ DODATKÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA	Antagoniści receptora angiotensyny II, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA01	losartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA02	eprosartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA03	walsartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA04	irbesartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA05	tazosartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA06	kandesartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA07	telmisartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA08	olmesartan medoksomil	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA09	azylsartan medoksomil	WHO Anatomical Therapeutic Chemical classification
0‑L	C09CA10	fimasartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C09D	ANTAGONIŚCI RECEPTORA ANGIOTENSYNY II, POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA	Antagoniści receptora angiotensyny II i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA01	losartan i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA02	eprosartan i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA03	walsartan i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA04	irbesartan i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA06	kandesartan i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA07	temisartan i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA08	olmesartan i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA09	azylsartan i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DA10	fimasartan i diuretyki	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB	Antagoniści receptora angiotensyny II i blokery kanału wapniowego	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB01	walsartan i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB02	olmesartan i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB04	telmisartan i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB05	irbesartan i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB06	losartan i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB07	kandesartan i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB08	walsartan i lerkanidypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DB09	fimasartan i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX	Antagoniści receptora angiotensyny II, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX01	walsartan, amlodypina i hydrochlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX02	walsartan i aliskiren	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX03	olmesartan, amlodypina i hydrochlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX04	walsartan i sakubitryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX05	walsartan i nebiwolol	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX06	kandesartan, amlodypina i hydrochlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX07	irbesartan, amlodypina i hydrochlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C09DX08	telmisartan, amlodypina i hydrochlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C09X	INNE LEKI DZIAŁAJĄCE NA UKŁAD RENINA-ANGIOTENSYNA	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA	Inhibitory reniny	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA01	remikiren	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA02	aliskiren	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA52	aliskiren i hydrochlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA53	aliskiren i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C09XA54	aliskiren, amlodypina i hydrochlorotiazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	C10	LEKI ZMNIEJSZAJĄCE STĘŻENIE LIPIDÓW W SUROWICY	WHO Anatomical Therapeutic Chemical classification
0‑L	C10A	LEKI ZMNIEJSZAJĄCE STĘŻENIE LIPIDÓW W SUROWICY, BEZ DODATKÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA	Inhibitory reduktazy HMG-CoA	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA01	symwastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA02	lowastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA03	prawastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA04	fluwastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA05	atorwastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA06	ceriwastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA07	rozuwastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AA08	pitawastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB	Fibraty	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB01	klofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB02	bezafibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB03	glinu klofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB04	gemfibrozyl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB05	fenofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB06	symfibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB07	ronifibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB08	cyprofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB09	etofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB10	klofibryd	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB11	fenofibrat choliny	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AB12	pemafibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC	Leki wiążące kwasy żółciowe	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC01	kolestyramina	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC02	kolestypol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC03	kolekstran	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AC04	kolesewelam	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD	Kwas nikoty i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD01	nicerytrol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD02	kwas nikoty	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD03	nikofuranoza	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD04	glinu nikotynian	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD05	alkohol nikotynylowy (pirydylokarbinol)	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD06	acypimoks	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AD52	kwas nikoty, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX	Inne leki zmniejszające stężenie lipidów w surowicy	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX01	dekstrotyroksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX02	probukol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX03	tiadenol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX05	meglutol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX06	triglicerydy omega-3 włącznie z innymi estrami i kwasami	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX07	magnezu pirydoksalu 5-fosforanu glutaminian	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX08	polikozanol	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX09	ezetymib	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX10	alipogen typarwowek	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX11	mipomersen	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX12	lomitapid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX13	ewolokumab	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX14	alirokumab	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX15	kwas bempediowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX16	inklisiran	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX17	ewinakumab	WHO Anatomical Therapeutic Chemical classification
0‑L	C10AX18	wolanesorsen	WHO Anatomical Therapeutic Chemical classification
0‑L	C10B	LEKI ZMNIEJSZAJĄCE STĘŻENIE LIPIDÓW W SUROWICY, POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA	Połaczenia różnych leków zmniejszających stężenie lipidów w surowicy	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA01	lowastatyna i kwas nikoty	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA02	symwastatyna i ezetymib	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA03	prawastatyna i fenofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA04	symwastatyna i fenofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA05	atorwastatyna i ezetymib	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA06	rozuwastatyna i ezetymib	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA07	rosuwastatyna i kwasy tłuszczowe omega-3	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA08	atorwastatyna i kwasy tłuszczowe omega-3	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA09	rozuwastatyna i fenofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA10	kwas bempediowy i ezetymib	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA11	prawastatyna i ezetymib	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BA12	prawastatyna, ezetymib i fenofibrat	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX	Leki zmniejszające stężenie lipidów w surowicy w połączeniu z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX01	symwastatyna i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX02	prawastatyna i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX03	atorwastatyna i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX04	symwastatyna, kwas acetylosalicylowy i ramipryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX05	rozuwastatyna i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX06	atorwastatyna, kwas acetylosalicylowy i ramipryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX07	rozuwastatyna, amlodypina i lizynopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX08	atorwastatyna i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX09	rozuwastatyna i amlodypina	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX10	rozuwastatyna i walsartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX11	atorwastatyna, amlodypina i peryndopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX12	atorwastatyna, kwas acetylosalicylowy i peryndopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX13	rozuwastatyna, peryndopryl i indapamid	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX14	rozuwastatyna, amlodypina i peryndopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX15	atorwastatyna i peryndopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX16	rozuwastatyna i fimasartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX17	rozuwastatyna i ramipryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX18	atorwastatyna, amlodypina i ramipryl	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX19	atorwastatyna, amlodypina i kandesartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX20	rozuwastatyna i telmisartan	WHO Anatomical Therapeutic Chemical classification
0‑L	C10BX21	rosuwastatyna i peryndopryl	WHO Anatomical Therapeutic Chemical classification
0‑L	D	LEKI STOSOWANE W DERMATOLOGII	WHO Anatomical Therapeutic Chemical classification
0‑L	D01	LEKI PRZECIWGRZYBICZE STOSOWANE W DERMATOLOGII	WHO Anatomical Therapeutic Chemical classification
0‑L	D01A	LEKI PRZECIWGRZYBICZE DO STOSOWANIA MIEJSCOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA	Antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA01	nystatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA02	natamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA03	hachimycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA04	pecylocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA06	mepartrycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA07	pirolnitryna	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA08	gryzeofulwina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AA20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC	Pochodne imidazolu i triazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC01	klotrymazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC02	mikonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC03	ekonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC04	chlormidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC05	izokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC06	tiabendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC07	tiokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC08	ketokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC09	sulkonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC10	bifonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC11	oksykonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC12	fentykonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC13	omokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC14	sertakonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC15	flukonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC16	flutrimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC17	eberkonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC18	lulikonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC19	efinakonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC20	imidazole/triazole w połączeniu z kortykosteroidami	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC21	netikonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC22	lanokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC52	mikonazol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AC60	bifonazol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE	Inne leki przeciwgrzybicze do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE01	bromochlorosalicylanilid	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE02	metylorozanilina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE03	tribromometakrezol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE04	kwas undecyle	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE05	polinoksylina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE06	2-(4-chlorofenoksy)etanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE07	chlorofenezyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE08	tyklaton	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE09	sulbentyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE10	etylu hydroksybenzoesan	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE11	haloprogina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE12	kwas salicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE13	selenu siarczek	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE14	cyklopiroks	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE15	terbinafina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE16	amorolfina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE17	dimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE18	tolnaftat	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE19	tolcyklat	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE21	flucytozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE22	naftyfina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE23	butenafina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE24	tawaborol	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE25	liranaftat	WHO Anatomical Therapeutic Chemical classification
0‑L	D01AE54	kwas undecyle, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D01B	LEKI PRZECIWGRZYBICZE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA	Leki przeciwgrzybicze do stosowania ogólnego	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA01	gryzeofulwina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA02	terbinafina	WHO Anatomical Therapeutic Chemical classification
0‑L	D01BA03	fosrawukonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D02	LEKI KERATOLITYCZNE I OSŁANIAJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	D02A	LEKI KERATOLITYCZNE I OSŁANIAJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AA	Preparaty silikonowe	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AB	Preparaty cynku	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AC	Preparaty zawierające wazelinę i tłuszcze	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AD	Plastry w płynie	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AE	Preparaty zawierające mocznik	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AE01	mocznik	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AE51	mocznik, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AF	Preparaty zawierające kwas salicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	D02AX	Inne leki keratolityczne i osłaniające	WHO Anatomical Therapeutic Chemical classification
0‑L	D02B	LEKI OSŁANIAJĄCE PRZED PROMIENIOWANIEM UV	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BA	Leki osłaniające przed promieniowaniem UV do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BA01	kwas aminobenzoesowy	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BA02	oktynoksat	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BB	Preparaty osłaniające przed promieniowaniem UV do stosowania ogólnego	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BB01	betakaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	D02BB02	afamelanotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	D03	PREPARATY DO LECZENIA RAN I OWRZODZEŃ	WHO Anatomical Therapeutic Chemical classification
0‑L	D03A	LEKI ZABLIŹNIAJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AA	Maści zawierające tran z wątroby dorsza	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX	Inne leki zabliźniające	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX01	kadeksomer z jodem	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX02	dekstranomer	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX03	deksopantenol	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX04	wapnia pantotenian	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX05	kwas hialuro	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX06	bekaplermina	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX09	krylanomer	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX10	enoksolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX11	sodu chloryn	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX12	trolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX13	kora brzozy	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX14	Centella asiatica herba, w tym kombinacje	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX15	trafermin	WHO Anatomical Therapeutic Chemical classification
0‑L	D03AX16	beremagen geperpawek	WHO Anatomical Therapeutic Chemical classification
0‑L	D03B	ENZYMY	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA	Enzymy proteolityczne	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA01	trypsyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA02	kolagenaza	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA03	bromelainy	WHO Anatomical Therapeutic Chemical classification
0‑L	D03BA52	kolagenaza, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D04	LEKI PRZECIWŚWIĄDOWE WŁĄCZNIE Z PRZECIWHISTAMIMI, ZNIECZULAJĄCYMI ITP.	WHO Anatomical Therapeutic Chemical classification
0‑L	D04A	LEKI PRZECIWŚWIĄDOWE WŁĄCZNIE Z PRZECIWHISTAMIMI, ZNIECZULAJĄCYMI ITP.	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA	Leki przeciwhistaminowe do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA01	tonzylamina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA02	mepiramina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA03	tenalidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA04	tripelenamina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA09	chloropiramina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA10	prometazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA12	tolpropamina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA13	dimetynden	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA14	klemastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA15	bamipina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA16	feniramina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA22	izotypendil	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA32	difenhydramina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA33	difenhydraminy metylobromek	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AA34	chlorfenoksamina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB	Leki znieczulające do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB01	lidokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB02	cynchokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB03	oksybuprokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB04	benzokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB05	kwinizokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB06	tetrakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AB07	pramokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AX	Inne leki przeciwświądowe	WHO Anatomical Therapeutic Chemical classification
0‑L	D04AX01	doksepina	WHO Anatomical Therapeutic Chemical classification
0‑L	D05	LEKI PRZECIWŁUSZCZYCOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	D05A	LEKI PRZECIWŁUSZCZYCOWE DO STOSOWANIA MIEJSCOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AA	Preparaty dziegciowe	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AC	Pochodne antracenu	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AC01	ditranol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AC51	ditranol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AD	Psoraleny do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AD01	trioksysalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AD02	metoksalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX	Inne leki przeciwłuszczycowe do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX01	kwas fumarowy	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX02	kalcypotriol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX03	kalcytriol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX04	takalcytol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX05	tazaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX06	roflumilast	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX07	tapinarof	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX52	kalcypotriol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D05AX55	tazaroten i ulobetasol	WHO Anatomical Therapeutic Chemical classification
0‑L	D05B	LEKI PRZECIWŁUSZCZYCOWE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA	Psoraleny do stosowania ogólnego	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA01	trioksysalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA02	metoksalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BA03	bergapten	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BB	Retynoidy o działaniu przeciwłuszczycowym	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BB01	etretynat	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BB02	acytretyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BX	Inne leki przeciwłuszczycowe do stosowania ogólnego	WHO Anatomical Therapeutic Chemical classification
0‑L	D05BX51	pochodne kwasu fumarowego, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D06	ANTYBIOTYKI I CHEMIOTERAPEUTYKI STOSOWANE W DERMATOLOGII	WHO Anatomical Therapeutic Chemical classification
0‑L	D06A	ANTYBIOTYKI DO STOSOWANIA MIEJSCOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA	Tetracyklina i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA01	demeklocyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA02	chlorotetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA03	oksytetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AA04	tetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX	Inne antybiotyki do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX01	kwas fusydowy	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX02	chloramfenikol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX04	neomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX05	bacytracyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX07	gentamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX08	tyrotrycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX09	mupirocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX10	wirginiamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX11	ryfaksymina	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX12	amikacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX13	retapamulina	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX14	ozenoksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06AX15	ryfamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06B	CHEMIOTERAPEUTYKI DO STOSOWANIA MIEJSCOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA	Sulfonamidy	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA01	sulfadiazyna srebrowa	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA02	sulfatiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA03	mafenid	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA04	sulfametyzol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA05	sulfanilamid	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA06	sulfamerazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BA51	sulfadiazyna srebrowa, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB	Leki przeciwwirusowe	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB01	idoksurydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB02	tromantadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB03	acyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB04	podofilotoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB05	inozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB06	pencyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB07	lizozym	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB08	ibacytabina	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB09	edoksudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB10	imikwimod	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB11	dokozanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB12	sinekatechiny	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BB53	acyklowir, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX	Inne chemioterapeutyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX01	metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX02	ingenolu mebutynian	WHO Anatomical Therapeutic Chemical classification
0‑L	D06BX03	tyrbanibulina	WHO Anatomical Therapeutic Chemical classification
0‑L	D06C	ANTYBIOTYKI I CHEMIOTERAPEUTYKI, POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	D07	KORTYKOSTEROIDY, LEKI DERMATOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	D07A	KORTYKOSTEROIDY, BEZ DODATKÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA	Kortykosteroidy o słabym działaniu (grupa I)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA01	metyloprednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA02	hydrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AA03	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB	Kortykosteroidy o umiarkowanie silnym działaniu (grupa II)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB01	klobetazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB02	hydrokortyzonu maślan	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB03	flumetazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB04	fluokortyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB05	fluperolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB06	fluorometolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB07	flupredniden	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB08	dezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB09	triamcynolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB10	alklometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB11	hydrokortyzonu butepran	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB19	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB21	klokortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AB30	połączenia kortykosteroidów	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC	Kortykosteroidy o silnym działaniu (grupa III)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC01	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC02	flukrolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC03	dezoksymetazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC04	fluocynolonu acetonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC05	fluokortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC06	diflukortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC07	fludroksykortyd	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC08	fluocynonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC09	budezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC10	diflorazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC11	amcynonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC12	halometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC13	mometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC14	metyloprednizolonu aceponian	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC15	beklometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC16	hydrokortyzonu aceponian	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC17	flutykazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC18	prednikarbat	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC19	difluprednat	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AC21	ulobetazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AD	Kortykosteroidy o bardzo silnym działaniu (grupa IV)	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AD01	klobetazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D07AD02	halcynonid	WHO Anatomical Therapeutic Chemical classification
0‑L	D07B	KORTYKOSTEROIDY, POŁĄCZENIA Z ANTYSEPTYKAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BA	Kortykosteroidy o słabym działaniu, połączenia z antyseptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BA01	prednizolon i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BA04	hydrokortyzon i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB	Kortykosteroidy o umiarkowanie silnym działaniu, połączenia z antyseptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB01	flumetazon i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB02	dezonid i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB03	triamcynolon i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BB04	hydrokortyzonu maślan i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC	Kortykosteroidy o silnym działaniu, połączenia z antyseptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC01	betametazon i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC02	fluocynolonu acetonid i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC03	fluokortolon i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BC04	diflukortolon i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07BD	Kortykosteroidy o bardzo silnym działaniu, połączenia z antyseptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	D07C	KORTYKOSTERIDY, POŁĄCZENIA Z ANTYBIOTYKAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA	kortykosteroidy o słabym działaniu, połączenia z antybiotykami	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA01	hydrokortyzon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA02	metyloprednizolon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CA03	prednizolon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB	Kortykosteroidy o umiarkowanie silnym działaniu, połączenia z antybiotykami	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB01	triamcynolon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB02	flupredniden i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB03	fluorometolon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB04	deksametazon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CB05	flumetazon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC	Kortykosteroidy o silnym działaniu, połączenia z antybiotykami	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC01	betametazon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC02	fluocynolonu acetonid i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC03	fludroksykortyd i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC04	beklometazon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC05	fluocynonid i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CC06	fluokortolon i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CD	Kortykosteroidy o bardzo silnym działaniu, połączenia z antybiotykami	WHO Anatomical Therapeutic Chemical classification
0‑L	D07CD01	klobetazol i antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	D07X	KORTYKOSTEROIDY, INNE POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XA	Kortykosteroidy o słabym działaniu, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XA01	hydrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XA02	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB	Kortykosteroidy o umiarkowanie silnym działaniu, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB01	flumetazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB02	triamcynolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB03	flupredniden	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB04	fluorometolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB05	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XB30	połączenia kortykosteroidów	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC	Kortykosteroidy o silnym działaniu, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC01	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC02	dezoksymetazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC03	mometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC04	diflukortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XC05	fluokortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D07XD	Kortykosteroidy o bardzo silnym działaniu, inne połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D08	ANTYSEPTYKI I PREPARATY DEZYNFEKUJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	D08A	ANTYSEPTYKI I PREPARATY DEZYNFEKUJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA	Pochodne akrydyny	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA01	etakrydyny mleczan	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA02	aminoakrydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AA03	euflawina	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AB	Związki glinu	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC	Biguanidy i amidyny	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC01	dibromopropamidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC02	chloroheksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC03	propamidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC04	heksamidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC05	poliheksanid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AC52	chloroheksydyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AD	Kwasu borowego produkty	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE	Fenol i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE01	heksachlorofen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE02	polikrezulen	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE03	fenol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE04	triklosan	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE05	chloroksylenol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AE06	bifenylol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AF	Pochodne nitrofuranu	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AF01	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG	Związki zawierające jod	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG01	jod/eter oktylofenoksypoliglikolowy	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG02	powidon jodowany	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG03	jod	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AG04	dijodohydroksypropan	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH	Pochodne chinoliny	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH01	dekwalinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH02	chlorchinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH03	oksychinolina	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AH30	kliochinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ	Czwartorzędowe związki amoniowe	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ01	benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ02	cetrymonium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ03	cetylopirydynium	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ04	cetrymid	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ05	benzoksoniowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ06	didecylodimetyloamoniowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ08	benzetoniowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ10	dekametoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ57	oktenidyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ58	benzetoniowy chlorek, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AJ59	dodekloniowy bromek, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK	Związki zawierające rtęć	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK01	rtęci(II) amidochlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK02	fenylortęci(II) boran	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK03	rtęci(II) chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK04	merbromina	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK05	rtęć metaliczna	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK06	tiomersal	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AK30	rtęci (II) jodek	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AL	Związki srebra	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AL01	srebra azotan	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AL30	srebro	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX	Inne antyseptyki i preparaty dezynfekujące	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX01	wodoru nadtlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX02	eozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX03	propanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX04	tozylochloramid sodowy	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX05	izopropanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX06	potasu nadmanganian	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX07	sodu podchloryn	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX08	Etanol	WHO Anatomical Therapeutic Chemical classification
0‑L	D08AX53	propanol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D09	OPATRUNKI LECZNICZE	WHO Anatomical Therapeutic Chemical classification
0‑L	D09A	OPATRUNKI LECZNICZE	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA	Opatrunki z lekami przeciwinfekcyjnymi	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA01	framycetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA02	kwas fusydy	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA03	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA04	fenylortęci (II) azotan	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA05	benzododecynium	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA06	triklosan	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA07	cetylopirydinium	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA08	glinu chlorowodorotlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA09	powidon jodowany	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA10	kliochinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA11	benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA12	chloroheksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AA13	jodoform	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AB	Opatrunki cynkowe	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AB01	Opatrunki cynkowe bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AB02	Opatrunki cynkowe z dodatkami	WHO Anatomical Therapeutic Chemical classification
0‑L	D09AX	Opatrunki z wazeliną	WHO Anatomical Therapeutic Chemical classification
0‑L	D10	LEKI PRZECIWTRĄDZIKOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	D10A	LEKI PRZECIWTRĄDZIKOWE DO STOSOWANIA MIEJSCOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA	Kortykosteroidy, połączenia stosowane w leczeniu trądziku	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA01	fluorometolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA02	metyloprednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AA03	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB	Preparaty zawierające siarkę	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB01	bitionol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB02	siarka	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB03	tioksolon	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AB05	mesulfen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD	Retynoidy do stosowania miejscowego w trądziku	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD01	tretynoina	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD02	retinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD03	adapalen	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD04	izotretynoina	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD05	motretynid	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD06	trifaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD51	tretynoina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD53	adapalen, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AD54	izotretynoina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AE	Nadtlenki	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AE01	benzoilu nadtlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AE51	benzoilu nadtlenek, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF	Leki przeciwinfekcyjne stosowane w trądziku	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF01	klindamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF02	erytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF03	chloramfenikol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF04	meklocyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF05	nadifloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF06	sulfacetamid	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF07	minocyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF51	klindamycyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AF52	erytromycyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX	Inne leki przeciwtrądzikowe do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX01	glinu chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX02	rezorcynol	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX03	kwas azelai	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX04	glinu tlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX05	dapson	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX06	klaskoteron	WHO Anatomical Therapeutic Chemical classification
0‑L	D10AX30	różne kombinacje	WHO Anatomical Therapeutic Chemical classification
0‑L	D10B	LEKI PRZECIWTRĄDZIKOWE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BA	Retynoidy stosowane w trądziku	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BA01	izotretynoina	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BX	Inne leki przeciwtrądzikowe do stosowania ogólnego	WHO Anatomical Therapeutic Chemical classification
0‑L	D10BX01	ichtazol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11	INNE LEKI DERMATOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	D11A	INNE LEKI DERMATOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AA	Leki hamujące pocenie	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AA01	glikopironium	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC	Szampony lecznicze	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC01	cetrymid	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC02	związki kadmu	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC03	związki selenu	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC06	powidon jodowany	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC08	związki siarki	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC09	ksenysalat	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AC30	inne	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AE	Androgeny do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AE01	metandienon	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AF	Preparaty przeciw brodawkom i odciskom	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH	Leki stosowane w leczeniu zapalenia skóry, z wyłączeniem kortykosteroidów	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH01	takrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH02	pimekrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH03	kwas kromoglika	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH04	alitretynoina	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH05	dupilumab	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH06	krysaborol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH07	tralokinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH08	abrocytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH09	ruksolitynib	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH10	lebrikizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH11	delgocytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AH12	nemolizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX	Inne leki dermatologiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX01	minoksydyl	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX02	kwas gamole	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX03	wapnia glukonian	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX04	litu bursztynian	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX05	magnezu siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX06	mechinol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX08	tyratrikol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX09	oksaceprol	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX10	finasteryd	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX11	hydrochinon	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX12	cynku pirytionian	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX13	monobenzon	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX16	eflornityna	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX18	diklofenak	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX21	brymonidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX22	iwermektyna	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX23	potasu aminobenzoesan	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX24	kwas deoksycholowy	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX25	wodoru nadtlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX26	kofeina	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX27	oksymetazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX52	kwas gamole, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	D11AX57	kolagen, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G	UKŁAD MOCZOWO-PŁCIOWY I HORMONY PŁCIOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	G01	LEKI PRZECIWINFEKCYJNE I ANTYSEPTYKI STOSOWANE W GINEKOLOGII	WHO Anatomical Therapeutic Chemical classification
0‑L	G01A	LEKI PRZECIWINFEKCYJNE I ANTYSEPTYKI, Z WYŁĄCZENIEM POŁĄCZEŃ Z KORTYKOSTEROIDAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA	Antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA01	nystatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA02	natamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA03	amfoterycyna B	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA04	kandycydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA05	chloramfenikol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA06	hachimycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA07	oksytetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA08	karfecylina	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA09	mepartrycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA10	klindamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA11	pentamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AA51	nystatyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AB	Związki arsenu	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AB01	acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC	Pochodne chinoliny	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC01	dijodohydroksychinolina	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC02	kliochinol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC03	chlorchinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC05	dekwalinium	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC06	broksychinolina	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AC30	oksychinolina	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD	Kwasy organiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD01	kwas mlekowy	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD02	kwas octowy	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AD03	kwas askorbowy	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AE	Sulfonamidy	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AE01	sulfatolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AE10	połączenia sulfonamidów	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF	Pochodne imidazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF01	metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF02	klotrymazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF04	mikonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF05	ekonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF06	ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF07	izokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF08	tiokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF11	ketokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF12	fentikonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF13	azanidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF14	propenidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF15	butokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF16	omokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF17	oksykonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF18	flutrimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF19	sertakonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF20	połączenia pochodnych imidazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF21	tinidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AF55	ekonazol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AG	Pochodne triazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AG02	terkonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX	Inne leki przeciwinfekcyjne i antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX01	klodantoina	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX02	inozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX03	polikrezulen	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX05	nifuratel	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX06	furazolidon	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX09	metylorozanilina	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX11	powidon jodowany	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX12	cyklopiroks	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX13	protiofat	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX14	lactobacillus	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX15	miedzi usninian	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX16	heksetydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX17	dapiwiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	G01AX66	oktenidyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G01B	LEKI PRZECIWINFEKCYJNE I ANTYSEPTYKI W POŁĄCZENIU Z KORTYKOSTEROIDAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BA	Antybiotyki i kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BC	Pochodne chinoliny i kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BD	Antyseptyki i kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BE	Sulfonamidy i kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	G01BF	Pochodne imidazolu i kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	G02	INNE LEKI STOSOWANE W GINEKOLOGII	WHO Anatomical Therapeutic Chemical classification
0‑L	G02A	LEKI PRZYSPIESZAJĄCE PORÓD	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB	Alkaloidy sporyszu	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB01	metyloergometryna	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB02	alkaloidy sporyszu	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AB03	ergometryna	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AC	Alkaloidy sporyszu i oksytocyna włącznie z analogami, w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AC01	metyloergometryna i oksytocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD	Prostaglandyny	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD01	dinoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD02	dinoproston	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD03	gemeprost	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD04	karboprost	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD05	sulproston	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AD06	mizoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	G02AX	Inne leki przyspieszające poród	WHO Anatomical Therapeutic Chemical classification
0‑L	G02B	ŚRODKI ANTYKONCEPCYJNE DO STOSOWANIA MIEJSCOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA	Środki antykoncepcyjne domaciczne	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA01	wkładka domaciczna	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA02	wkładka domaciczna zawierająca miedź	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BA03	wkładka domaciczna z progestagenem	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BB	Dopochwowe środki antykoncepcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BB01	pierścień dopochwowy z progestagenem i estrogenem	WHO Anatomical Therapeutic Chemical classification
0‑L	G02BB02	pierścień dopochwowy z progestagenem	WHO Anatomical Therapeutic Chemical classification
0‑L	G02C	INNE LEKI STOSOWANE W GINEKOLOGII	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA	Sympatykomimetyki hamujące poród	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA01	rytodryna	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA02	bufenina	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CA03	fenoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB	Inhibitory prolaktyny	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB01	bromokryptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB02	lizuryd	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB03	kabergolina	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB04	chinagolid	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB05	metergolina	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CB06	terguryd	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC	Dopochwowe leki przeciwzapalne	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC01	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC02	naproksen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC03	benzydamina	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CC04	flunoksaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX	Inne leki stosowane w ginekologii	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX01	atozyban	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX02	flibanseryna	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX03	owoc niepokalanka pospolitego	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX04	kłącze pluskwicy groniastej	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX05	bremelanotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	G02CX06	fezolinetant	WHO Anatomical Therapeutic Chemical classification
0‑L	G03	HORMONY PŁCIOWE I MODULATORY UKŁADU PŁCIOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	G03A	HORMONALNE ŚRODKI ANTYKONCEPCYJNE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA	Progestageny i estrogeny, stałe połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA01	etynodiol i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA02	chingestanol i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA03	linestrenol i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA04	megestrol i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA05	noretysteron i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA06	norgestrel i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA07	lewonorgestrel i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA08	medroksyprogesteron i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA09	dezogestrel i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA10	gestoden i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA11	norgestymat i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA12	drospirenon i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA13	norelgestromin i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA14	nomegestrol i estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA15	chlormadynon i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA16	dienogest i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA17	medroksyprogesteron i estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AA18	drospirenon i estetrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB	Progestageny i estrogeny, preparaty sekwencyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB01	megestrol i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB02	linestrenol i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB03	lewonorgestrel i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB04	noretysteron i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB05	dezogestrel i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB06	gestoden i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB07	chlormadynon i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB08	dienogest i estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AB09	norgestymat i etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC	Progestageny	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC01	noretysteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC02	linestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC03	lewonorgestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC04	chingestanol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC05	megestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC06	medroksyprogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC07	norgestrienon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC08	etonogestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC09	dezogestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AC10	drospirenon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AD	Preparaty stosowane w antykoncepcji postkoitalnej	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AD01	lewonorgestrel	WHO Anatomical Therapeutic Chemical classification
0‑L	G03AD02	uliprystal	WHO Anatomical Therapeutic Chemical classification
0‑L	G03B	ANDROGENY	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA	pochodne 3-oksoandrostenu (4)	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA01	fluoksymesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA02	metylotestosteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BA03	testosteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BB	pochodne 5-androstanonu (3)	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BB01	mesterolon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03BB02	androstanolon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03C	ESTROGENY	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA	Estrogeny naturalne i półsyntetyczne, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA01	etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA03	estradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA04	estriol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA06	chlorotrianizen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA07	estron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA09	promestrien	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA53	estradiol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CA57	estrogeny skoniugowane	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB	Estrogeny syntetyczne, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB01	dienestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB02	dietylostylbestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB03	metalenestryl	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CB04	moksestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC	Estrogeny, połączenia z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC02	dienestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC03	metalenestryl	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC04	estron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC05	dietylostylbestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC06	estriol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CC07	estrogeny skoniugowane i bazedoksyfen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CX	Inne estrogeny	WHO Anatomical Therapeutic Chemical classification
0‑L	G03CX01	tybolon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03D	PROGESTAGENY	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA	Pochodne pregnenu (4)	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA01	gestonoron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA02	medroksyprogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA03	hydroksyprogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DA04	progesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB	Pochodne pregnadienu	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB01	dydrogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB02	megestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB03	medrogeston	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB04	nomegestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB05	demegeston	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB06	chlormadynon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB07	promegeston	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DB08	dienogest	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC	Pochodne estrenu	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC01	allilestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC02	noretysteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC03	linestrenol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC04	etysteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC06	etynodiol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03DC31	metyloestrenolon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03E	ANDROGENY I ŻEŃSKIE HORMONY PŁCIOWE W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA	Androgeny i estrogeny	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA01	metylotestosteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA02	testosteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EA03	prasteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EB	Androgen, progestagen i estrogen w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EK	Androgeny i żeńskie hormony płciowe w połączeniu z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	G03EK01	metylotestosteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03F	PROGESTAGENY I ESTROGENY W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA	Progestageny i estrogeny, stałe połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA01	noretysteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA02	hydroksyprogesteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA03	etysteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA04	progesteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA05	metylonortestosteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA06	etynodiol i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA07	linestrenol i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA08	megestrol i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA09	noretynodrel i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA10	norgestrel i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA11	lewonorgestrel i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA12	medroksyprogesteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA13	norgestymat i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA14	dydrogesteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA15	dienogest i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA16	trimegeston i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FA17	drospirenon i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB	Progestageny i estrogeny, preparaty sekwencyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB01	norgestrel i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB02	linestrenol i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB03	chlormadynon i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB04	megestrol i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB05	noretysteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB06	medroksyprogesteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB07	medrogeston i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB08	dydrogesteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB09	lewonorgestrel i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB10	dezogestrel i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB11	trimegeston i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03FB12	nomegestrol i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03G	GONADOTROPINY I INNE LEKI POBUDZAJĄCE OWULACJĘ	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA	Gonadotropiny	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA01	gonadotropina kosmówkowa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA02	gonadotropina ludzka menopauzalna	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA03	gonadotropina surowicy	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA04	urofolitropina	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA05	folitropina alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA06	folitropina beta	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA07	lutropina alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA08	choriogonadotropina alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA09	koryfolitropina alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA10	folitropina delta	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GA30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB	Leki pobudzjące owulację, syntetyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB01	cyklofenil	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB02	klomifen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03GB03	epimestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03H	ANTYANDROGENY	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HA	Antyandrogeny, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HA01	cyproteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HB	Antyandrogeny i estrogeny	WHO Anatomical Therapeutic Chemical classification
0‑L	G03HB01	cyproteron i estrogen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03X	INNE HORMONY PŁCIOWE I MODULATORY UKŁADU PŁCIOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XA	Antygonadotropiny i związki podobne	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XA01	danazol	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XA02	gestrinon	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB	Modulatory receptora progesteronowego	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB01	mifepryston	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB02	uliprystal	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XB51	mifepryston, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC	Selektywne modulatory receptora estrogenowego	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC01	raloksyfen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC02	bazedoksyfen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC03	lazofoksyfen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC04	ormeloksyfen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XC05	ospemifen	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XX	Inne hormony płciowe i modulatory układu płciowego	WHO Anatomical Therapeutic Chemical classification
0‑L	G03XX01	prasteron	WHO Anatomical Therapeutic Chemical classification
0‑L	G04	LEKI UROLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	G04B	LEKI UROLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BA	Leki zakwaszające	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BA01	amo chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BA03	wapnia chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BC	Leki rozpuszczające złogi	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD	Leki stosowane w częstomoczu i w nietrzymaniu moczu	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD01	emepronium	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD02	flawoksat	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD03	meladrazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD04	oksybutynina	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD05	terodylina	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD06	propiweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD07	tolterodyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD08	solifenacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD09	trospium	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD10	daryfenacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD11	fezoterodyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD12	mirabegron	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD13	desfezoterodyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD14	imidafenacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BD15	wibegron	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE	Leki stosowane w zaburzeniach erekcji	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE01	alprostadyl	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE02	papaweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE03	syldenafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE04	johimbina	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE06	moksysylit	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE07	apomorfina	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE08	tadalafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE09	wardenafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE10	awanafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE11	udenafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BE52	papaweryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX	Inne leki urologiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX01	magnezu wodorotlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX03	kwas acetohydroksamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX06	fenazopirydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX10	sukcynimid	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX11	kolagen	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX12	fenylu salicylan	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX13	dimetylosulfotlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX14	dapoksetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX15	sodu pentozanu polisiarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX16	tiopronina	WHO Anatomical Therapeutic Chemical classification
0‑L	G04BX17	salicylan sodu i metenamina	WHO Anatomical Therapeutic Chemical classification
0‑L	G04C	LEKI STOSOWANE W ŁAGODNYM ROZROŚCIE GRUCZOŁU KROKOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA	Antagoniści receptora alfa-adrenergicznego	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA01	alfuzosyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA02	tamsulosyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA03	terazosyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA04	sylodosyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA51	alfuzosyna i finasteryd	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA52	tamsulosyna i dutasteryd	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA53	tamsulosyna i solifenacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA54	tamsulozyna i tadalafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CA55	doksazosyna i finasteryd	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB	Inhibitory 5-alfa reduktazy testosteronu	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB01	finasteryd	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB02	dutasteryd	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CB51	finasteryd i tadalafil	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX	Inne leki stosowane w łagodnym rozroście gruczołu krokowego	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX01	Kora śliwy afrykańskiej	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX02	Owoc palmy sabal	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX03	mepartrycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	G04CX04	feksapotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H	LEKI HORMONALNE DO STOSOWANIA OGÓLNEGO, Z WYŁĄCZENIEM HORMONÓW PŁCIOWYCH I INSULIN	WHO Anatomical Therapeutic Chemical classification
0‑L	H01	HORMONY PRZYSADKI I PODWZGÓRZA I ANALOGI	WHO Anatomical Therapeutic Chemical classification
0‑L	H01A	HORMONY PRZEDNIEGO PŁATA PRZYSADKI I ANALOGI	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AA	ACTH (Adrenokortykotropina)	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AA01	kortykotropina	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AA02	tetrakozaktyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AB	Tyreotropina	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AB01	tyreotropina alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC	Somatropina i agoniści somatropiny	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC01	somatropina	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC02	somatrem	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC03	mekasermina	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC04	sermorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC05	rinfabat mekaserminy	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC06	tesamorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC07	somapacytan	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC08	somatrogon	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AC09	lonapegsomatropina	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AX	Inne hormony przedniego płata przysadki i analogów	WHO Anatomical Therapeutic Chemical classification
0‑L	H01AX01	pegwisomant	WHO Anatomical Therapeutic Chemical classification
0‑L	H01B	HORMONY TYLNEGO PŁATA PRZYSADKI	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA	Wazopresyna i analogi	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA01	wazopresyna (argipresyna)	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA02	desmopresyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA03	lipresyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA04	terlipresyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BA05	ornipresyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB	Oksytocyna i analogi	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB01	demoksytocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB02	oksytocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H01BB03	karbetocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H01C	HORMONY PODWZGÓRZA	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA	Hormony uwalniające gonadotropinę	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA01	gonadorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CA02	nafarelina	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB	Somatostatyna i analogi	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB01	somatostatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB02	oktreotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB03	lanreotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB04	wapreotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CB05	pasyreotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC	Hormony uwalniające antygonadotropinę	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC01	ganireliks	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC02	cetroreliks	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC03	elagoliks	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC04	linzagoliks	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC53	elagoliks, estradiol i noretysteron	WHO Anatomical Therapeutic Chemical classification
0‑L	H01CC54	relugoliks, estradiol i noretysteron	WHO Anatomical Therapeutic Chemical classification
0‑L	H02	KORTYKOSTEROIDY DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	H02A	KORTYKOSTEROIDY DO STOSOWANIA OGÓLNEGO, BEZ DODATKÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA	Mineralokortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA01	aldosteron	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA02	fludrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AA03	dezoksykorton	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB	Glikokortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB01	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB02	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB03	fluokortolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB04	metyloprednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB05	parametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB06	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB07	prednizon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB08	triamcynolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB09	hydrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB10	kortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB11	prednyliden	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB12	rymeksolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB13	deflazakort	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB14	kloprednol	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB15	meprednizon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB17	kortywazol	WHO Anatomical Therapeutic Chemical classification
0‑L	H02AB18	wamorolon	WHO Anatomical Therapeutic Chemical classification
0‑L	H02B	KORTYKOSTEROIDY DO STOSOWANIA OGÓLNEGO, POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	H02BX	Kortykosteroidy do stosowania ogólnego, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	H02BX01	metyloprednizolon, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	H02C	LEKI PRZECIWNADNERCZOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA	Antykortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA01	trilostan	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA02	osylodrostat	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA03	ketokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	H02CA04	lewoketokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	H03	LEKI STOSOWANE W CHOROBACH TARCZYCY	WHO Anatomical Therapeutic Chemical classification
0‑L	H03A	LEKI ZAWIERAJĄCE HORMONY TARCZYCY	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA	Hormony tarczycy	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA01	lewotyroksyna sodowa	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA02	liotyronina sodowa	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA03	połączenia lewotyroksyny i liotyroniny	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA04	tyratrykol	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA05	preparaty gruczołu tarczycowego	WHO Anatomical Therapeutic Chemical classification
0‑L	H03AA51	sól sodowa lewotyroksyny i związki jodu	WHO Anatomical Therapeutic Chemical classification
0‑L	H03B	LEKI PRZECIWTARCZYCOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA	Tiouracyle	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA01	metylotiouracyl	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA02	propylotiouracyl	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BA03	benzylotiouracyl	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB	Pochodne imidazolu zawierające siarkę	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB01	karbimazol	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB02	tiamazol	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BB52	tiamazol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BC	Nadchlorany	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BC01	potasu nadchloran	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BX	Inne leki przeciwtarczycowe	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BX01	dijodotyrozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H03BX02	dibromotyrozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	H03C	LECZENIE JODEM	WHO Anatomical Therapeutic Chemical classification
0‑L	H03CA	Leczenie jodem	WHO Anatomical Therapeutic Chemical classification
0‑L	H04	HORMONY TRZUSTKI	WHO Anatomical Therapeutic Chemical classification
0‑L	H04A	HORMONY GLIKOGENOLITYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	H04AA	Hormony glikogenolityczne	WHO Anatomical Therapeutic Chemical classification
0‑L	H04AA01	glukagon	WHO Anatomical Therapeutic Chemical classification
0‑L	H04AA02	dasiglukagon	WHO Anatomical Therapeutic Chemical classification
0‑L	H05	LEKI WPŁYWAJĄCE NA HOMEOSTAZĘ WAPNIA	WHO Anatomical Therapeutic Chemical classification
0‑L	H05A	HORMONY PRZYTARCZYC I ANALOGI	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA	Hormony przytarczyc i analogi	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA01	wyciąg z gruczołów przytarczycznych	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA02	teryparatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA03	hormon przytarczycowy	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA04	abaloparatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H05AA05	palopegteryparatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H05B	HORMONY PRZECIWPRZYTARCZYCOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA	Preparaty kalcytoniny	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA01	kalcytonina łososiowa syntetyczna	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA02	kalcytonina wieprzowa naturalna	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA03	kalcytonina ludzka syntetyczna	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BA04	elkatonina	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX	Inne hormony przeciwprzytarczycowe	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX01	cynakalcet	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX02	parykalcytol	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX03	dokserkalcyferol	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX04	etelkalcetyd	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX05	kalcyfediol	WHO Anatomical Therapeutic Chemical classification
0‑L	H05BX06	ewokalcet	WHO Anatomical Therapeutic Chemical classification
0‑L	J	LEKI PRZECIWINFEKCYJNE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	J01	LEKI PRZECIWBAKTERYJNE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	J01A	TETRACYKLINY	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA	Tetracykliny	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA01	demeklocyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA02	doksycyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA03	chlorotetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA04	limecyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA05	metacyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA06	oksytetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA07	tetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA08	minocyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA09	rolitetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA10	penimepicyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA11	klomocyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA12	tygecyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA13	erawacyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA14	sarecyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA15	omadacyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA20	połączenia tetracyklin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01AA56	oksytetracyklina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01B	AMFENIKOLE	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA	Amfenikole	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA01	chloramfenikol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA02	tiamfenikol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01BA52	tiamfenikol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01C	BETA-LAKTAMOWE LEKI PRZECIWBAKTERYJNE, PENICYLINY	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA	Penicyliny o szerokim spektrum działania	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA01	ampicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA02	piwampicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA03	karbenicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA04	amoksycylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA05	karindacylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA06	bakampicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA07	epicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA08	piwmecylinam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA09	azlocylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA10	mezlocylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA11	mecylinam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA12	piperacylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA13	tykarcylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA14	metampicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA15	talampicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA16	sulbenicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA17	temocylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA18	hetacylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA19	aspoksycylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CA51	ampicylina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE	Penicyliny wrażliwe na beta-laktamazę	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE01	benzylopenicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE02	fenoksymetylopenicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE03	propycylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE04	azydocylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE05	fenetycylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE06	penamecylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE07	klometocylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE08	benzylopenicylina benzatynowa	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE09	benzylopenicylina prokainowa	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE10	fenoksymetylopenicylina benzatynowa	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CE30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF	Penicyliny oporne na beta-laktamazę	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF01	dikloksacylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF02	kloksacylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF03	metycylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF04	oksacylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF05	flukloksacylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CF06	nafcylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CG	Inhibitory beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CG01	sulbaktam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CG02	tazobaktam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR	Połączenia penicylin, włącznie z inhibitorami beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR01	ampicylina i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR02	amoksycylina i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR03	tykarcylina i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR04	sultamycylina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR05	piperacylina i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01CR50	połączenia penicylin	WHO Anatomical Therapeutic Chemical classification
0‑L	J01D	INNE BETA-LAKTAMOWE LEKI PRZECIWBAKTERYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB	Cefalosporyny I generacji	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB01	cefaleksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB02	cefalorydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB03	cefalotyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB04	cefazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB05	cefadroksyl	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB06	cefazedon	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB07	cefatryzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB08	cefapiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB09	cefradyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB10	cefacetryl	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB11	cefroksadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DB12	ceftezol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC	Cefalosporyny II generacji	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC01	cefoksytyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC02	cefuroksym	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC03	cefamandol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC04	cefaklor	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC05	cefotetan	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC06	cefonicyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC07	cefotiam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC08	lorakarbef	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC09	cefmetazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC10	cefprozyl	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC11	ceforanid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC12	cefminoks	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC13	cefbuperazon	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC14	flomoksef	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DC52	cefuroksym i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD	Cefalosporyny III generacji	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD01	cefotaksym	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD02	ceftazydym	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD03	cefsulodyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD04	ceftriakson	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD05	cefmenoksym	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD06	latamoksef	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD07	ceftyzoksym	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD08	cefiksym	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD09	cefodyzym	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD10	cefetamet	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD11	cefpiramid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD12	cefoperazon	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD13	cefpodoksym	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD14	ceftibuten	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD15	cefdynir	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD16	cefditoren	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD17	cefkapen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD18	cefteram	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD51	cefotaksym i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD52	ceftazydym i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD54	ceftriakson, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD58	cefiksym i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD62	cefoperazon i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD63	ceftriakson i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DD64	cefpodoksym i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE	Cefalosporyny IV generacji	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE01	cefepim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE02	cefpirom	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE03	cefozopran	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DE51	cefepim i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DF	Monobaktamy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DF01	aztreonam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DF02	karumonam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH	Karbapenemy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH02	meropenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH03	ertapenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH04	doripenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH05	biapenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH06	tebipenem piwoksyl	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH51	imipenem i cylastatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH52	meropenem i waborbaktam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH55	panipenem i betamipron	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DH56	imipenem, cylastatyna i relebaktam	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI	Inne cefalosporyny i penemy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI01	ceftobiprol medokaril	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI02	ceftarolina fosamil	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI03	faropenem	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI04	cefiderokol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01DI54	ceftolozan i inhibitor beta-laktamazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01E	SULFONAMIDY I TRIMETOPRIM	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA	Trimetoprim i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA01	trimetoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA02	bromidoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EA03	iklaprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB	Sulfonamidy krótko działające	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB01	sulfaizodymidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB02	sulfametyzol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB03	sulfadymidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB04	sulfapirydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB05	sulfafurazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB06	sulfanilamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB07	sulfatiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB08	sulfatiomocznik	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EB20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC	Sulfonamidy o średnim czasie działania	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC01	sulfametoksazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC02	sulfadiazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC03	sulfamoksol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EC20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED	Sulfonamidy długo działające	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED01	sulfadimetoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED02	sulfalen	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED03	sulfametomidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED04	sulfametoksydiazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED05	sulfametoksypirydazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED06	sulfaperyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED07	sulfamerazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED08	sulfafenazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED09	sulfamazon	WHO Anatomical Therapeutic Chemical classification
0‑L	J01ED20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE	Połączenia sulfonamidów i trimetoprimu, włącznie z pochodnymi	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE01	sulfametoksazol i trimetoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE02	sulfadiazyna i trimetoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE03	sulfametrol i trimetoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE04	sulfamoksol i trimetoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE05	sulfadymidyna i trimetoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE06	sulfadiazyna i tetroksoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01EE07	sulfamerazyna i trimetoprim	WHO Anatomical Therapeutic Chemical classification
0‑L	J01F	MAKROLIDY, LINKOZAMIDY I STREPTOGRAMINY	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA	Makrolidy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA01	erytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA02	spiramycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA03	midekamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA05	oleandomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA06	roksytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA07	jozamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA08	troleandomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA09	klarytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA10	azytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA11	miokamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA12	rokitamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA13	dirytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA14	flurytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA15	telitromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FA16	solitromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FF	Linkozamidy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FF01	klindamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FF02	linkomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FG	Streptograminy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FG01	prystynamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01FG02	chinuprystyna/dalfoprystyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01G	AMINOGLIKOZYDY	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GA	Streptomycyny	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GA01	streptomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GA02	streptoduocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB	Inne aminoglikozydy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB01	tobramycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB03	gentamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB04	kanamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB05	neomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB06	amikacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB07	netylmycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB08	sysomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB09	dibekacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB10	rybostamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB11	izepamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB12	arbekacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB13	bekanamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01GB14	plazomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01M	CHINOLONY	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA	Fluorochinolony	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA01	ofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA02	cyprofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA03	pefloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA04	enoksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA05	temafloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA06	norfloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA07	lomefloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA08	fleroksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA09	sparfloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA10	rufloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA11	grepafloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA12	lewofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA13	trowafloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA14	moksyfloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA15	gemifloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA16	gatifloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA17	prulifloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA18	pazufloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA19	garenoksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA21	sytafloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA22	tozufloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA23	delafloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA24	lewonadifloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MA25	laskufloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB	Inne chinolony	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB01	rozoksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB02	kwas nalidyksowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB03	kwas piromidowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB04	kwas pipemidowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB05	kwas oksoli	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB06	cynoksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB07	flumechina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01MB08	nemonoksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01R	POŁĄCZENIA LEKÓW PRZECIWBAKTERYJNYCH	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA	Połączenia leków przeciwbakteryjnych	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA01	penicyliny, połączenia z innymi lekami przeciwbakteryjnymi	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA02	sulfonamidy, połączenia z innymi lekami przeciwbakteryjnymi (z wyłączeniem trimetoprimu)	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA03	cefuroksym i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA04	spiramycyna i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA05	lewofloksacyna i ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA06	cefepim i amikacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA07	azytromycyna, flukonazol i seknidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA08	tetracyklina i oleandomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA09	ofloksacyna i ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA10	cyprofloksacyna i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA11	cyprofloksacyna i tynidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA12	cyprofloksacyna i ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA13	norfloksacyna i tynidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA14	norfloksacyna i metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA15	cefiksym i ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01RA16	cefyksym i azytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01X	INNE LEKI PRZECIWBAKTERYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA	Glikopeptydy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA01	wankomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA02	teikoplanina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA03	telawancyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA04	dalbawancyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XA05	orytawancyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XB	Polimyksyny	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XB01	kolistyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XB02	polimyksyna B	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XC	Steroidowe leki przeciwbakteryjne	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XC01	kwas fusydy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD	Pochodne imidazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD01	metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD02	tynidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XD03	ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE	Pochodne nitrofuranu	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE01	nitrofurantoina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE02	nifurtoinol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE03	furazydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XE51	nitrofurantoina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX	Inne leki przeciwbakteryjne	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX01	fosfomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX02	ksybornol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX03	klofoktol	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX04	spektynomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX05	metenamina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX06	kwas migdałowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX07	nitroksolina	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX08	linezolid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX09	daptomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX10	bacytracyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX11	tedyzolid	WHO Anatomical Therapeutic Chemical classification
0‑L	J01XX12	lefamulina	WHO Anatomical Therapeutic Chemical classification
0‑L	J02	LEKI PRZECIWGRZYBICZE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	J02A	LEKI PRZECIWGRZYBICZE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AA	Antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AA01	amfoterycyna B	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AA02	hachimycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AB	Pochodne imidazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AB01	mikonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AB02	ketokonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC	Pochodne triazolu i tetrazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC01	flukonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC02	itrakonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC03	worykonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC04	posakonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC05	izawukonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AC06	otesekonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX	Inne leki przeciwgrzybicze do stosowania ogólnego	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX01	flucytozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX04	kaspofungina	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX05	mykafungina	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX06	anidulafungina	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX07	ibreksafungerp	WHO Anatomical Therapeutic Chemical classification
0‑L	J02AX08	octan rezafunginy	WHO Anatomical Therapeutic Chemical classification
0‑L	J04	Leki przeciwprątkowe	WHO Anatomical Therapeutic Chemical classification
0‑L	J04A	Leki stosowane w leczeniu gruźlicy	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA	Kwas aminosalicylowy i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA01	kwas 4-aminosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA02	sodu aminosalicylan	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AA03	wapnia aminosalicylan	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB	Antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB01	cykloseryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB02	ryfampicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB03	ryfamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB04	ryfabutyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB05	ryfapentyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB06	enwiomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AB30	kapreomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AC	Hydrazydy	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AC01	izoniazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AC51	izoniazyd, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD	Pochodne tiomocznika	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD01	protionamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD02	tiokarlid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AD03	etionamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK	Inne leki stosowane w leczeniu gruźlicy	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK01	pirazynamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK02	etambutol	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK03	teryzydon	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK04	morynamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK05	bedakilina	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK06	delamanid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK07	tioacetazon	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AK08	pretomanid	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM	Leki stosowane w leczeniu gruźlicy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM01	streptomycyna i izoniazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM02	ryfampicyna i izoniazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM03	etambutol i izoniazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM04	tioacetazon i izoniazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM05	ryfampicyna, pirazynamid i izoniazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM06	ryfampicyna, pirazynamid, etambutol i izoniazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM07	ryfampicyna, etambutol i izoniazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J04AM08	izoniazyd, sulfametoksazol, trimetoprim i pirydoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J04B	LEKI STOSOWANE W LECZENIU TRĄDU	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA	Leki stosowane w leczeniu trądu	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA01	klofazymina	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA02	dapson	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA03	aldesulfon sodowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA50	dapson i ryfampicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J04BA51	dapson, ryfampicyna i klofazymina	WHO Anatomical Therapeutic Chemical classification
0‑L	J05	LEKI PRZECIWWIRUSOWE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	J05A	LEKI O BEZPOŚREDNIM DZIAŁANIU PRZECIWWIRUSOWYM	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AA	Tiosemikarbazony	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AA01	metysazon	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB	Nukleozydy i nukleotydy z wyłączeniem inhibitorów odwrotnej transkryptazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB01	acyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB02	idoksurydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB03	widarabina	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB06	gancyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB09	famcyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB11	walacyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB12	cydofowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB13	pencyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB14	walgancyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB15	brywudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB16	remdesiwir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB17	brincydofowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AB18	molnupirawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AC	Cykliczne aminy	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AC02	rymantadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AC03	tromantadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AD	Pochodne kwasu fosfonowego	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AD01	foskarnet	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AD02	fosfonet	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE	Inhibitory proteazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE01	sakwinawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE02	indynawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE03	rytonawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE04	nelfinawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE05	amprenawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE07	fozamprenawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE08	atazanawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE09	typranawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE10	darunawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE16	enzytrelwir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AE30	nirmatrelwir i rytonawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF	Nukleozydy i nukleotydy – inhibitory odwrotnej transkryptazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF01	zydowudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF02	didanozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF03	zalcytabina	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF04	stawudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF05	lamiwudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF06	abakawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF07	tenofowir dizoproksyl	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF08	adefowir dipiwoksyl	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF09	emtrycytabina	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF10	entekawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF11	telbiwudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF12	klewudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AF13	tenofowir alafenamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG	Nienukleozydowe inhibitory odwrotnej transkryptazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG01	newirapina	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG02	delawirdyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG03	efawirenz	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG04	etrawiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG05	rilpiwiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AG06	dorawiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH	Inhibitory neuraminidazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH01	zanamiwir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH02	oseltamiwir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH03	peramiwir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AH04	laninamiwir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ	Inhibitory integrazy	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ01	raltegrawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ02	elwitegrawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ03	dolutegrawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AJ04	kabotagrawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP	Leki przeciwwirusowe stosowane w leczeniu zakażeń HCV	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP01	rybawiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP02	telaprewir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP03	boceprewir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP04	faldaprewir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP05	symeprewir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP06	azunaprewir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP07	daklataswir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP08	sofosbuwir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP09	dazabuwir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP10	elbaswir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP11	grazoprewir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP12	koblopaswir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP13	rawidaswir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP51	sofosbuwir i ledypaswir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP52	dazabuwir, ombitaswir, parytaprewir i rytonawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP53	ombitaswir, parytaprewir i rytonawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP54	elbaswir i grazoprewir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP55	sofosbuwir i welpataswir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP56	sofosbuwir, welpataswir i woksylaprewir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP57	glekaprewir i pibrentaswir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AP58	daklataswir, azunaprewir i beklabuwir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR	Leki przeciwwirusowe stosowanie w leczeniu zakażenia HIV, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR01	zydowudyna i lamiwudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR02	lamiwudyna i abakawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR03	tenofowir dizoproksyl i emtrycytabina	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR04	zydowudyna, lamiwudyna i abakawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR05	zydowudyna, lamiwudyna i newirapina	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR06	emtrycytabina, tenofowir dizoproksyl i efawirenz	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR07	stawudyna, lamiwudyna i newirapina	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR08	emtrycytabina, tenofowir dizoproksyl i rylpiwiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR09	emtrycytabina, tenofowir dizoproksyl, elwitegrawir i kobicystat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR10	lopinawir i rytonawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR11	lamiwudyna, tenofowir dizoproksyl i efawirenz	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR12	lamiwudyna i tenofowir dizoproksyl	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR13	lamiwudyna, abakawir i dolutegrawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR14	darunawir i kobicystat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR15	atazanawir i kobicystat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR16	lamiwudyna i raltegrawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR17	emtrycytabina i tenofowir alafenamid	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR18	emtrycytabina, tenofowir alafenamid, elwitegrawir i kobicystat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR19	emtrycytabina, tenofowir alafenamid i rylpiwiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR20	emtrycytabina, tenofowir alafenamid i biktegrawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR21	dolutegrawir i rylpiwiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR22	emtrycytabina, tenofowir alafenamid, darunawir i kobicystat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR23	atazanawir i rytonawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR24	lamiwudyna, tenofowir dizoproksyl i dorawiryna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR25	lamiwudyna i dolutegrawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR26	darunawir i rytonawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR27	lamiwudyna, tenofowir, dizoproksyl i dolutegrawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AR28	stawudyna i lamiwudyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX	Inne leki przeciwwirusowe	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX01	moroksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX02	lizozym	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX05	inozyna pranobeks	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX06	plekonaryl	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX07	enfuwirtyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX09	marawirok	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX10	maribawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX13	umifenowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX17	enizaminy jodek	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX18	letermowir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX19	tyloron	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX21	kwas pentanediowy imidazoliloetanamidu	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX23	ibalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX24	tekowirymat	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX25	baloksawir marboksyl	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX26	amenamewir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX27	fawipirawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX28	bulowirtyd	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX29	fostemsawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J05AX31	lenakapawir	WHO Anatomical Therapeutic Chemical classification
0‑L	J06	SUROWICE ODPORNOŚCIOWE I IMMUNOGLOBULINY	WHO Anatomical Therapeutic Chemical classification
0‑L	J06A	SUROWICE ODPORNOŚCIOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA	Surowice odpornościowe	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA01	antytoksyna błonicza	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA02	antytoksyna tężcowa	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA03	antytoksyna jadu węży	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA04	antytoksyna botulinowa	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA05	surowica przeciw zgorzeli gazowej	WHO Anatomical Therapeutic Chemical classification
0‑L	J06AA06	surowica przeciw wściekliźnie	WHO Anatomical Therapeutic Chemical classification
0‑L	J06B	IMMUNOGLOBULINY	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BA	Immunoglobiliny ludzkie normalne	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BA01	immoglobuliny ludzkie normalne do podania pozanaczyniowego	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BA02	immoglobuliny ludzkie normalne do podania naczyniowego	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB	Immunoglobuliny swoiste	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB01	immunoglobulina anty-D (Rh)	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB02	immunoglobulina przeciw tężcowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB03	immunoglobulina przeciw ospie i półpaścowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB04	immunoglobulina przeciw wirusowemu zapalniu wątroby typu B	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB05	immunoglobulina przeciw wściekliznie	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB06	immunoglobulina przeciw różyczce	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB07	immunoglobulina przeciw wirusowi krowianki	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB08	immunoglobulina przeciwgronkowcowa	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB09	immunoglobulina przeciw wirusowi cytomegalii	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB10	immunoglobulina przeciw błonicy	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB11	immunoglobulina przeciw wirusowemu zapaleniu wątroby typu A	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB12	immunoglobulina przeciw kleszczowemu zapaleniu mózgu	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB13	immunoglobulina przeciw krztuścowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB14	immunoglobulina przeciw odrze	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB15	immunoglobulina przeciw śwince	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB19	immunoglobulina przeciw wąglikowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BB30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BC	Przeciwbakteryjne przeciwciała monoklonalne	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BC01	nebakumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BC02	raksybakumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BC03	bezlotoksumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BC04	obiltoksaksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BD	Przeciwwirusowe przeciwciała monoklonalne	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BD01	paliwizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BD02	motawizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BD03	tiksagewymab i cilgawymab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BD04	ansuwimab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BD05	sotrowimab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BD06	regdanwimab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BD07	kasiriwimab i imdewimab	WHO Anatomical Therapeutic Chemical classification
0‑L	J06BD08	nirsewimab	WHO Anatomical Therapeutic Chemical classification
0‑L	J07	SZCZEPIONKI	WHO Anatomical Therapeutic Chemical classification
0‑L	J07A	SZCZEPIONKI PRZECIWBAKTERYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AC	Szczepionki przeciw wąglikowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AC01	antygen wąglikowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AD	Szczepionki przeciw brucelozie	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AD01	antygen brucelozy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE	Szczepionki przeciw cholerze	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE01	szczepionka przeciw cholerze, inaktywowana, całe komórki	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE02	szczepionka przeciw cholerze, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AE51	szczepionka przeciw cholerze w połączeniach ze szczepionką przeciw durowi brzusznemu, inaktywowana, całe komórki	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AF	Szczepionki przeciw błonicy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AF01	toksoid błoniczy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG	Szczepionki przeciw haemophilus typ b	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG01	szczepionka przeciw haemophilus typ b, oczyszczony antygen, skoniugowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG51	szczepionka przeciw haemophilus typ b, połączenia z toksoidami	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG52	szczepionka przeciw haemophilus typ b, połączenia ze szczepionką przeciw krztuścowi i toksoidami	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG53	szczepionka przeciw haemophilus typ b, połączenia ze szczepionką meningokokową grupy C, skoniugowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AG54	szczepionka przeciw haemophilus typ b, połączenia ze szczepionką meningokokową grupy C,Y, skoniugowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH	Szczepionki meningokokowe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH01	szczepionka meningokokowa grupy A, oczyszczony antygen polisacharydowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH02	inne szczepionki meningokokowe monowalentne, oczyszczony antygen polisacharydowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH03	szczepionka meningokokowa grupy A,C, dwuwalentna, oczyszczony antygen polisacharydowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH04	szczepionka meningokokowa grupy A,C,Y,W-135, czterowalentna, oczyszczony antygen polisacharydowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH05	inne szczepionki meningokokowe, poliwalentne, oczyszczony antygen polisacharydowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH06	szczepionka meningokokowa grupy B, antygen pęcherzyków zewnątrzbłoch	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH07	szczepionka meningokokowa grupy C, oczyszczony antygen polisacharydowy, skoniugowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH08	szczepionka meningokokowa grupy A,C,Y,W-135, czterowalentna, oczyszczony antygen polisacharydowy, skoniugowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH09	szczepionka meningokokowa grupy B, poliwalentna	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AH10	szczepionka meningokokowa grupy A, oczyszczony antygen polisacharydowy, skoniugowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ	Szczepionki przeciw krztuścowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ01	szczepionka przeciw krztuścowi, inaktywowana, całe komórki	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ02	szczepionka przeciw krztuścowi, oczyszczony antygen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ51	szczepionka przeciw krztuścowi, połączenia z toksoidami, inaktywowana, całe komórki	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AJ52	szczepionka przeciw krztuścowi, połączenia z toksoidami, oczyszczony antygen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AK	Szczepionki przeciw dżumie	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AK01	szczepionka przeciw dżumie, inaktywowana, całe komórki	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL	Szczepionki przeciwpneumokokowe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL01	szczepionka przeciw pneumokokom, oczyszczony antygen polisacharydowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL02	szczepionka przeciw pneumokokom, oczyszczony antygen polisacharydowy, skoniugowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AL52	szczepionka przeciw pneumokokom, oczyszczony antygen polisacharydowy i przeciw haemophilus influenzae, skoniugowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM	Szczepionki przeciw tężcowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM01	toksoid tężcowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM51	toksid tężcowy, połączenia z toksoidem błoniczym	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AM52	toksid tężcowy, połączenia z immunoglobulinami przeciwtężcowymi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AN	Szczepionki przeciw gruźlicy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AN01	szczepionka przeciw gruźlicy, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP	Szczepionki przeciw durowi brzusznemu	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP01	szczepionka przeciw durowi brzusznemu, doustna, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP02	szczepionka przeciw durowi brzusznemu, inaktywowana, całe komórki	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP03	szczepionka przeciw durowi brzusznemu, oczyszczony antygen polisacharydowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AP10	szczepionki przeciw durowi brzusznemu, połączenia ze szczepionkami przeciw durowi rzekomemu	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AR	Szczepionki przeciw durowi plamistemu	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AR01	szczepionka przeciw durowi plamistemu , inaktywowana, całe komórki	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AX	Inne szczepionki przeciwbakteryjne	WHO Anatomical Therapeutic Chemical classification
0‑L	J07AX01	szczepionki przeciw leptospirze	WHO Anatomical Therapeutic Chemical classification
0‑L	J07B	Szczepionki przeciwwirusowe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA	Szczepionki przeciw wirusowemu zapaleniu mózgu	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA01	szczepionka przeciw kleszczowemu zapaleniu mózgu, inaktywowana, cały wirion	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA02	szczepionka przeciw japońskiemu zapaleniu mózgu, inaktywowana, cały wirion	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BA03	szczepionka przeciw japońskiemu zapaleniu mózgu, żywa, atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB	Szczepionki przeciw grypie	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB01	szczepionka przeciw grypie, inaktywowana, cały wirion	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB02	szczepionka przeciw grypie, inaktywowana, rozszczepiony wirion lub antygen powierzchniowy	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB03	szczepionka przeciw grypie, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BB04	grypa, cząsteczki wirusopodobne	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC	Szczepionki przeciw wirusowemu zapaleniu wątroby	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC01	szczepionka przeciw wirusowemu zapaleniu wątroby typu B, oczyszczony antygen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC02	szczepionka przeciw wirusowemu zapaleniu wątroby typu A, inaktywowana cały wirion	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BC20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD	Szczepionki przeciw odrze	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD01	szczepionka przeciw odrze, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD51	szczepionka przeciw odrze, połączenia ze szczepionką przeciw śwince, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD52	szczepionka przeciw odrze, połączenia ze szczepionkami przeciw śwince i różyczce, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD53	szczepionka przeciw odrze, połączenia ze szczepionką przeciw różyczce, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BD54	Szczepionka przeciw odrze, połączenia ze szczepionkami przeciw śwince, różyczce i ospie wietrznej, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BE	Szczepionki przeciw śwince	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BE01	szczepionka przeciw śwince, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF	Szczepionki przeciw poliomyelitis	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF01	szczepionka przeciw poliomyelitis, monowalentna, doustna, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF02	szczepionka przeciw poliomyelitis, trójwalentna, doustna, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF03	szczepionka przeciw poliomyelitis, trójwalentna, doustna, inaktywowana, cały wirion	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BF04	szczepionka przeciw poliomyelitis, dwuwalentna, doustna, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BG	Szczepionki przeciw wściekliźnie	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BG01	szczepionka przeciw wściekliźnie, inaktywowana, cały wirion	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BH	Szczepionki przeciw rotawirusom	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BH01	szczepionka przeciw rotawirusom, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BH02	szczepionka przeciw rotawirusom, pięciowalentna, zawierająca reasortanty ludzko-bydlęce	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BJ	Szczepionki przeciw różyczce	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BJ01	szczepionka przeciw różyczce, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BJ51	szczepionka przeciw różyczce, połączenia ze szczepionką przeciw śwince, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK	Szczepionki przeciw ospie wietrznej i półpaścowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK01	szczepionka przeciw ospie wietrznej, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK02	szczepionka przeciw półpaścowi, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BK03	szczepionka przeciw półpaścowi, oczyszczony antygen	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BL	Szczepionki przeciw żółtej febrze	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BL01	szczepionka przeciw żółtej febrze, żywa atenuowana	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM	Szczepionki przeciw ludzkiemu wirusowi brodawczaka	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM01	szczepionka przeciw ludzkiemu wirusowi brodawczaka, podtypy wirusa 6, 11, 16, 18	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM02	szczepionka przeciw ludzkiemu wirusowi brodawczaka, podtypy wirusa 16, 18	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BM03	szczepionka przeciw ludzkiemu wirusowi brodawczaka, podtypy wirusa 6, 11, 16, 18, 31, 33, 45, 52 i 58	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BN	szczepionki Covid-19	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BN01	covid-19, szczepionka oparta na RNA	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BN02	covid-19, wektor wirusowy, niereplikujący się	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BN03	covid-19, inaktywowany wirus	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BN04	covid-19, podjednostka białkowa	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BN05	covid-19, cząsteczki wirusopodobne	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX	Inne szczepionki przeciwwirusowe	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX01	szczepionki przeciwko ospie prawdziwej i ospie małpiej	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX02	szczepionki przeciwko eboli	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX04	szczepionki przeciwko wirusowi dengi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX05	szczepionki przeciwko syncytialnemu wirusowi oddechowemu	WHO Anatomical Therapeutic Chemical classification
0‑L	J07BX06	szczepionki przeciwko enterowirusowi 71	WHO Anatomical Therapeutic Chemical classification
0‑L	J07C	SZCZEPIONKI PRZECIWBAKTERYJNE I PRZECIWWIRUSOWE, POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA	szczepionki przeciwbakteryjne i przeciwwirusowe, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA01	szczepionka przeciw błonicy, poliomyelitis i tężcowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA02	szczepionka przeciw błonicy, krztuścowi, poliomyelitis i tężcowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA03	szczepionka przeciw błonicy, różyczce i tężcowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA04	szczepionka przeciw haemophilus typ b i poliomyelitis	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA05	szczepionka przeciw błonicy, wirusowemu zapaleniu wątroby typu B, krztuścowi i tężcowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA06	szczepionka przeciw błonicy, haemophilus typ b, krztuścowi, poliomyelitis i tężcowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA07	szczepionka przeciw błonicy, wirusowemu zapaleniu wątroby typu B i tężcowi	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA08	szczepionka przeciw haemophilus typ b i wirusowemu zapaleniu wątroby typu B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA09	szczepionka przeciw błonicy, haemophilus typ b, krztuścowi, poliomyelitis, tężcowi i wirusowemu zapaleniu wątroby typu B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA10	szczepionka przeciw durowi brzusznemu i wirusowemu zapaleniu wątroby typu A	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA11	szczepionka przeciw błonicy, haemophilus typ b, krztuścowi, tężcowi i wirusowemu zapaleniu wątroby typu B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA12	szczepionka przeciw błonicy, krztuścowi, poliomyelitis, tężcowi i wirusowemu zapaleniu wątroby typu B	WHO Anatomical Therapeutic Chemical classification
0‑L	J07CA13	szczepionka przeciw błonicy, haemophilus typ b, krztuścowi, tężcowi, wirusowemu zapaleniu wątroby typu B i meningokokowa grupy A+C	WHO Anatomical Therapeutic Chemical classification
0‑L	J07X	INNE SZCZEPIONKI	WHO Anatomical Therapeutic Chemical classification
0‑L	J07XA	Szczepionki pasożytnicze	WHO Anatomical Therapeutic Chemical classification
0‑L	J07XA01	szczepionki na malarię	WHO Anatomical Therapeutic Chemical classification
0‑L	L	LEKI PRZECIWNOWOTWOROWE I IMMUNOMODULUJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	L01	CYTOSTATYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	L01A	LEKI ALKILUJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA	Analogi iperytu azotowego	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA01	cyklofosfamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA02	chlorambucyl	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA03	melfalan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA05	chlormetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA06	ifosfamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA07	trofosfamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA08	prednimustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA09	bendamustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AA10	melfalan flufenamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB	Alkilosulfoniany	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB01	busulfan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB02	treosulfan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AB03	mannosulfan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC	Etylenoiminy	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC01	tiotepa	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC02	triazychon	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AC03	karbochon	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD	Pochodne nitrozomocznika	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD01	karmustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD02	lomustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD03	semustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD04	streptozotocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD05	fotemustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD06	nimustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD07	ranimustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AD08	uramustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AG	Epoksydy	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AG01	etoglucyd	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX	Inne leki alkilujące	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX01	mitobronitol	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX02	pipobroman	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX03	temozolomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01AX04	dakarbazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01B	ANTYMETABOLITY	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA	Analogi kwasu foliowego	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA01	metotreksat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA03	raltitreksed	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA04	pemetreksed	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BA05	pralatreksat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB	Analogi puryn	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB02	merkaptopuryna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB03	tioguanina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB04	kladrybina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB05	fludarabina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB06	klofarabina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BB07	nelarabina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC	Analogi pirymidyn	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC01	cytarabina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC02	fluorouracyl	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC03	tegafur	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC04	karmofur	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC05	gemcytabina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC06	kapecytabina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC07	azacytydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC08	decytabina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC09	floksurydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC52	fluorouracyl, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC53	tegafur, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC58	decytabina, kombinacje	WHO Anatomical Therapeutic Chemical classification
0‑L	L01BC59	triflurydyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	L01C	ALKALOIDY ROŚLINNE I INNE ZWIĄZKI POCHODZENIA NATURALNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA	Alkaloidy Vinca i analogi	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA01	winblastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA02	winkrystyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA03	windezyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA04	winorelbina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA05	winflunina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CA06	wintafolid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CB	Pochodne podofilotoksyny	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CB01	etopozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CB02	tenipozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CC	Pochodne kolchicyny	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CC01	demekolcyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD	Taksoidy	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD01	paklitaksel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD02	docetaksel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD03	paklitaksel poliglumeks	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD04	kabazytaksel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CD51	paklitaksel i encekwidar	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE	Inhibitory topoizomerazy 1 (TOP1)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE01	topotekan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE02	irinotekan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE03	etirinotekan pegol	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CE04	belotekan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CX	Inne alkaloidy roślinne i związki pochodzenia naturalnego	WHO Anatomical Therapeutic Chemical classification
0‑L	L01CX01	trabektedyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01D	ANTYBIOTYKI CYTOTOKSYCZNE I SUBSTANCJE POKREWNE	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DA	Aktynomycyny	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DA01	daktynomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB	Antracykliny i substancje pokrewne	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB01	doksorubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB02	daunorubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB03	epirubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB04	aklarubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB05	zorubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB06	idarubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB07	mitoksantron	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB08	pirarubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB09	walrubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB10	amrubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DB11	piksantron	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC	Inne antybiotyki cytotoksyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC01	bleomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC02	plikamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC03	mitomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01DC04	iksabepilon	WHO Anatomical Therapeutic Chemical classification
0‑L	L01E	INHIBITORY KINAZY PROTEINOWEJ	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA	Inhibitory kinazy tyrozynowej BCR-ABL	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA01	imatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA02	dazatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA03	nilotynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA04	bosutynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA05	ponatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EA06	ascyminib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB	Inhibitory kinazy tyrozynowej receptora naskórkowego czynnika wzrostu (EGFR)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB01	gefitynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB02	erlotynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB03	afatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB04	ozymertynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB05	rocyletynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB06	olmutynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB07	dakomitynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB08	ikotynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB09	lazertynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB10	mobocertynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EB11	aumolertynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EC	Inhibitory kinazy serynowo-treoninowej B-Raf (BRAF)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EC01	wemurafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EC02	dabrafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EC03	enkorafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED	Inhibitory kinazy chłoniaka anaplastycznego (ALK)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED01	kryzotynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED02	cerytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED03	alektynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED04	brygatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01ED05	lorlatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE	Inhibitory kinazy białkowej aktywowanej mitogenami (MEK)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE01	trametynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE02	kobimetynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE03	binimetynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EE04	selumetynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EF	Inhibitory kinazy cyklino-zależnej (CDK)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EF01	palbocyklib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EF02	rybocyklib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EF03	abemacyklib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EG	Inhibitory kimazy mTOR ssaczego celu rapamycyny	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EG01	temsyrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EG02	ewerolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EG03	ridaforolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EG04	sirolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EH	Inhibitory kinazy tyrozynowej receptora ludzkiego naskórkowego czynnika wzrostu 2 (HER2)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EH01	lapatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EH02	neratynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EH03	tukatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EJ	Inhibitory kinazy janusowej (JAK)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EJ01	ruksolitynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EJ02	fedratynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EJ03	pakrytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EJ04	mamelotynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EK	Inhibitory kinazy tyrozynowej receptora czynnika wzrostu śródbłonka naczyniowego (VEGFR)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EK01	aksytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EK02	cedyranib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EK03	tiwozanib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EK04	frukwitynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL	Inhibitory kinazy tyrozynowej Brutona (BTK)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL01	ibrutynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL02	akalabrutynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL03	zanubrutynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL04	orelabrutynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EL05	pitobrutynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM	Inhibitory 3-kinazy fosfatydyloinozytolu (PI3K)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM01	idelalizyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM02	kopanlizyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM03	alpelizyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM04	duwelizyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EM05	parsaklizib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EN	Inhibitory kinazy tyrozynowej receptora czynnika wzrostu fibroblastów (FGFR)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EN01	erdafitynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EN02	pemigatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EN03	infigratynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EN04	futybatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX	Inne inhibitory kinaz białkowych	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX01	sunitynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX02	sorafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX03	pazopanib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX04	wandetanib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX05	regorafenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX06	masytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX07	kabozantynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX08	lenwatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX09	nintedanib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX10	midostauryna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX11	kwizartynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX12	larotrektynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX13	gilterytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX14	entrektynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX15	peksydartynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX17	kapmatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX18	awaprytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX19	ripretynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX21	tepotynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX22	selperkatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX23	pralsetynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX24	surufatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX25	umbralizyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX26	sitrawatynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01EX27	kapiwasertyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01F	PRZECIWCIAŁA MONOKLONALNE I KONIUGATY LEKÓW Z PRZECIWCIAŁAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FA	Inhibitory CD20 (Klastry różnicowania 20)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FA01	rytuksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FA02	ofatumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FA03	obinutuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FB	Inhibitory CD22 (Klastry różnicowania 22)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FB01	inotuzumab ozogamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FB02	moksetumomab pasudotoks	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FC	Inhibitory CD38 (Klastry różnicowania 38)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FC01	daratumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FC02	izatuksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FD	Inhibitory HER2 (Receptora ludzkiego naskórkowego czynnika wzrostu 2)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FD01	trastuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FD02	pertuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FD03	trastuzumab emtanzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FD04	trastuzumab derukstekan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FD05	trastuzumab duokarmazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FD06	margetuksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FE	Inhibitory EGFR (receptora naskórkowego czynnika wzrostu)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FE01	cetuksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FE02	panitumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FE03	necitumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF	Inhibitory receptora PD-1/PDL-1 (Białko programowanej śmierci komórkowej 1/ligand śmierci 1)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF01	niwolumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF02	pembrolizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF03	durwalumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF04	awelumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF05	atezolizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF06	cemiplimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF07	dostarlimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF08	prolgolimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF09	tislelizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF10	retifanlimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF11	sugemalimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF12	serplulimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FF13	toripalimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FG	Inhibitory VEGF/VEGFR (czynnik wzrostu śródbłonka naczyniowego)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FG01	bewacyzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FG02	ramucyrumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX	Inne przeciwciała monoklonalne i koniugaty leków z przeciwciałami	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX01	edrekolomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX02	gemtuzumab ozogamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX03	katumaksomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX04	ipilimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX05	brentuksymab wedotyny	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX06	dinutuksymab beta	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX07	blinatumomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX08	elotuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX09	mogamulizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX10	olaratumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX11	bermekimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX12	tafasitamab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX13	enfortumab wedotyny	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX14	polatuzumab wedotyny	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX15	belantamab mafodotyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX16	oportuzumab monatoks	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX17	sakituzumab gowitekan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX18	amiwantamab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX19	sabatolimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX20	tremelimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX21	naksytamab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX22	lonkastuksymab tezyryna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX23	tisotumab wedotin	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX24	teklistamab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX25	mosunetuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX26	mirwetuksymab sorawtanzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX27	epkoritamab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX28	glofitamab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FX29	talkwetamab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FY	Kombinacje przeciwciał monoklonalnych i koniugatów przeciwciało-lek	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FY01	pertuzumab i trastuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FY02	niwolumab i relatlimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01FY03	prolgolimab i nurulimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L01X	INNE LEKI PRZECIWNOWOTWOROWE	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA	Związki platyny	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA01	cisplatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA02	karboplatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA03	oksaliplatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA04	satraplatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XA05	poliplatilen	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XB	Metylohydrazyny	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XB01	prokarbazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD	Leki stosowane w terapii fotodynamicznej	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD01	porfimer sodowy	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD03	metylu aminolewulinian	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD04	kwas aminolewuli	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD05	temoporfina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD06	efaproksiral	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XD07	padeliporfina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XF	Retinody stosowane w leczeniu nowotworów	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XF01	tretynoina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XF02	alitretynoina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XF03	beksaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XG	Inhibitory proteasomów	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XG01	bortezomib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XG02	karfilzomib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XG03	iksazomib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH	Inhibitory deacetylazy histonowej (HDAC)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH01	worynostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH02	romidepsyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH03	panobinostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH04	belinostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XH05	entynostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XJ	inhibitor szlaku hedgehog	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XJ01	wismodegib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XJ02	sonidegib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XJ03	glasdegib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK	Inhibitory polimerazy poli(ADP-rybozy)	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK01	olaparyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK02	niraparyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK03	rucaparyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK04	talazoparyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK05	weliparyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK06	pamiparyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XK52	niraparyb i abirateron	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL	Przeciwnowotworowa terapia komórkowa i genowa	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL01	sitimagen ceradenowek	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL02	talimogen laherparepwek	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL03	aksykabtagen cyloleucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL04	tisagenlecleucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL05	ciltakabtagen autoleucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL06	breksukabtagen autoleucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL07	idekabtagen wicleucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL08	lisokabtagen maraleucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL09	tabelekleucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL10	nadofaragen firadenowek	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XL11	lifileucel	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX	Inne leki przeciwnowotworowe	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX01	amsakryna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX02	asparaginaza	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX03	altretamina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX05	hydroksymocznik	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX07	lonidamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX08	pentostatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX10	mazoprokol	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX11	estramustyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX16	mitoguazon	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX18	tiofurazon	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX23	mitotan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX24	pegaspargaza	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX27	arsenu trójtlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX29	denileukina diftitoks	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX33	celekoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX35	anagrelid	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX36	oblimersen	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX40	omacetaksyny mepebursztynian	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX41	eribulina	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX44	aflibercept	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX52	wenetoklaks	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX53	wozaroksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX57	plitydepsyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX58	epakadostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX59	enazydenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX62	iwosydenib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX66	selineksor	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX67	tagraksofusp	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX69	lurbinektedyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX72	tazemetostat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX73	sotorasib	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX74	belzutifan	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX75	tebentafusp	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX77	adagrazyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX78	nawitoklaks	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX79	eflornityna	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XX80	imetelstat	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XY	Połączenia leków przeciwnowotworowych	WHO Anatomical Therapeutic Chemical classification
0‑L	L01XY01	cytarabina i daunorubicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L02	LEKI HORMONALNE	WHO Anatomical Therapeutic Chemical classification
0‑L	L02A	HORMONY I ZWIĄZKI POKREWNE	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA	Estrogeny	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA01	dietylostylbestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA02	poliestradiolu fosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA03	etynyloestradiol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AA04	fosfestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB	Progestageny	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB01	megestrol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB02	medroksyprogesteron	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AB03	gestonoron	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE	Analogi hormonu uwalniającego gonadotropinę	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE01	buserelina	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE02	leuprorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE03	goserelina	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE04	tryptorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE05	histrelina	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AE51	leuprorelina i bikalutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02AX	Inne hormony	WHO Anatomical Therapeutic Chemical classification
0‑L	L02B	ANTAGONIŚCI HORMONÓW I ZWIĄZKI POKREWNE	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA	Antyestrogeny	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA01	tamoksyfen	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA02	toremifen	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA03	fulwestrant	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BA04	elacestrant	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB	Antyandrogeny	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB01	flutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB02	nilutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB03	bikalutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB04	enzalutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB05	apalutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BB06	darolutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG	Inhibitory aromatazy	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG01	aminoglutetymid	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG02	formestan	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG03	anastrozol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG04	letrozol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG05	worozol	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BG06	eksemestan	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX	Inni antagoniści hormonów i związki pokrewne	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX01	abareliks	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX02	degareliks	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX03	abirateron	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX04	relugoliks	WHO Anatomical Therapeutic Chemical classification
0‑L	L02BX53	abirateron i prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	L03	LEKI IMMUNOSTYMULUJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	L03A	LEKI IMMUNOSTYMULUJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA	Czynniki stymulujące tworzenie kolonii	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA02	filgrastym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA03	molgramostym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA09	sargramostym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA10	lenograstym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA12	ancestym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA13	pegfilgrastym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA14	lipegfilgrastym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA15	balugrastym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA16	empegfilgrastym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA17	pegteograstym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA18	efbemalenograstym alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AA19	eflapegrastym	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB	Interferony	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB01	interferon alfa naturalny	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB02	interferon beta naturalny	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB03	interferon gamma	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB04	interferon alfa-2a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB05	interferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB06	interferon alfa-n1	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB07	interferon beta-1a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB08	interferon beta-1b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB09	interferon alfakon-1	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB10	peginterferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB11	peginterferon alfa-2a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB12	albinterferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB13	peginterferon beta-1a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB14	cepeginterferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB15	ropeginterferon alfa-2b	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB16	peginterferon alfakon-2	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB17	sampeginterferon beta-1a	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB60	peginterferon alfa-2b, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AB61	peginterferon alfa-2a, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AC	Interleukiny	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AC01	aldesleukina	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AC02	oprelwekina	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX	Inne leki immunostymulujące	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX01	lentinan	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX02	rochinimeks	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX03	szczepionka BCG	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX04	pegademaza	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX05	pidotymod	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX07	kwas poliinozyno-cytydylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX08	kwas poliinozyno-cytydylowy związany z polikationową polietylenoiminą	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX09	tymopentyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX10	immunocyjanina	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX11	tazonermina	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX12	szczepionka przeciw czerniakowi	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX13	glatirameru octan	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX14	histaminy dichlorowodorek	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX15	mifamurtyd	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX16	pleryksafor	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX17	sipuleucel-T	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX18	krydanimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX19	dazyprotymut-T	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX21	elapegademaza	WHO Anatomical Therapeutic Chemical classification
0‑L	L03AX22	leniolizyb	WHO Anatomical Therapeutic Chemical classification
0‑L	L04	LEKI IMMUNOSUPRESYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	L04A	LEKI IMMUNOSUPRESYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA	Selektywne leki immunosupresyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA03	immunoglobulina przeciw limfocytom T (końska)	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA04	immunoglobulina przeciw limfocytom T (królicza)	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA06	kwas mykofenolowy	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA15	alefacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA19	gusperymus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA22	abetymus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA24	abatacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA28	belatacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA32	apremilast	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA40	kladrybina	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA41	imlifidaza	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA48	belumosudil	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AA58	efgartigimod alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB	Inhibitory czynnika martwicy nowotworu alfa (TNF-alfa)	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB01	etanercept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB02	infliksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB03	afelimomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB04	adalimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB05	certolizumab pegol	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB06	golimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AB07	opinercept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC	Inhibitory interleukiny	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC01	daklizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC02	bazyliksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC03	anakinra	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC04	rylonacept	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC05	ustekinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC07	tocylizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC08	kanakinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC09	briakinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC10	sekukinumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC11	syltuksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC12	brodalumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC13	iksekizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC14	sarylumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC15	syrukumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC16	guzelkumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC17	tyldrakizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC18	rizankizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC19	satralizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC20	netakimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC21	bimekizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC22	spesolimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC23	olokizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC24	mirikizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AC25	lewilimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD	Inhibitory kalcyneuryny	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD01	cyklosporyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD02	takrolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AD03	woklosporyna	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AE	Modulatory receptora 1-fosforanu sfingozyny (S1P).	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AE01	fingolimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AE02	ozanimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AE03	siponimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AE04	ponesimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AE05	etrasimod	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AF	Inhibitory kinazy janusowej (JAK)	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AF01	tofacytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AF02	barycytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AF03	upadacytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AF04	filgotynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AF05	itacytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AF06	peficytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AF07	deukrawacytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AF08	ritlecytynib	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG	Przeciwciała monoklonalne	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG01	muromonab-CD3	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG02	efalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG03	natalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG04	belimumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG05	wedolizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG06	alemtuzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG07	begelomab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG08	okrelizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG09	emapalumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG10	inebilizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG11	anifrolumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG12	ofatumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG13	teprotumumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG14	ublituksymab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG15	diwozylimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AG16	rozanoliksizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AH	Inhibitory kinazy rapamycyny (mTOR) u ssaków	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AH01	sirolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AH02	ewerolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ	Inhibitory dopełniacza	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ01	ekulizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ02	rawulizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ03	pegketakoplan	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ04	sutimlimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ05	awakopan	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ06	zilukoplan	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ07	krowalimab	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ08	iptakopan	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AJ09	danikopan	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AK	Inhibitory dehydrogenazy dihydroorotanowej (DHODH).	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AK01	leflunomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AK02	teryflunomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX	Inne leki immunosupresyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX01	azatiopryna	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX02	talidomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX03	metotreksat	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX04	lenalidomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX05	pirfenidon	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX06	pomalidomid	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX07	dimetylu fumaran	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX08	darwadstrocel	WHO Anatomical Therapeutic Chemical classification
0‑L	L04AX09	fumaran diroksymelu	WHO Anatomical Therapeutic Chemical classification
0‑L	M	UKŁAD MIĘŚNIOWO-SZKIELETOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	M01	LEKI PRZECIWZAPALNE I PRZECIWREUMATYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	M01A	NIESTEROIDOWE LEKI PRZECIWZAPALNE I PRZECIWREUMATYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA	Butylopirazolidyny	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA01	fenylobutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA02	mofebutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA03	oksyfenbutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA05	klofezon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AA06	kebuzon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB	Pochodne kwasu octowego i substancje pokrewne	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB01	indometacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB02	sulindak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB03	tolmetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB04	zomepirak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB05	diklofenak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB06	alklofenak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB07	bumadyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB08	etodolak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB09	lonazolak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB10	fentiazak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB11	acemetacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB12	difenpiramid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB13	oksametacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB14	proglumetacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB15	ketorolak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB16	aceklofenak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB17	bufeksamak	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB51	indometacyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AB55	diklofenak, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC	Oksykamy	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC01	piroksykam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC02	tenoksykam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC04	droksykam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC05	lornoksykam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC06	meloksykam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AC56	meloksykam, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE	Pochodne kwasu propionowego	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE01	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE02	naproksen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE03	ketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE04	fenoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE05	fenbufen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE06	benoksaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE07	suprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE08	pirprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE09	flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE10	indoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE11	kwas tiaprofe	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE12	oksaprozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE13	ibuproksam	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE14	deksibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE15	flunoksaprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE16	alminoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE17	deksketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE18	naprokscynod	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE51	ibuprofen, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE52	naproksen i ezomeprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE53	ketoprofen, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE56	naproksen i mizoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AE57	naproksen i difenhydramina	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG	Fenamaty	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG01	kwas mefenamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG02	kwas tolfenamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG03	kwas flufenamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AG04	kwas meklofenamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH	Koksyby	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH01	celekoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH02	rofekoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH03	waldekoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH04	parekoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH05	etorykoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH06	lumirakoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AH07	polmakoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX	Inne niesteroidowe leki przeciwzapalne i przeciwreumatyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX01	nabumeton	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX02	kwas niflumi	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX04	azapropazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX05	glukozamina	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX07	benzydamina	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX12	glukozaminoglikanu polisiarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX13	prokwazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX14	orgoteina	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX17	nimesulid	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX18	feprazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX21	diacereina	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX22	morniflumat	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX23	tenidap	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX24	oksaceprol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX25	chondroityny siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX26	awokado i soi olej, frakcje niezmydlające się	WHO Anatomical Therapeutic Chemical classification
0‑L	M01AX68	feprazon, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M01B	LEKI PRZECIWZAPALNE/PRZECIWREUMATYCZNE W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA	Leki przeciwzapalne/przeciwreumatyczne w połączeniu z kortykosteroidami	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA01	fenylobutazon i kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA02	dipirocetyl i kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BA03	kwas acetylosalicylowy i kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	M01BX	Inne leki przeciwzapalne/przeciwreumatyczne w połączeniu z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	M01C	SWOISTE LEKI PRZECIWREUMATYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CA	Chinoliny	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CA03	oksycynchofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB	Preparaty złota	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB01	sodu aurotiojabłczan	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB02	sodu aurotiosiarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB03	auranofina	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB04	aurotioglukoza	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CB05	aurotioprol	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CC	Penicylamina i związki podobne	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CC01	penicylamina	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CC02	bucylamina	WHO Anatomical Therapeutic Chemical classification
0‑L	M01CX	Inne swoiste leki przeciwreumatyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	M02	LEKI DO STOSOWANIA MIEJSCOWEGO W BÓLACH STAWÓW I MIĘŚNI	WHO Anatomical Therapeutic Chemical classification
0‑L	M02A	LEKI DO STOSOWANIA MIEJSCOWEGO W BÓLACH STAWÓW I MIĘŚNI	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA	Niesteroidowe leki przeciwzapalne do stosowania miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA01	fenylobutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA02	mofebutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA03	klofezon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA04	oksyfenbutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA05	benzydamina	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA06	etofenamat	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA07	piroksykam	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA08	felbinak	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA09	bufeksamak	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA10	ketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA11	bendazak	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA12	naproksen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA13	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA14	fentiazak	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA15	diklofenak	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA16	feprazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA17	kwas niflumi	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA18	kwas meklofenamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA19	flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA21	tolmetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA22	suksybuzon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA23	indometacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA24	nifenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA25	aceklofenak	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA26	nimesulid	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA27	deksketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA28	piketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA29	esflurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AA31	loksoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AB	Kapsaicyna i związki podobne	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AB01	kapsaicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AB02	zukapsaicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AC	Leki z pochodnymi kwasu salicylowego	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX	Inne leki do stosowania miejscowego w bólach stawów i mięśni	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX02	tolazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX03	dimetylosulfotlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX05	idrocylamid	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX06	tolperyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	M02AX10	różne	WHO Anatomical Therapeutic Chemical classification
0‑L	M03	LEKI ZWIOTCZAJĄCE MIĘŚNIE	WHO Anatomical Therapeutic Chemical classification
0‑L	M03A	LEKI ZWIOTCZAJĄCE MIĘŚNIE DZIAŁAJĄCE OBWODOWO	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA	Alkaloidy kurary	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA01	alkuronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA02	tubokuraryna	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AA04	dimetylotubokuraryna	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AB	Pochodne choliny	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AB01	suksametonium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC	Inne czwartorzędowe związki amoniowe	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC01	pankuronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC02	galamina	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC03	wekuronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC04	atrakurium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC05	heksafluronium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC06	pipekuroniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC07	doksakuriowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC08	fazadyniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC09	rokuroniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC10	miwakuriowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AC11	cisatrakurium	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AX	Inne leki zwiotczające mięśnie działające obwodowo	WHO Anatomical Therapeutic Chemical classification
0‑L	M03AX01	toksyna botulinowa	WHO Anatomical Therapeutic Chemical classification
0‑L	M03B	LEKI ZWIOTCZAJĄCE MIĘŚNIE DZIAŁAJĄCE OŚRODKOWO	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA	Estry kwasu karbaminowego	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA01	fenprobamat	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA02	karyzoprodol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA03	metokarbamol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA04	styramat	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA05	febarbamat	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA51	fenprobamat, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA52	karyzoprodol, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA53	metokarbamol, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA71	fenprobamat, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA72	karyzoprodol, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BA73	metokarbamol, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB	Oksazolu, tiazyny i triazyny pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB02	chlormezanon	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB03	chlorzoksazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB52	chlormezanon, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB53	chlorzoksazon, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB72	chlormezanon, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BB73	chlorzoksazon, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BC	Etery chemicznie zbliżone do leków przeciwhistamich	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BC01	orfenadryna (cytrynian)	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BC51	orfenadryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX	Inne leki działające ośrodkowo	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX01	baklofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX02	tyzanidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX03	prydynol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX04	tolperyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX05	tiokolchikozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX06	mefenezyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX07	tetrazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX08	cyklobenzapryna	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX09	eperyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX30	fenyramidol	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX53	pridinol, kombinacje	WHO Anatomical Therapeutic Chemical classification
0‑L	M03BX55	tiokolchikozyd, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M03C	LEKI ZWIOTCZAJĄCE MIĘŚNIE DZIAŁAJĄCE BEZPOŚREDNIO	WHO Anatomical Therapeutic Chemical classification
0‑L	M03CA	Dantrolen i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	M03CA01	dantrolen	WHO Anatomical Therapeutic Chemical classification
0‑L	M04	LEKI PRZECIW DNIE MOCZANOWEJ	WHO Anatomical Therapeutic Chemical classification
0‑L	M04A	LEKI PRZECIW DNIE MOCZANOWEJ	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA	Leki hamujące wytwarzanie kwasu moczowego	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA01	allopurynol	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA02	tizopuryna	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA03	febuksostat	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AA51	allopurynol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB	Leki zwiększające wydalanie kwasu moczowego	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB01	probenecyd	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB02	sulfinpirazon	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB03	benzbromaron	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB04	izobromindion	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AB05	lezynurad	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC	Leki niewpływające na metabolizm kwasu moczowego	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC01	kolchicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC02	cynchofen	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AC51	kolchicyna i probenecyd	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AX	Inne leki przeciw dnie moczanowej	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AX01	oksydaza moczanowa	WHO Anatomical Therapeutic Chemical classification
0‑L	M04AX02	peglotykaza	WHO Anatomical Therapeutic Chemical classification
0‑L	M05	LEKI STOSOWANE W CHOROBACH KOŚCI	WHO Anatomical Therapeutic Chemical classification
0‑L	M05B	LEKI WPŁYWAJĄCE NA STRUKTURĘ I MINERALIZACJĘ KOŚCI	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA	Bisfosfoniany	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA01	kwas etydro	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA02	kwas klodro	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA03	kwas pamidro	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA04	kwas alendro	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA05	kwas tiludro	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA06	kwas ibandro	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA07	kwas ryzedro	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BA08	kwas zoledro	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB	Bisfosfoniany, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB01	kwas etydro i wapń, sekwencyjnie	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB02	kwas ryzedro i wapń, sekwencyjnie	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB03	kwas alendro i cholekalcyferol	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB04	kwas ryzedro, wapń i cholekalcyferol, sekwencyjnie	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB05	kwas alendro, wapń i cholekalcyferol, sekwencyjnie	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB06	kwas alendro i alfakalcydol, sekwencyjnie	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB07	kwas ryzedro i cholekalcyferol	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB08	kwas zoledro, wapń i cholekalcyferol, sekwencyjnie	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BB09	kwas ibandro i cholekalcyferol	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BC	Morfogenetyczne białka kości	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BC01	dibotermina alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BC02	eptotermina alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX	Inne leki wpływające na strukturę i mineralizację kości	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX01	ipryflawon	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX02	glinu chlorowodorotlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX03	strontu ranelinian	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX04	denosumab	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX05	burosumab	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX06	romosozumab	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX07	wosorytyd	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX08	menatetrenon	WHO Anatomical Therapeutic Chemical classification
0‑L	M05BX53	strontu ranelinian i cholekalcyferol	WHO Anatomical Therapeutic Chemical classification
0‑L	M09	INNE LEKI STOSOWANE W ZABURZENIACH UKŁADU MIĘŚNIOWO-SZKIELETOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	M09A	INNE LEKI STOSOWANE W ZABURZENIACH UKŁADU MIĘŚNIOWO-SZKIELETOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AA	Chinina i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AA01	hydrochinina	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AA72	chinina, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB	Enzymy	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB01	chymopapaina	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB02	kolagenaza Clostridium histolyticum	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB03	bromelainy	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AB52	trypsyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX	Inne leki stosowane w zaburzeniach układu mięśniowo-szkieletowego	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX01	kwas hialuro	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX02	chondrocyty, autologiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX03	ataluren	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX04	drisapersen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX05	kwas aceneuramowy	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX06	eteplirsen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX07	nusinersen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX08	golodirsen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX09	onasemnogen abeparwowek	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX10	rysdyplam	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX11	palowaroten	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX12	wiltolarsen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX13	kasimersen	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX14	giwinostat	WHO Anatomical Therapeutic Chemical classification
0‑L	M09AX15	delandistrogen mokseparwowek	WHO Anatomical Therapeutic Chemical classification
0‑L	N	UKŁAD NERWOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	N01	LEKI ZNIECZULAJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	N01A	LEKI DO ZNIECZULENIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AA	Etery	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AA01	eter dietylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AA02	eter winylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB	Chlorowcowane węglowodory	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB01	halotan	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB02	chloroform	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB04	enfluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB05	trichloroetylen	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB06	izofluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB07	desfluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AB08	sewofluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF	Barbiturany, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF01	metoheksytal	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF02	heksobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AF03	tiopental	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AG	Barbiturany w połączeniu z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AG01	narkobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH	Opioidowe leki znieczulające	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH01	fentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH02	alfentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH03	sufentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH04	fenoperydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH05	anilerydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH06	remifentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AH51	fentanyl, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX	Inne leki do znieczulenia ogólnego	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX03	ketamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX04	propanidyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX05	alfaksalon	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX07	etomidat	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX10	propofol	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX11	sodu hydroksymaślan	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX13	podtlenek azotu	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX14	esketamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX15	ksenon	WHO Anatomical Therapeutic Chemical classification
0‑L	N01AX63	podtlenek azotu, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01B	LEKI DO ZNIECZULENIA MIEJSCOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA	Estry kwasu aminobenzoesowego	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA01	metabutetamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA02	prokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA03	tetrakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA04	chloroprokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA05	benzokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA52	prokaina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BA53	tetrakaina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB	Amidy	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB01	bupiwakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB02	lidokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB03	mepiwakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB04	prylokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB05	butanilikaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB06	cynchokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB07	etydokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB08	artykaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB09	ropiwakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB10	lewobupiwakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB51	bupiwakaina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB52	lidokaina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB53	mepiwakaina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB54	prylokaina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB57	etydokaina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB58	artykaina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BB59	bupiwakaina i meloksykam	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BC	Estry kwasu benzoesowego	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BC01	kokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX	Inne leki do znieczulenia miejscowego	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX01	etylu chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX02	dyklonina	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX03	fenol	WHO Anatomical Therapeutic Chemical classification
0‑L	N01BX04	kapsaicyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02	LEKI PRZECIWBÓLOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	N02A	OPIOIDY	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA	Naturalne alkaloidy opium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA01	morfina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA02	opium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA03	hydromorfon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA04	nikomorfina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA05	oksykodon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA08	dihydrokodeina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA10	papaweretum	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA11	oksymorfon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA51	morfina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA53	hydromorfon i nalokson	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA55	oksykodon i nalokson	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA56	oksykodon i naltrekson	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA58	dihydrokodeina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA59	kodeina, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AA79	kodeina, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB	Pochodne fenylopiperydyny	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB01	ketobemidon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB02	petydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB03	fentanyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB52	petydyna, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AB72	petydyna, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC	Pochodne difenylopropyloaminy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC01	dekstromoramid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC03	pirytramid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC04	dekstropropoksyfen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC05	bezytramid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC52	metadon, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC54	dekstropropoksyfen, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AC74	dekstropropoksyfen, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD	Pochodne benzomorfanu	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD01	pentazocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD02	fenazocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AD51	pentazocyna i nalokson	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AE	Pochodne orypawiny	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AE01	buprenorfina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AF	Pochodne morfinanu	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AF01	butorfanol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AF02	nalbufina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG	Opioidy w połączeniu z lekami przeciwskurczowymi	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG01	morfina i leki przeciwskurczowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG02	ketobemidon i leki przeciwskurczowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG03	petydyna i leki przeciwskurczowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AG04	hydromorfon i leki przeciwskurczowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ	Opioidy w połączeniu z nieopioidowymi lekami przeciwbólowymi	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ01	dihydrokodeina i paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ02	dihydrokodeina i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ03	dihydrokodeina i inne nieopioidowe leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ06	kodeina i paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ07	kodeina i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ08	kodeina i ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ09	kodeina i inne nieopioidowe leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ13	tramadol i paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ14	tramadol i deksketoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ15	tramadol i inne nieopioidowe leki przeciwbólowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ16	tramadol i celekoksyb	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ17	oksykodon i paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ18	oksykodon i kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ19	oksykodon i ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ22	hydrokodon i paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AJ23	hydrokodon i ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX	Inne opioidy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX01	tylidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX02	tramadol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX03	dezocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX05	meptazynol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX06	tapentadol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX07	olicerydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02AX51	tilidyna i nalokson	WHO Anatomical Therapeutic Chemical classification
0‑L	N02B	INNE LEKI PRZECIWBÓLOWE I PRZECIWGORĄCZKOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA	Kwas salicylowy i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA01	kwas acetylosalicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA02	aloksypryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA03	choliny salicylan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA04	sodu salicylan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA05	salicylamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA06	salsalat	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA07	etenzamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA08	morfoliny salicylan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA09	dipirocetyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA10	benorylat	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA11	diflunizal	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA12	potasu salicylan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA14	guacetyzal	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA15	karbazalat wapniowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA16	imidazolu salicylan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA51	kwas acetylosalicylowy, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA55	salicylamid, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA57	etenzamid, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA59	dipirocetyl, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA65	karbazalat wapniowy, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA67	salicylan magnezu, kombinacje, z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA71	kwas acetylosalicylowy, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA75	salicylamid, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA77	etenzamid, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BA79	dipirocetyl, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB	Pirazolony	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB01	fenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB02	metamizol sodowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB03	aminofenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB04	propyfenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB05	nifenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB51	fenazon, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB52	metamizol sodowy, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB53	aminofenazon, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB54	propyfenazon, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB71	fenazon, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB72	metamizol sodowy, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB73	aminofenazon, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BB74	propyfenazon, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE	Anilidy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE01	paracetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE03	fenacetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE04	bucetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE05	propacetamol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE51	paracetamol, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE53	fenacetyna, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE54	bucetyna, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE71	paracetamol, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE73	fenacetyna, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BE74	bucetyna, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BF	Gabapentynoidy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BF01	gabapentyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BF02	pregabalina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BF03	mirogabalina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG	Inne leki przeciwbólowe i przeciwgorączkowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG02	rymazolium	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG03	glafenina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG04	floktafenina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG05	wiminol	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG06	nefopam	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG07	flupirtyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG08	zykonotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG09	metoksyfluran	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG10	kannabinoidy	WHO Anatomical Therapeutic Chemical classification
0‑L	N02BG12	tanezumab	WHO Anatomical Therapeutic Chemical classification
0‑L	N02C	LEKI PRZECIWMIGRENOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA	Alkaloidy sporyszu	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA01	dihydroergotamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA02	ergotamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA04	metysergid	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA07	lizuryd	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA51	dihydroergotamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA52	ergotamina, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CA72	ergotamina, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CB	Pochodne kortykosteroidów	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CB01	flumedrokson	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC	Selektywni agoniści receptora serotoninowego (5HT1)	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC01	sumatryptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC02	naratryptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC03	zolmitryptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC04	ryzatryptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC05	almotryptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC06	eletryptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC07	frowatryptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC08	lasmiditan	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CC51	sumatryptan i naproksen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD	Antagoniści peptydów związanych z genem kalcytoniny (CGRP)	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD01	erenumab	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD02	galcanezumab	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD03	fremanezumab	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD04	ubrogepant	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD05	eptinezumab	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD06	rimegepant	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CD07	atogepant	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX	Inne leki przeciwmigrenowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX01	pizotyfen	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX02	klonidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX03	iprazochrom	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX05	dimetotiazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N02CX06	oksetoron	WHO Anatomical Therapeutic Chemical classification
0‑L	N03	LEKI PRZECIWPADACZKOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	N03A	LEKI PRZECIWPADACZKOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA	Barbiturany i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA01	metylofenobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA02	fenobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA03	prymidon	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA04	barbeksaklon	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AA30	metarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB	Pochodne hydantoiny	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB01	etotoina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB02	fenytoina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB03	amino(difenylohydantoiny) walerianian	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB04	mefenytoina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB05	fosfenytoina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB52	fenytoina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AB54	mefenytoina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC	Pochodne oksazolidyny	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC01	parametadion	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC02	trimetadion	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AC03	etadion	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD	Pochodne imidu kwasu bursztynowego	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD01	etosuksymid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD02	fensuksymid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD03	mesuksymid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AD51	etosuksymid, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AE	Pochodne benzodiazepiny	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AE01	klonazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF	Pochodne karboksamidu	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF01	karbamazepina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF02	okskarbazepina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF03	rufinamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AF04	eslikarbazepina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG	Pochodne kwasów tłuszczowych	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG01	kwas walproi	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG02	walpromid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG03	kwas aminomasłowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG04	wigabatryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG05	progabid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AG06	tiagabina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX	Inne leki przeciwpadaczkowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX03	sultiam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX07	fenacemid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX09	lamotrygina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX10	felbamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX11	topiramat	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX13	feneturyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX14	lewetyracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX15	zonisamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX17	styrypentol	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX18	lakozamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX19	karysbamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX21	retygabina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX22	perampanel	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX23	brywaracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX24	kanabidiol	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX25	cenobamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX26	fenfluramina	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX27	ganaksolon	WHO Anatomical Therapeutic Chemical classification
0‑L	N03AX30	beklamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N04	LEKI STOSOWANE W CHOROBIE PARKINSONA	WHO Anatomical Therapeutic Chemical classification
0‑L	N04A	LEKI CHOLINOLITYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA	Aminy trzeciorzędowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA01	triheksyfenidyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA02	biperyden	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA03	metyksen	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA04	procyklidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA05	profenamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA08	deksetymid	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA09	fenglutarymid	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA10	mazatykol	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA11	bornapryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AA12	tropatepina	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AB	Etery chemicznie zbliżone do leków przeciwhistamich	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AB01	etanautyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AB02	orfenadryny chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AC	Etery tropiny lub pochodne tropiny	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AC01	benzatropina	WHO Anatomical Therapeutic Chemical classification
0‑L	N04AC30	etybenzatropina	WHO Anatomical Therapeutic Chemical classification
0‑L	N04B	LEKI DOPAMINERGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA	Dopa i pochodne dopy	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA01	lewodopa	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA02	lewodopa i inhibitor dekarboksylazy	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA03	lewodopa, inhibitor dekarboksylazy i inhibitor COMT	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA04	melewodopa	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA05	melewodopa i inhibitor dekarboksylazy	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA06	etylewodopa i inhibitor dekarboksylazy	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BA07	foslewodopa i inhibitor dekarboksylazy	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BB	Pochodne adamantanu	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BB01	amantadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC	Agoniści dopaminy	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC01	bromokryptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC02	pergolid	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC03	dihydroergokryptyny mezylan	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC04	ropinirol	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC05	pramipeksol	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC06	kabergolina	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC07	apomorfina	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC08	pirybedyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BC09	rotygotyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD	Inhibitory monoaminooksydazy typu B	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD01	selegilina	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD02	rasagilina	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BD03	safinamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX	Inne leki dopaminergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX01	tolkapon	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX02	entakapon	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX03	budypina	WHO Anatomical Therapeutic Chemical classification
0‑L	N04BX04	opikapon	WHO Anatomical Therapeutic Chemical classification
0‑L	N04C	INNE LEKI STOSOWANE W CHOROBIE PARKINSONA	WHO Anatomical Therapeutic Chemical classification
0‑L	N04CX	Inne leki stosowane w leczeniu choroby parkinsona	WHO Anatomical Therapeutic Chemical classification
0‑L	N04CX01	istradefylina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05	LEKI PSYCHOLEPTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	N05A	LEKI PRZECIWPSYCHOTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA	Fenotiazyny z alifatycznym łańcuchem bocznym	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA01	chloropromazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA02	lewomepromazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA03	promazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA04	acepromazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA05	triflupromazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA06	cyjamemazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AA07	chloroproetazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB	Fenotiazyny ze strukturą piperazyny	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB01	diksyrazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB02	flufenazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB03	perfenazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB04	prochloroperazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB05	tiopropazat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB06	trifluoperazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB07	acetofenazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB08	tioproperazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB09	butaperazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AB10	perazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC	Fenotiazyny ze strukturą piperydyny	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC01	akceptacja	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC02	akceptacja	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC03	mezorydazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AC04	pipotiazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD	akceptacja	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD01	haloperydol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD02	trifluperydol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD03	melperon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD04	moperon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD05	pipamperon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD06	bromoperydol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD07	benperydol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD08	droperydol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD09	fluanizon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AD10	lumateperon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE	Pochodne indolu	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE01	oksypertyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE02	molindon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE03	sertyndol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE04	zyprazydon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AE05	lurazydon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF	Pochodne tioksantenu	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF01	flupentyksol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF02	klopentyksol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF03	chloroprotyksen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF04	tiotyksen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AF05	zuklopentyksol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG	Pochodne difenylobutylopiperydyny	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG01	fluspirylen	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG02	pimozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AG03	penflurydol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH	Diazepiny, oksazepiny, tiazepiny i oksepiny	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH01	loksapina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH02	klozapina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH03	olanzapina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH04	kwetiapina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH05	azenapina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH06	klotiapina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AH53	olanzapina i samidorfan	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL	Benzamidy	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL01	sulpiryd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL02	sultopryd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL03	tiapryd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL04	remoksypryd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL05	akceptacja	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL06	weralipryd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AL07	lewosulpiryd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AN	Lit	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AN01	lit	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX	Inne leki przeciwpsychotyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX07	protypendyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX08	rysperydon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX10	mozapramina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX11	zotepina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX12	arypiprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX13	paliperydon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX14	iloperydon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX15	karyprazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX16	brekspiprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05AX17	pimawanseryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05B	ANKSJOLITYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA	Pochodne benzodiazepiny	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA01	diazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA02	chlorodiazepoksyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA03	medazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA04	oksazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA05	potasu klorazepan	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA06	lorazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA07	adynazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA08	bromazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA09	klobazam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA10	ketazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA11	prazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA12	alprazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA13	halazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA14	pinazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA15	kamazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA16	nordazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA17	fludiazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA18	etylu loflazepan	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA19	etyzolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA21	klotiazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA22	kloksazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA23	tofizopam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA24	bentazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA25	meksazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BA56	lorazepam, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB	akceptacja	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB01	hydroksyzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB02	kaptodiam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BB51	hydroksyzyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC	Karbaminiany	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC01	meprobamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC03	emylkamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC04	mebutamat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BC51	meprobamat, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BD	Pochodne dibenzobicyklooktadienu	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BD01	benzoktamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BE	Pochodne azaspirodekanodionu	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BE01	buspiron	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX	Inne anksjolityki	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX01	mefenoksalon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX02	gedokarnil	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX03	etyfoksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX04	fabomotyzol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05BX05	olejek eteryczny lawendowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N05C	LEKI NASENNE I USPOKAJAJĄCE	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA	Barbiturany, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA01	pentobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA02	amobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA03	butobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA04	barbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA05	aprobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA06	sekobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA07	talbutal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA08	winylbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA09	winbarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA10	cyklobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA11	heptabarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA12	repozal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA15	metoheksytal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA16	heksobarbital	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA19	tiopental	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA20	akceptacja	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA21	akceptacja	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CA22	proksybarbal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CB	Barbiturany, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CB01	połączenia barbituranów	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CB02	barbiturany w połączeniu z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC	Aldehydy i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC01	wodzian chloralu	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC02	chloralodol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC03	acetyloglicynoamidu chloralu wodzian	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC04	dichloralfenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CC05	paraldehyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD	Pochodne benzodiazepiny	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD01	flurazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD02	nitrazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD03	flunitrazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD04	estazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD05	triazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD06	lormetazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD07	temazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD08	midazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD09	brotyzolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD10	kwazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD11	loprazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD12	doksefazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD13	cynolazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD14	remimazolam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CD15	nimetazepam	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE	Pochodne piperydynodionu	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE01	glutetymid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE02	metyprylon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CE03	pirytyldion	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF	Benzodiazepiny leki pokrewne	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF01	zopiklon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF02	zolpidem	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF03	zaleplon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CF04	eszopiklon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CH	Agoniści receptora melatoniny	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CH01	melatonina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CH02	ramelteon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CH03	tazymelteon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CJ	Antagoniści receptora oreksyny	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CJ01	suworeksant	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CJ02	lemboreksant	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CJ03	daridoreksant	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM	Inne leki nasenne i uspokajające	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM01	metakwalon	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM02	klometiazol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM03	bromizowal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM04	karbromal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM05	skopolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM06	propiomazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM07	triklofos	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM08	etchlorwynol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM09	Korzeń kozłka	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM10	heksapropymat	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM11	bromki	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM12	apronal	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM13	walnoktamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM15	metylopentynol	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM16	niaprazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CM18	deksmedetomidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX	Leki nasenne i uspokajające w połączeniu, z wyłączeniem barbituranów	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX01	meprobamat, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX02	metakwalon, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX03	metylopentynol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX04	klometiazol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX05	emepronium, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N05CX06	dipiperonyloaminoetanol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N06	LEKI PSYCHOANALEPTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	N06A	LEKI PRZECIWDEPRESYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA	Nieselektywne inhibitory wychwytu zwrotnego monoaminy	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA01	dezypramina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA02	imipramina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA03	imipraminy tlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA04	klomipramina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA05	opipramol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA06	trimipramina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA07	lofepramina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA08	dibenzepina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA09	amitryptylina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA10	nortryptylina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA11	protryptylina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA12	doksepina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA13	ipryndol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA14	melitracen	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA15	butryptylina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA16	dozulepina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA17	amoksapina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA18	dimetakryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA19	amineptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA21	maprotylina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AA23	chinupramina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB	Selektywne inhibitory wychwytu zwrotnego serotoniny	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB02	zymeldyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB03	fluoksetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB04	cytalopram	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB05	paroksetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB06	sertralina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB07	alaproklat	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB08	fluwoksamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB09	etoperydon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AB10	escytalopram	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF	Nieselektywne inhibitory monoaminooksydazy	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF01	izokarboksazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF02	nialamid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF03	fenelzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF04	tranylcypromina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF05	iproniazyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AF06	iproklozyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AG	Inhibitory monoaminooksydazy typu A	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AG02	moklobemid	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AG03	toloksaton	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX	Inne leki przeciwdepresyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX01	oksytryptan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX02	tryptofan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX03	mianseryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX04	nomifensyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX05	trazodon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX06	nefazodon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX07	minapryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX08	bifemelan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX09	wiloksazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX10	oksaflozan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX11	mirtazapina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX12	bupropion	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX13	medyfoksamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX14	tianeptyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX15	piwagabina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX16	wenlafaksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX17	milnacypran	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX18	reboksetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX19	gepiron	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX21	duloksetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX22	agomelatyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX23	deswenlafaksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX24	wilazodon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX25	Ziele dziurawca	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX26	wortioksetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX27	esketamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX28	lewomilnacypran	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX29	breksanolon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06AX62	bupropion i dekstrometorfan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06B	LEKI PSYCHOSTYMULUJĄCE, LEKI STOSOWANE W ADHD I NOOTROPOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA	Sympatykomimetyki działające ośrodkowo	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA01	amfetamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA02	deksamfetamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA03	metamfetamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA04	metylofenidat	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA05	pemolina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA06	fenkamfamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA07	modafinil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA08	fenozolon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA09	atomoksetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA10	fenetylina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA11	deksmetylofenidat	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA12	lisdeksamfetamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA13	armodafinil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA14	solriamfetol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BA15	deksmetylofenidat i serdeksmetylofenidat	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BC	Pochodne ksantyny	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BC01	kofeina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BC02	propentofylina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX	Inne leki psychostymulujące i nootropowe	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX01	meklofenoksat	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX02	pirytynol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX03	piracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX04	deanol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX05	fipeksyd	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX06	cytykolina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX07	oksyracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX08	pirysudanol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX09	linopirdyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX10	nizofenon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX11	aniracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX12	acetylokarnityna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX13	idebenon	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX14	prolintan	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX15	pipradrol	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX16	pramiracetam	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX17	adrafinil	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX18	winpocetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX21	temgikoluryl	WHO Anatomical Therapeutic Chemical classification
0‑L	N06BX22	fenibut	WHO Anatomical Therapeutic Chemical classification
0‑L	N06C	LEKI PSYCHOLEPTYCZNE I PSYCHOANALEPTYCZNE W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA	Leki przeciwdepresyjne w połączeniu z lekami psycholeptycznymi	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA01	amitryptylina i leki psycholeptyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA02	melitracen i leki psycholeptyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CA03	fluoksetyna i leki psycholeptyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	N06CB	Leki psychostymulujące w połączeniu z lekami psycholeptycznymi	WHO Anatomical Therapeutic Chemical classification
0‑L	N06D	LEKI STOSOWANE W ZESPOŁACH OTĘPIENNYCH	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA	Inhibitory cholinoesterazy	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA01	takryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA02	donepezyl	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA03	rywastygmina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA04	galantamina	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA05	ipidakryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA52	donepezyl i memantyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DA53	donepezyl, memantyna i liść miłorzębu japońskiego	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX	Inne leki stosowane w zespołach otępiennych	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX01	memantyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX02	Liść miłorzębu japońskiego	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX03	adukanumab	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX04	lekanemab	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX05	donanemab	WHO Anatomical Therapeutic Chemical classification
0‑L	N06DX30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N07	INNE LEKI DZIAŁAJĄCE NA UKŁAD NERWOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	N07A	PARASYMPATYKOMIMETYKI	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA	Inhibitory cholinoesterazy	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA01	neostygmina	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA02	pirydostygmina	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA03	distygmina	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA30	ambenonium	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AA51	neostygmina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AB	Estry choliny	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AB01	karbachol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AB02	betanechol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX	Inne parasympatykomimetyki	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX01	pilokarpina	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX02	choliny alfosceran	WHO Anatomical Therapeutic Chemical classification
0‑L	N07AX03	cewimelina	WHO Anatomical Therapeutic Chemical classification
0‑L	N07B	LEKI STOSOWANE W UZALEŻNIENIACH	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA	Leki stosowane w uzależnieniu od nikotyny	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA01	nikotyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA03	wareniklina	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BA04	cytyzynyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB	Leki stosowane w uzależnieniu od alkoholu	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB01	disulfiram	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB02	wapnia karbimid	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB03	akamprozat	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB04	naltrekson	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BB05	nalmefen	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC	Leki stosowane w uzależnieniu od opioidów	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC01	buprenorfina	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC02	metadon	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC03	lewacetylometadol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC04	lofeksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC05	lewometadon	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC06	diamorfina	WHO Anatomical Therapeutic Chemical classification
0‑L	N07BC51	buprenorfina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N07C	LEKI PRZECIW ZAWROTOM GŁOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA	Leki przeciw zawrotom głowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA01	betahistyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA02	cynaryzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA03	flunaryzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA04	acetyloleucyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07CA52	cynaryzyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	N07X	INNE LEKI DZIAŁAJĄCE NA UKŁAD NERWOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XA	Gangliozydy i pochodne gangliozydu	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX	Inne leki działające na układ nerwowy	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX01	tyrylazad	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX02	ryluzol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX03	ksaliproden	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX04	sodu hydroksymaślan	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX05	amifamprydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX06	tetrabenazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX07	famprydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX08	tafamidys	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX10	lakwinimod	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX11	pitolisant	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX12	patysyran	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX13	walbenazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX14	edarawon	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX15	inotersen	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX16	deutetrabenazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX17	arimoklomol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX18	wutrisiran	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX19	fenylomaślan sodu i ursodoksykoltauryna	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX21	eplontersen	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX22	tofersen	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX23	troriluzol	WHO Anatomical Therapeutic Chemical classification
0‑L	N07XX59	dekstrometorfan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P	LEKI PRZECIWPASOŻYTNICZE, ŚRODKI OWADOBÓJCZE I REPELENTY	WHO Anatomical Therapeutic Chemical classification
0‑L	P01	LEKI PRZECIWPIERWOTNIAKOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	P01A	LEKI PRZECIW AMEBOZIE I INNYM CHOROBOM PIERWOTNIAKOWYM	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA	Pochodne hydroksychinoliny	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA01	broksychinolina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA02	kliochinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA04	chlorochinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA05	tylbrochinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA30	tylbrochinol i tilichinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AA52	kliochinol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB	Pochodne nitroimidazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB01	metronidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB02	tynidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB03	ornidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB04	azanidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB05	propenidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB06	nimorazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB07	seknidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB51	metronidazol i furazolidon	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AB52	metronidazol i diloksanid	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC	Pochodne dichloroacetamidu	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC01	diloksanid	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC02	klefamid	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC03	etofamid	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AC04	teklozan	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR	Związki arsenu	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR01	arstinol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR02	difetarson	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR03	glikobiarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AR53	glikobiarsol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX	Inne leki przeciw amebozie i innym chorobom pierwotniakowym	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX01	chiniofon	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX02	emetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX04	fanchinon	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX05	mepakryna	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX06	atowakwon	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX07	trimetreksat	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX08	tenonitrozol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX09	dehydroemetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX10	fumagilina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX11	nitazoksanid	WHO Anatomical Therapeutic Chemical classification
0‑L	P01AX52	emetyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P01B	LEKI PRZECIWMALARYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA	Pochodne aminochinoliny	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA01	chlorochina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA02	hydroksychlorochina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA03	prymachina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA06	amodiachina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BA07	tafenochina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB	Biguanidy	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB01	proguanil	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB02	cykloguanilu embonian	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB51	proguanil i atowakwon	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BB52	chlorokwina i proguanil	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BC	Metanolochinoliny	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BC01	chinina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BC02	meflochina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BD	Diaminopirymidyny	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BD01	pirymetamina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BD51	pirymetamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE	Artemizynina i pochodne, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE01	artemizynina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE02	artemeter	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE03	artezunat	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE04	artemotyl	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BE05	artenimol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF	Artemizynina i pochodne, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF01	artemeter i lumefantryna	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF02	artezunat i meflochina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF03	artezunat i amodiachina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF04	artezunat, sulfalen i pirymetamina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF05	artenimol i piperachina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF06	artezunat i pironarydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF07	artemizynina i piperachina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF08	artemizynina i naftochina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BF09	artesunat, sulfadoksyna i pirymetamina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BX	Inne leki przeciwmalaryczne	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BX01	halofantryna	WHO Anatomical Therapeutic Chemical classification
0‑L	P01BX02	arterolan i piperachina	WHO Anatomical Therapeutic Chemical classification
0‑L	P01C	LEKI PRZECIW LEISZMANIOZIE I TRYPANOSOMATOZIE	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CA	Pochodne nitroimidazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CA02	benznidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CA03	feksynidazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CB	Związki antymonu	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CB01	megluminy antymonian	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CB02	sodu styboglukonian	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CC	Pochodne nitrofuranu	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CC01	nifurtymoks	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CC02	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CD	Związki arsenu	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CD01	melarsoprol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CD02	acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX	Inne leki przeciw leiszmaniozie i trypanosomatozom	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX01	pentamidyny izetionian	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX02	suramina sodowa	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX03	eflornityna	WHO Anatomical Therapeutic Chemical classification
0‑L	P01CX04	miltefosyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P02	LEKI PRZECIW ROBAKOM	WHO Anatomical Therapeutic Chemical classification
0‑L	P02B	LEKI PRZECIW PŁAZIŃCOM	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA	Pochodne chinoliny i substancje pokrewne	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA01	prazykwantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA02	oksamnichina	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BA03	arprazykwantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BB	Związki fosforoorganiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BB01	metryfonat	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX	Inne leki przeciw płazińcom	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX01	bitionol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX02	nirydazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX03	stybofen	WHO Anatomical Therapeutic Chemical classification
0‑L	P02BX04	triklabendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02C	LEKI PRZECIW OBLEŃCOM	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA	Pochodne benzimidazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA01	mebendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA02	tiabendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA03	albendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA04	cyklobendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA05	flubendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA06	fenbendazol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CA51	mebendazol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CB	Piperazyna i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CB01	piperazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CB02	dietylokarbamazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CC	Pochodne tetrahydropirymidyny	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CC01	pyrantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CC02	oksantel	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CE	Pochodne imidazotiazolu	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CE01	lewamizol	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CF	Awermektyny	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CF01	iwermektyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX	Inne leki przeciw obleńcom	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX01	pirwinium	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX02	befenium	WHO Anatomical Therapeutic Chemical classification
0‑L	P02CX03	moksydektyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P02D	LEKI PRZECIW TASIEMCOM	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DA	Pochodne kwasu salicylowego	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DA01	niklozamid	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DX	Inne leki przeciw tasiemcom	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DX01	dezaspidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P02DX02	dichlorofen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03	LEKI PRZECIW PASOŻYTOM ZEWNĘTRZNYM, WŁĄCZNIE Z PRZECIWŚWIERZBOWYMI, ŚRODKAMI OWADOBÓJCZYMI I REPELENTAMI	WHO Anatomical Therapeutic Chemical classification
0‑L	P03A	LEKI PRZECIW PASOŻYTOM ZEWNĘTRZNYM, WŁĄCZNIE Z PRZECIWŚWIERZBOWYMI	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA	Preparaty zawierające siarkę	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA01	diksantogen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA02	potasu polisiarczek	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA03	mesulfen	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA04	disulfiram	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA05	tiram	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AA54	disulfiram, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB	Preparaty zawierające chlor	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB01	klofenotan	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB02	lindan	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AB51	klofenotan, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC	Pyretryny, włącznie ze związkami syntetycznymi	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC01	pyretrum	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC02	bioallertyna	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC03	fenotryna	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC04	permetryna	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC51	pyretrum, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC52	bioallertyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC53	fenotryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AC54	permetryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX	Inne leki przeciw pasożytom zewnętrznym, włącznie z przeciwświerzbowymi	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX01	benzylu benzoesan	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX02	miedzi oleinian	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX03	malation	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX04	gorzkla właściwa	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX05	dimetykon	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX06	alkohol benzylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	P03AX07	abametapir	WHO Anatomical Therapeutic Chemical classification
0‑L	P03B	ŚRODKI OWADOBÓJCZE I REPELENTY	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA	Pyretryny	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA01	cyflutryna	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA02	cypermetryna	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA03	dekametryna	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BA04	tetrametryna	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX	Inne środki owadobójcze i repelenty	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX01	dietylotoluamid	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX02	dimetylu ftalan	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX03	dibutylu ftalan	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX04	dibutylu bursztynian	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX05	dimetylokarban	WHO Anatomical Therapeutic Chemical classification
0‑L	P03BX06	etoheksadiol	WHO Anatomical Therapeutic Chemical classification
0‑L	R	UKŁAD ODDECHOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	R01	LEKI DO NOSA	WHO Anatomical Therapeutic Chemical classification
0‑L	R01A	LEKI ZMNIEJSZAJĄCE PRZEKRWIENIE BŁONY ŚLUZOWEJ I INNE LEKI DO NOSA DO STOSOWANIA MIEJSCOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA	Sympatykomimetyki, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA02	cyklopentamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA03	efedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA04	fenylefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA05	oksymetazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA06	tetryzolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA07	ksylometazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA08	nafazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA09	tramazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA10	metyzolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA11	tuaminoheptan	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA12	fenoksazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA13	tymazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA14	epinefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AA15	indanazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB	Sympatykomimetyki, połączenia z wyłączeniem kortykosteroidów	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB01	fenylefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB02	nafazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB03	tetryzolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB05	efedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB06	ksylometazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB07	oksymetazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AB08	tuaminoheptan	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC	Leki przeciwalergiczne, z wyłączeniem kortykosteroidów	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC01	kwas kromoglika	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC02	lewokabastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC03	azelastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC04	antazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC05	kwas spaglumowy	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC06	tonzylamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC07	nedokromil	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC08	olopatadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AC51	kwas kromoglika, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD	Kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD01	beklometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD02	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD03	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD04	flunizolid	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD05	budezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD06	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD07	tyksokortol	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD08	flutykazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD09	mometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD11	triamcynolon	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD12	flutykazonu furoinian	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD13	cyklezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD52	prednizolon, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD53	deksametazon, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD57	tyksokortol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD58	flutykazon, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD59	mometazon, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AD60	hydrokortyzon, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX	Inne leki do nosa	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX01	wapnia heksaminy tiocyjanian	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX02	retynol	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX03	ipratropiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX05	rytiometan	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX06	mupirocyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX07	heksamidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX08	framycetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX09	kwas hialuro	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX10	różne	WHO Anatomical Therapeutic Chemical classification
0‑L	R01AX30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01B	LEKI ZMNIEJSZAJĄCE PRZEKRWIENIE BŁONY ŚLUZOWEJ NOSA DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA	Sympatykomimetyki	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA01	fenylopropanolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA02	pseudoefedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA03	fenylefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA51	fenylopropanolamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA52	pseudoefedryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R01BA53	fenylefryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R02	LEKI STOSOWANE W CHOROBACH GARDŁA	WHO Anatomical Therapeutic Chemical classification
0‑L	R02A	LEKI STOSOWANE W CHOROBACH GARDŁA	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA	Antyseptyki	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA01	ambazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA02	dekwalinium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA03	alkohol dichlorobenzylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA05	chloroheksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA06	cetylopirydynium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA09	benzetonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA10	mirystyl – benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA11	chlorchinaldol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA12	heksylorezorcynol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA13	akryflawiniowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA14	oksychinolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA15	powidon jodowany	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA16	benzalkonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA17	cetrymonium	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA18	heksamidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA19	fenol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA20	różne	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AA21	oktenidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB	Antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB01	neomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB02	tyrotrycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB03	fusafungina	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB04	bacytracyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AB30	gramicydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD	Leki znieczulające miejscowo	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD01	benzokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD02	lidokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD03	kokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD04	dyklonina	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AD05	ambroksol	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AX	Inne leki stosowane w chorobach gardła	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AX01	flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AX02	ibuprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	R02AX03	benzydamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03	LEKI STOSOWANE W CHOROBACH PRZEBIEGAJĄCYCH ZE SKURCZEM OSKRZELI	WHO Anatomical Therapeutic Chemical classification
0‑L	R03A	LEKI ADRENERGICZNE, WZIEWNE	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AA	Agoniści receptorów alfa- i beta-adrenergicznych	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AA01	epinefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AB	Nieselektywni agoniści receptorów beta-adrenergicznych	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AB02	izoprenalina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AB03	orcyprenalina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC	Selektywni agoniści receptorów beta-2-adrenergicznych	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC02	salbutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC03	terbutalina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC04	fenoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC05	rymiterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC06	heksoprenalina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC07	izoetaryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC08	pirbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC09	tretochinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC10	karbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC11	tulobuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC12	salmeterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC13	formoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC14	klenbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC15	reproterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC16	prokaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC17	bitolterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC18	indakaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AC19	olodaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AH	Połączenia leków adrenergicznych	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK	Leki adrenergiczne w połączeniu z krortykosteroidami lub innymi lekami, z wyłączeniem leków cholinolitycznych	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK01	epinefryna i inne leki stosowane w chorobach przebigających ze skurczem oskrzeli	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK02	izoprenalina i inne leki stosowane w chorobach przebigających ze skurczem oskrzeli	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK04	salbutamol i sodu kromoglikan	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK05	reproterol i sodu kromoglikan	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK06	salmeterol i flutykazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK07	formoterol i budezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK08	formoterol i beklometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK09	formoterol i mometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK10	wilanterol i flutykazonu furoinian	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK11	formoterol i flutykazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK12	salmeterol i budezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK13	salbutamol i beklometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK14	indakaterol i mometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AK15	salbutamol i budezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL	Leki adrenergiczne w połączeniu z lekami cholinolitycznymi włącznie z potrójnymi połączeniami z kortykosteroidami	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL01	fenoterol i ipratropiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL02	salbutamol i ipratropiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL03	wilanterol i umeklidyniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL04	indakaterol i glikopironiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL05	formoterol i aklidyniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL06	olodaterol i tiotropiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL07	formoterol i glikopironiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL08	wilanterol, umeklidyniowy bromek i flutykazonu furoinian	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL09	formoterol, glikopironiowy bromek i beklometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL10	formoterol i tiotropiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL11	formoterol, glikopironiowy bromek i budezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03AL12	indakaterol, glikopironiowy bromek i mometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03B	INNE LEKI STOSOWANE W CHOROBACH PRZEBIEGAJĄCYCH ZE SKURCZEM OSKRZELI, WZIEWNE	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA	Glikokortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA01	beklometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA02	budezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA03	flunizolid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA04	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA05	flutykazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA06	triamcynolon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA07	mometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA08	cyklezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BA09	flutykazonu furoinian	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB	Leki cholinolityczne	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB01	ipratropiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB02	oksytropiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB03	preparaty bielunia dziędzierzawy	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB04	tiotropiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB05	aklidyniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB06	glikopironiowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB07	umeklidyniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB08	rewefenacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BB54	tiotropiowy bromek, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BC	Leki przeciwalergiczne, z wyłączeniem kortykosteroidów	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BC01	kwas kromoglika	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BC03	nedokromil	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BX	Inne leki stosowane w chorobach przebiegających ze skurczem oskrzeli, wziewne	WHO Anatomical Therapeutic Chemical classification
0‑L	R03BX01	fenspiryd	WHO Anatomical Therapeutic Chemical classification
0‑L	R03C	LEKI ADRENERGICZNE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CA	Agoniści receptorów alfa- i beta-adrenergicznych	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CA02	efedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB	Nieselektywni agoniści receptorów beta-adrenergicznych	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB01	izoprenalina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB02	metoksyfenamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB03	orcyprenalina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB51	izoprenalina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CB53	orcyprenalina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC	Selektywni agoniści receptorów beta-2-adrenergicznych	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC02	salbutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC03	terbutalina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC04	fenoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC05	heksoprenalina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC06	izoetaryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC07	pirbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC08	prokaterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC09	tretochinol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC10	karbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC11	tulobuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC12	bambuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC13	klenbuterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC14	reproterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC15	formoterol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC53	terbutalina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CC63	klenbuterol i ambroksol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03CK	Leki adrenergiczne i inne leki stosowane w chorobach przebiegających ze skurczem oskrzeli	WHO Anatomical Therapeutic Chemical classification
0‑L	R03D	INNE LEKI DO STOSOWANIA OGÓLNEGO W CHOROBACH PRZEBIEGAJĄCYCH ZE SKURCZEM OSKRZELI	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA	Ksantyny	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA01	diprofilina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA02	choliny teofilinian	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA03	proksyfilina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA04	teofilina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA05	aminofilina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA06	etamifilina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA07	teobromina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA08	bamifilina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA09	acefilina z piperazyną	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA10	bufilina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA11	boksofilina	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA12	mepyraminy teofilinooctan	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA20	połączenia ksantyn	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA51	diprofilina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA54	teofilina, połączenia z wyłączeniem psycholeptyków	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA55	aminofilina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA57	teobromina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DA74	teofilina, połączenia z psycholeptykami	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB	Ksantyny i leki adrenergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB01	diprofilina i leki adrenergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB02	choliny teofilinian i leki adrenergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB03	proksyfilina i leki adrenergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB04	teofilina i leki adrenergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB05	aminofilina i leki adrenergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DB06	etamifilina i leki adrenergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC	Antagoniści receptora leukotrienowego	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC01	zafirlukast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC02	pranlukast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC03	montelukast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC04	ibudilast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DC53	montelukast, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX	Inne leki do stosowania ogólnego w chorobach przebiegających ze skurczem oskrzeli	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX01	amleksanoks	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX02	eprozynol	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX03	fenspiryd	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX05	omalizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX06	seratrodast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX07	roflumilast	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX08	reslizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX09	mepolizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX10	benralizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R03DX11	tezepelumab	WHO Anatomical Therapeutic Chemical classification
0‑L	R05	LEKI STOSOWANE W KASZLU I PRZEZIĘBIENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	R05C	LEKI WYKRZTUŚNE, Z WYŁĄCZENIEM POŁĄCZEŃ Z LEKAMI PRZECIWKASZLOWYMI	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA	Leki wykrztuśne	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA01	tyloksapol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA02	potasu jodek	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA03	gwajafenezyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA04	ipekakuana	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA05	altheae radix (korzeń prawoślazu)	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA06	krzyżownica	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA07	antymonu pentasiarczek	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA08	kreozot	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA09	gwajakolosulfonian	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA10	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA11	lewowerbenon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA12	liść bluszczu pospolitego	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CA13	cyneol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB	Mukolityki	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB01	acetylocysteina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB02	bromoheksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB03	karbocysteina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB04	eprazynon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB05	mesna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB06	ambroksol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB07	sobrerol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB08	domiodol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB09	letosteina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB10	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB11	stepronina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB13	dornaza alfa (dezoksyrybonukleaza)	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB14	nelteneksyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB15	erdosteina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05CB16	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05D	LEKI PRZECIWKASZLOWE, Z WYŁĄCZENIEM POŁĄCZEŃ Z LEKAMI WYKRZTUŚNYMI	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA	Alkaloidy opium i pochodne	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA01	etylomorfina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA03	hydrokodon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA04	kodeina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA05	alkaloidy opium z morfiną	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA06	normetadon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA07	noskapina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA08	folkodyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA09	dekstrometorfan	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA10	tebakon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA11	dimemorfan	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA12	acetylodihydrokodeina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DA20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB	Inne leki przeciwkaszlowe	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB01	benzonatat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB02	benproperyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB03	klobutynol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB04	izoaminil	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB05	pentoksyweryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB07	oksolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB09	okseladyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB10	klofedanol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB11	pipazetat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB12	bibenzoniowy bromek	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB13	butamirat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB14	fedrylat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB15	zipeprol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB16	dibunat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB17	droksypropina	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB18	prenoksdiazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB19	dropropizyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB20	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB21	kloperastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB22	meprotyksol	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB23	piperydion	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB24	typepidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB25	morklofon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB26	nepinalon	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB27	lewodropropizyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB28	dimetoksanat	WHO Anatomical Therapeutic Chemical classification
0‑L	R05DB29	gefapiksant	WHO Anatomical Therapeutic Chemical classification
0‑L	R05F	LEKI PRZECIWKASZLOWE I WYKRZTUŚNE, POŁĄCZENIA	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FA	Pochodne opium i leki wykrztuśne	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FA01	pochodne opium i mukolityki	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FA02	pochodne opium i leki wykrztuśne	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FB	Inne leki przeciwkaszlowe i wykrztuśne	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FB01	leki przeciwkaszlowe i mukolityki	WHO Anatomical Therapeutic Chemical classification
0‑L	R05FB02	leki przeciwkaszlowe i wykrztuśne	WHO Anatomical Therapeutic Chemical classification
0‑L	R05X	INNE PREPARATY PRZECIW PRZEZIĘBIENIOM	WHO Anatomical Therapeutic Chemical classification
0‑L	R06	LEKI PRZECIWHISTAMINOWE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	R06A	LEKI PRZECIWHISTAMINOWE DO STOSOWANIA OGÓLNEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA	Aminoalkilowe etery	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA01	bromazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA02	difenhydramina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA04	klemastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA06	chlorfenoksamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA07	difenylopiralina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA08	karbinoksamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA09	doksylamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA10	trimetobenzamid	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA11	dimenhydrynat	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA52	difenhydramina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA54	klemastyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA56	chlorfenoksamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA57	difenylopiralina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA59	doksylamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AA61	dimenhydrynat, kombinacje	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB	Alkiloaminy podstawione	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB01	bromofeniramina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB02	deksochlorofeniramina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB03	dimetynden	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB04	chlorofenamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB05	feniramina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB06	deksbromofeniramina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB07	talastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB51	bromofeniramina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB52	dekschlorofeniramina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB54	chlorofenamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AB56	deksbromofeniramina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC	Etylenodiaminy podstawione	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC01	mepiramina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC02	histapirodyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC03	chloropiramina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC04	tripelenamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC05	metapirylen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC06	tonzylamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC52	histapirodyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AC53	chlorpiramina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD	Pochodne fenotiazyny	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD01	alimemazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD02	prometazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD03	tietyloperazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD04	metdylazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD05	hydroksyetyloprometazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD06	tiazynam	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD07	mekwitazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD08	oksomemazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD09	izotipendyl	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD52	prometazyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AD55	hydroksyetyloprometazyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE	Pochodne piperazyny	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE01	buklizyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE03	cyklizyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE04	chlorocyklizyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE05	meklozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE06	oksatomid	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE07	cetyryzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE09	lewocetyryzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE51	buklizyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE53	cyklizyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AE55	meklozyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AK	Połączenia leków przeciwhistamich	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX	Inne leki przeciwhistaminowe do stosowania ogólnego	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX01	bamipina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX02	cyproheptadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX03	tenalidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX04	fenindamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX05	antazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX07	triprolidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX08	pirobutamina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX09	azatadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX11	astemizol	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX12	terfenadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX13	loratadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX15	mebhydrolina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX16	deptropina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX17	ketotifen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX18	akrywastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX19	azelastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX21	trytokwalina	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX22	ebastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX23	pimetiksen	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX24	epinastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX25	mizolastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX26	feksofenadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX27	desloratadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX28	rupatadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX29	bilastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX31	chifenadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX32	sekwifenadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX53	tenalidyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R06AX58	pirobutamina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R07	INNE LEKI STOSOWANE W CHOROBACH UKŁADU ODDECHOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	R07A	INNE LEKI STOSOWANE W CHOROBACH UKŁADU ODDECHOWEGO	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA	Surfaktanty płucne	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA01	kolfoscerylu palmitynian	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA02	naturalne fosfolipidy	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AA30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB	Leki pobudzające czynność oddechową	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB01	doksapram	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB02	niketamid	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB03	pentetrazol	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB04	etamiwan	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB05	bemegryd	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB06	pretkamid	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB07	almitryna	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB08	dimeflina	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB09	mepiksanoks	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB52	niketamid, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AB53	pentetrazol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX	Inne leki stosowane w chorobach układu oddechowego	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX01	tlenek azotu	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX02	iwakaftor	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX30	iwakaftor i lumakaftor	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX31	iwakaftor i tezakaftor	WHO Anatomical Therapeutic Chemical classification
0‑L	R07AX32	iwakaftor, tezakaftor i eleksakaftor	WHO Anatomical Therapeutic Chemical classification
0‑L	S	NARZĄDY ZMYSŁÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	S01	LEKI OFTALMOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S01A	LEKI PRZECIWINFEKCYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA	Antybiotyki	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA01	chloramfenikol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA02	chlorotetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA03	neomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA04	oksytetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA05	tyrotrycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA07	framycetyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA09	tetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA10	natamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA11	gentamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA12	tobramycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA13	kwas fusydy	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA14	benzylopenicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA15	dihydrostreptomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA16	ryfamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA17	erytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA18	polimyksyna B	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA19	ampicylina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA20	antybiotyki w połączeniu z innymi lekami	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA21	amikacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA22	mikronomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA23	netylmycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA24	kanamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA25	azydamfenikol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA26	azytromycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA27	cefuroksym	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA28	wankomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA29	dibekacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA30	połączenia różnych antybiotyków	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA31	cefmenoksym	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AA32	bacytracyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB	Sulfonamidy	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB01	sulfametyzol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB02	sulfafurazol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB03	sulfadikramid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB04	sulfacetamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AB05	sulfafenazol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD	Leki przeciwwirusowe	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD01	idoksurydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD02	triflurydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD03	acyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD05	interferon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD06	widarabina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD07	famcyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD08	fomiwirsen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AD09	gancyklowir	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE	Fluorochinolony	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE01	ofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE02	norfloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE03	cyprofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE04	lomefloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE05	lewofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE06	gatyfloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE07	moksyfloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE08	bezyfloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AE09	tosufloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX	Inne leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX01	związki rtęci	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX02	związki srebra	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX03	związki cynku	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX04	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX05	bibrokatol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX06	rezorcynol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX07	sodu boran	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX08	heksamidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX09	chloroheksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX10	sodu propionian	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX14	dibromopropamidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX15	propamidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX16	pikloksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX18	powidon jodowany	WHO Anatomical Therapeutic Chemical classification
0‑L	S01AX24	poliheksanid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01B	LEKI PRZECIWZAPALNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA	Kortykosteroidy, bez dodatków	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA01	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA02	hydrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA03	kortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA04	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA05	triamcynolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA06	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA07	fluorometolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA08	medryzon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA09	klobetazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA10	alklometazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA11	dezonid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA12	formokortal	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA13	rimeksolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA14	loteprednol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA15	fluocynolonu acetonid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BA16	difluprednat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB	Kortykosteroidy i leki rozszerzające źrenice w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB01	hydrokortyzon i leki rozszerzające źrenice	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB02	prednizolon i leki rozszerzające źrenice	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB03	fluorometolon i leki rozszerzające źrenice	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BB04	betametazon i leki rozszerzające źrenice	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC	Niesteroidowe leki przeciwzapalne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC01	indometacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC02	oksyfenbutazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC03	diklofenak	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC04	flurbiprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC05	ketorolak	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC06	piroksykam	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC07	bendazak	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC08	kwas salicylowy	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC09	pranoprofen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC10	nepafenak	WHO Anatomical Therapeutic Chemical classification
0‑L	S01BC11	bromfenak	WHO Anatomical Therapeutic Chemical classification
0‑L	S01C	LEKI PRZECIWZAPALNE I PRZECIWINFEKCYJNE W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA	Kortykosteroidy i leki przeciwinfekcyjne w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA01	deksametazon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA02	prednizolon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA03	hydrokortyzon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA04	fluokortolon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA05	betametazon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA06	fludrokortyzon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA07	fluorometolon I leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA08	metyloprednizolon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA09	chloroprednizolon leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA10	fluocynolonu acetonid i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA11	klobetazon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CA12	loteprednol i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB	Kortykosteroidy/ leki przeciwinfekcyjne/ leki rozszerzające źrenice w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB01	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB02	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB03	hydrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB04	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CB05	fluorometolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CC	Leki przeciwzapalne, połączenie leków niesteroidowych i przeciwinfekcyjnch	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CC01	diklofenak i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01CC02	indometacyna i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01E	LEKI STOSOWANE W JASKRZE I ZWĘŻAJĄCE ŹRENICE	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA	Sympatykomimetyki stosowane w leczeniu jaskry	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA01	epinefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA02	dipiwefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA03	apraklonidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA04	klonidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA05	brymonidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EA51	epinefryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB	Parasympatykomimetyki	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB01	pilokarpina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB02	karbachol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB03	ekotiopat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB04	demekarium	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB05	fizostygmina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB06	neostygmina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB07	fluostygmina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB08	aceklidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB09	acetylocholina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB10	paraokson	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB51	pilokarpina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EB58	aceklidyna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC	Inhibitory anhydrazy węglanowej	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC01	acetazolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC02	diklofenamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC03	dorzolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC04	brynzolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC05	metazolamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EC54	brynzolamid, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED	Beta-adrenolityki	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED01	tymolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED02	betaksolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED03	lewobunolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED04	metypranolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED05	karteolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED06	befunolol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED51	tymolol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED52	betaksolol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED54	metypranolol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01ED55	karteolol, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE	Analogi prostaglandyny	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE01	latanoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE02	unoproston	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE03	bimatoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE04	trawoprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE05	tafluprost	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE06	latanoprosten bunod	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EE51	latanoprost i netarsudyl	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX	Inne leki stosowane w jaskrze	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX01	guanetydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX02	dapiprazol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX05	netarsudyl	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX06	omidenepag	WHO Anatomical Therapeutic Chemical classification
0‑L	S01EX07	ripasudyl	WHO Anatomical Therapeutic Chemical classification
0‑L	S01F	LEKI ROZSZERZAJĄCE ŹRENICE I PORAŻAJĄCE AKOMODACJE	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA	Leki cholinolityczne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA01	atropina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA02	skopolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA03	metyloskopolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA04	cyklopentolat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA05	homatropina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA06	tropikamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA54	cyklopentolat, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FA56	tropikamid, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB	Sympatykomimetyki, z wyłączeniem leków stosowanych w jaskrze	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB01	fenylefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB02	efedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB03	ibopamina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01FB51	fenylefryna i ketorolak	WHO Anatomical Therapeutic Chemical classification
0‑L	S01G	LEKI ZWĘŻAJĄCE NACZYNIA KRWIONOŚNE I PRZECIWALERGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA	Sympatykomimetyki stosowane jako leki zwężające naczynia krwionośne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA01	nafazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA02	tetryzolina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA03	ksylometazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA04	oksymetazolina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA05	fenylefryna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA06	oksedryna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA07	brymonidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA51	nafazolina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA52	tetryzolina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA53	ksylometazolina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA55	fenylefryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GA56	oksedryna, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX	Inne leki przeciwalergiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX01	kwas kromoglika	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX02	lewokabastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX03	kwas spaglumowy	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX04	nedokromil	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX05	lodoksamid	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX06	emedastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX07	azelastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX08	ketotifen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX09	olopatadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX10	epinastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX11	alkaftadyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX12	cetyryzyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX13	bilastyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01GX51	kwas kromoglika, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01H	LEKI ZNIECZULAJĄCE MIEJSCOWO	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA	Leki znieczulające miejscowo	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA01	kokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA02	oksybuprokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA03	tetrakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA04	proksymetakaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA05	prokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA06	cynchokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA07	lidokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA08	chloroprokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01HA30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01J	PREPARATY DIAGNOSTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA	Preparaty barwiące	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA01	fluoresceina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA02	róż bengalski sodowy	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JA51	fluoresceina, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01JX	Inne preparaty diagnostyczne oftalmologiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01K	POMOCNICZE ŚRODKI CHIRURGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA	Substancje wiskoelastyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA01	kwas hialuro	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA02	hypromeloza	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KA51	kwas hialuro, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KX	Inne pomocnicze środki chirurgiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KX01	chymotrypsyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01KX02	błękit trypanowy	WHO Anatomical Therapeutic Chemical classification
0‑L	S01L	LEKI STOSOWANE W CHOROBACH NACZYNIOWYCH OKA	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA	Leki przeciwneowaskularyzacyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA01	werteporfina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA02	anekortaw	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA03	pegaptanib	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA04	ranibizumab	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA05	aflibercept	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA06	brolucyzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA07	abicipar pegol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA08	bewacyzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	S01LA09	farycymab	WHO Anatomical Therapeutic Chemical classification
0‑L	S01X	INNE LEKI OFTALMOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA	Inne leki oftalmologiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA01	gwajazulen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA02	retynol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA03	sodu chlorek, roztwór hipertoniczny	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA04	potasu jodek	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA05	sodu edetynian	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA06	etylomorfina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA07	ałun	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA08	acetylocysteina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA09	jodoheparynat	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA10	inozyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA11	nandrolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA12	deksopantenol	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA13	alteplaza	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA14	heparyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA15	kwas askorbowy	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA18	cyklosporyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA19	komórki macierzyste rąbka rogówki, autologiczne	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA20	sztuczne łzy i inne obojętne preparaty	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA21	markaptamina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA22	okryplazmina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA23	sirolimus	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA24	cenegermin	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA25	lifitegrast	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA26	ryboflawina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA27	Woretygen neparwowek	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA28	wareniklina	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA29	sepofarsen	WHO Anatomical Therapeutic Chemical classification
0‑L	S01XA31	pegketakoplan	WHO Anatomical Therapeutic Chemical classification
0‑L	S02	LEKI OTOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S02A	LEKI PRZECIWINFEKCYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA	Leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA01	chloramfenikol	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA02	nitrofural	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA03	kwas borowy	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA04	glinu acetowinian	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA05	kliochinol	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA06	wodoru nadtlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA07	neomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA08	tetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA09	chloroheksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA10	kwas octowy	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA11	polimyksyna B	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA12	ryfamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA13	mikonazol	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA14	gentamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA15	cyprofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA16	ofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA17	fosfomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA18	cefmenoksym	WHO Anatomical Therapeutic Chemical classification
0‑L	S02AA30	leki przeciwinfekcyjne, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S02B	KORTYKOSTEROIDY	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA	Kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA01	hydrokortyzon	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA03	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA06	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA07	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S02BA08	fluocynolonu acetonid	WHO Anatomical Therapeutic Chemical classification
0‑L	S02C	KORTYKOSTEROIDY I LEKI PRZECIWINFEKCYJNE W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA	Kortykosteroidy i leki przeciwinfekcyjne w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA01	prednizolon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA02	flumetazon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA03	hydrokortyzon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA04	triamcynolon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA05	fluocynolonu acetonid i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA06	deksametazon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S02CA07	fludrokortyzon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S02D	INNE LEKI OTOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA	Leki przeciwbólowe i znieczulające	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA01	lidokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA02	kokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA03	fenazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA04	cynchokaina	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DA30	połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S02DC	Leki obojętne	WHO Anatomical Therapeutic Chemical classification
0‑L	S03	LEKI OFTALMOLOGICZNE I OTOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S03A	LEKI PRZECIWINFEKCYJNE	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA	Leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA01	neomycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA02	tetracyklina	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA03	polimyksyna B	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA04	chloroheksydyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA05	heksamidyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA06	gentamycyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA07	cyprofloksacyna	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA08	chloramfenikol	WHO Anatomical Therapeutic Chemical classification
0‑L	S03AA30	leki przeciwinfekcyjne, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	S03B	KORTYKOSTEROIDY	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA	Kortykosteroidy	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA01	deksametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA02	prednizolon	WHO Anatomical Therapeutic Chemical classification
0‑L	S03BA03	betametazon	WHO Anatomical Therapeutic Chemical classification
0‑L	S03C	KORTYKOSTEROIDY I LEKI PRZECIWINFEKCYJNE W POŁĄCZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA	Kortykosteroidy i leki przeciwinfekcyjne w połączeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA01	deksametazon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA02	prednizolon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA04	hydrokortyzon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA05	fludrokortyzon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA06	betametazon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S03CA07	metyloprednizolon i leki przeciwinfekcyjne	WHO Anatomical Therapeutic Chemical classification
0‑L	S03D	INNE PREPARATY OFTALMOLOGICZNE I OTOLOGICZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	V	RÓŻNE	WHO Anatomical Therapeutic Chemical classification
0‑L	V01	ALERGENY	WHO Anatomical Therapeutic Chemical classification
0‑L	V01A	ALERGENY	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA	Wyciągi alergenów	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA01	pierze	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA02	pyłki traw	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA03	roztocza kurzu domowego	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA04	grzyby pleśniowe i drożdże	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA05	pyłki drzew	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA07	owady	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA08	pokarm	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA09	tkaniny	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA10	kwiaty	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA11	zwierzęta	WHO Anatomical Therapeutic Chemical classification
0‑L	V01AA20	różne	WHO Anatomical Therapeutic Chemical classification
0‑L	V03	WSZYSTKIE INNE PRODUKTY LECZNICZE	WHO Anatomical Therapeutic Chemical classification
0‑L	V03A	WSZYSTKIE INNE PRODUKTY LECZNICZE	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB	Odtrutki	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB01	ipekakuana	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB02	nalorfina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB03	edetyniany	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB04	pralidoksym	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB05	prednizolon i prometazyna	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB06	tiosiarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB08	sodu azotyn	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB09	dimerkaprol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB13	obidoksym	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB14	protamina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB15	nalokson	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB16	etanol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB17	metylotioniniowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB18	potasu nadmanganian	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB19	fizostygmina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB20	miedzi siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB21	potasu jodek	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB22	amylu azotyn	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB23	acetylocysteina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB24	przeciwciała przeciw digoksynie	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB25	flumazenil	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB26	metionina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB27	4-dimetyloaminofenol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB29	cholinoesteraza	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB31	błękit pruski	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB32	glutation	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB33	hydroksokobalamina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB34	fomepizol	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB35	sugammadeks	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB36	fentolamina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB37	idarucyzumab	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB38	andeksanet alfa	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AB54	pralidoksym i atropina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC	Czynniki wiążące żelazo	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC01	deferoksamina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC02	deferypron	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AC03	deferazyroks	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE	Leki stosowane w leczeniu hiperkaliemii i hiperfosfatemii	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE01	polistyrenosulfonian	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE02	sewelamer	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE03	lantanu węglan	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE04	wapnia octan i magnezu węglan	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE05	cukrożelazowy tlenowodorotlenek	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE06	kolestylan	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE07	wapnia octan	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE08	żelaza(III) cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE09	wapnia patyromer	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AE10	sodu cyrkonu cyklokrzemian	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF	Leki zmniejszające toksyczność leków przeciwnowotworowych	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF01	mesna	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF02	deksrazoksan	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF03	wapnia folinian	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF04	wapnia lewofolinian	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF05	amifostyna	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF06	sodu folinian	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF07	rasburykaza	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF08	palifermina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF09	glukarpidaza	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF10	sodu lewofolinian	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF11	arginina i lizyna	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AF12	trilacyklib	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AG	Leki stosowane w leczeniu hiperkalcemii	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AG01	sodu fosforan celulozy	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AG05	fosforan sodu	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AH	Leki stosowane w leczeniu hipoglikemii	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AH01	diazoksyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AK	Kleje tkankowe	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AM	Leki stosowane do embolizacji	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN	Gazy medyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN01	tlen	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN02	dwutlenek węgla	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN03	hel	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN04	azot	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AN05	powietrze medyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AX	Inne produkty lecznicze	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AX02	nalfurafina	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AX03	kobicystat	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AX04	difelikefalin	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AZ	Leki hamujące przewodzenie nerwowe	WHO Anatomical Therapeutic Chemical classification
0‑L	V03AZ01	etanol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04	PREPARATY DIAGNOSTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	V04B	TESTY DO BADANIA MOCZU	WHO Anatomical Therapeutic Chemical classification
0‑L	V04C	INNE PREPARATY DIAGNOSTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CA	Testy stosowane w cukrzycy	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CA01	tolbutamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CA02	glukoza	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CB	Testy do badania wchłaniania tłuszczów	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CB01	witaminy A koncentraty	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC	Testy drożności dróg żółciowych	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC01	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC02	magnezu siarczan	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC03	synkalid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CC04	ceruletyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD	Testy czynności przysadki	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD01	metyrapon	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD03	sermorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD04	kortykorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD05	somatorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CD06	macymorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE	Testy czynności wątroby	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE01	galaktoza	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE02	sulfobromoftaleina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CE03	metacetyna (13C)	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CF	Preparaty stosowane w diagnostyce gruźlicy	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CF01	tuberkulina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG	Testy wydzielania żołądkowego	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG01	żywice katiomienne	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG02	betazol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG03	histaminy fosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG04	pentagastryna	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG05	metylotioniniowy chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CG30	kofeina i sodu benzoesan	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH	Testy czynności nerek i uszkodzeń moczowodów	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH01	inulina i inne polifruktozany	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH02	indygokarmin	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH03	fenolosulfonoftaleina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH04	alsaktyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CH30	kwas aminohipurowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CJ	Testy czynności tarczycy	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CJ01	tyreotropina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CJ02	protyrelina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK	Testy czynności trzustki	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK01	sekretyna	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK02	pankreozymina (cholecystokinina)	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CK03	bentyromid	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CL	Testy stosowane w chorobach alergicznych	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CM	Testy stosowane w zaburzeniach płodności	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CM01	gonadorelina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX	Inne preparaty diagnostyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX01	zieleń indocyjaniny	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX02	kwas foliowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX03	metacholina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX04	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX05	13C-mocznik	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX06	heksaminolewulinat	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX07	edrofonium	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX08	tlenek węgla	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX09	błękit sulfanowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX10	pafolacianina	WHO Anatomical Therapeutic Chemical classification
0‑L	V04CX11	chlorek litu	WHO Anatomical Therapeutic Chemical classification
0‑L	V06	PREPARATY ŻYWIENIOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	V06A	PREPARATY ŻYWIENIOWE STOSOWANE W LECZENIU OTYŁOŚCI	WHO Anatomical Therapeutic Chemical classification
0‑L	V06AA	Preparaty żywieniowe ubogokaloryczne	WHO Anatomical Therapeutic Chemical classification
0‑L	V06B	PREPARATY UZUPEŁNIAJĄCE NIEDOBÓR BIAŁEK	WHO Anatomical Therapeutic Chemical classification
0‑L	V06C	PREPARATY ŻYWIENIOWE DLA NIEMOWLĄT	WHO Anatomical Therapeutic Chemical classification
0‑L	V06CA	Preparaty żywieniowe niezawierające fenyloalaniny	WHO Anatomical Therapeutic Chemical classification
0‑L	V06D	INNE PREPARATY ŻYWIENIOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DA	Węglowodany/białka/związki mineralne/witaminy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DB	Tłuszcze/węglowodany/białka/związki mineralne/witaminy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DC	Węglowodany	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DC01	glukoza	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DC02	fruktoza	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DD	Aminokwasy, włącznie z połączeniami z polipeptydami	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DE	Aminokwasy/weglowodany/związki mineralne/witaminy, połączenia	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DF	Preparaty mlekozastępcze	WHO Anatomical Therapeutic Chemical classification
0‑L	V06DX	Inne połączenia substancji odżywczych	WHO Anatomical Therapeutic Chemical classification
0‑L	V07	WSZYSTKIE INNE PREPARATY NIETERAPEUTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	V07A	WSZYSTKIE INNE PREPARATY NIETERAPEUTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AA	Plastry	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AB	Rozpuszczalniki i rozcieńczalniki, włącznie z roztworami do irygacji	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AC	Preparaty pomocnicze do przetaczania krwi	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AD	Preparaty pomocnicze do badania krwi	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AN	Sprzęt stosowany w nietrzymaniu moczu/kału	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AR	Testy wrażliwości, dyski i tabletki	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AS	Zestawy do stomii	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AT	Kosmetyki	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AV	Techniczne preparaty dezynfekujące	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AX	Preparaty do mycia itp.	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AY	Inne nieterapeutyczne preparaty pomocnicze	WHO Anatomical Therapeutic Chemical classification
0‑L	V07AZ	Chemikalia i reagenty do analiz	WHO Anatomical Therapeutic Chemical classification
0‑L	V08	ŚRODKI KONTRASTOWE	WHO Anatomical Therapeutic Chemical classification
0‑L	V08A	ŚRODKI KONTRASTOWE DO BADANIA RTG, ZAWIERAJĄCE JOD	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA	Rozpuszczalne w wodzie, wydalane przez nerki środki kontrastowe o dużej osmolarności do badania RTG	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA01	kwas diatryzoi	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA02	kwas metryzoi	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA03	jodamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA04	kwas jotalamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA05	kwas joksytalamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA06	kwas joglikowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA07	kwas acetryzoi	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA08	kwas jokarmowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA09	metiodal	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AA10	diodon	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB	Rozpuszczalne w wodzie, wydalane przez nerki środki kontrastowe o małej osmolarności do badania RTG	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB01	metryzamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB02	joheksol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB03	kwas joksagly	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB04	jopamidol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB05	jopromid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB06	jotrolan	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB07	jowersol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB08	jopentol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB09	jodyksanol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB10	jomeprol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB11	jobitrydol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AB12	joksylan	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC	Rozpuszczalne w wodzie, wydalane przez wątrobę, środki kontrastowe do badania RTG	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC01	kwas jodoksamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC02	kwas jotroksowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC03	kwas joglikamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC04	adypiodon	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC05	kwas jobenzamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC06	kwas jopanoi	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC07	kwas jocetamowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC08	sodu jopodan	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC09	kwas tyropa	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AC10	wapnia jopodan	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD	Nierozpuszczalne w wodzie środki kontrastowe do badania RTG	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD01	estry etylowe jodowanych kwasów tłuszczowych	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD02	jopidol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD03	propyljodon	WHO Anatomical Therapeutic Chemical classification
0‑L	V08AD04	jofendylan	WHO Anatomical Therapeutic Chemical classification
0‑L	V08B	ŚRODKI KONTRASTOWE DO BADANIA RTG, NIEZAWIERAJĄCE JODU	WHO Anatomical Therapeutic Chemical classification
0‑L	V08BA	Środki kontrastowe do badania RTG zawierające siarczan baru	WHO Anatomical Therapeutic Chemical classification
0‑L	V08BA01	baru siarczan z substancjami zawieszającymi	WHO Anatomical Therapeutic Chemical classification
0‑L	V08BA02	baru siarczan bez substancji zawieszających	WHO Anatomical Therapeutic Chemical classification
0‑L	V08C	ŚRODKI KONTRASTOWE DO MRI	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA	Paramagnetyczne środki kontrastowe	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA01	kwas gadopentetowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA02	kwas gadoterowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA03	gadodiamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA04	gadoterydol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA05	mangafodypir	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA06	gadowersetamid	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA07	żelaza(III)-amonowego cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA08	kwas gadobe	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA09	gadobutrol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA10	kwas gadoksetowy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA11	gadofosweset	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CA12	gadopiklenol	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB	Superparamagnetyczne środki kontrastowe	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB01	ferumoksyl	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB02	ferysten	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CB03	żelaza tlenku nanocząstki	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CX	Inne środki kontrastowe do MRI	WHO Anatomical Therapeutic Chemical classification
0‑L	V08CX01	perflubron	WHO Anatomical Therapeutic Chemical classification
0‑L	V08D	ŚRODKI KONTRASTOWE DO USG	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA	Środki kontrastowe do USG	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA01	perflutren, mikrosfery ludzkiej albuminy	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA02	galaktozy mikrocząstki	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA03	perflenapent	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA04	perflutren, mikrosfery fosfolipidowe	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA05	siarki heksafluorek, mikrosfery fosfolipidowe	WHO Anatomical Therapeutic Chemical classification
0‑L	V08DA06	perflubutan, mikrosfery fosfolipidowe	WHO Anatomical Therapeutic Chemical classification
0‑L	V09	RADIOFARMACEUTYKI DIAGNOSTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	V09A	OŚRODKOWY UKŁAD NERWOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AA	Technetu (99mTc) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AA01	techneto(99mTc)eksametazym	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AA02	techneto(99mTc)bicyzynian	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB	Jodu (123I) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB01	jofetamina znakowana 123I	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB02	jolopryd znakowany 123I	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AB03	joflupan znakowany 123I	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX	Inne radiofarmaceutyki stosowane w diagnostyce ośrodkowego układu nerwowego	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX01	kwas pentety z indem (111In)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX03	2beta-karbometoksy-3beta-(4-jodofenylo)-tropan z jodem (124I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX04	flutemetamol (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX05	florbetapir (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX06	florbetaben (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09AX07	flortaucypir (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09B	UKŁAD SZKIELETOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA	Technetu (99mTc) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA01	kwas oksydro z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA02	kwas medro z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA03	technetu (99mTc) pirofosforan	WHO Anatomical Therapeutic Chemical classification
0‑L	V09BA04	kwas butedro z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09C	UKŁAD MOCZOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA	Technetu (99mTc) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA01	kwas pentety z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA02	technetu (99mTc) sukcymer	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA03	techneto(99mTc)mertiatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA04	technetu (99mTc) gluceptan	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA05	technetu (99mTc) glukonian	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CA06	technetu (99mTc) etylenodicysteina	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX	Inne radiofarmaceutyki stosowane w diagnostyce układu moczowego	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX01	sodu jodohipuran (123I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX02	sodu jodohipuran (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX03	sodu jotalamian (125I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09CX04	chromu (51Cr) edetynian	WHO Anatomical Therapeutic Chemical classification
0‑L	V09D	WĄTROBA I UKŁAD SIATECZKOWO-ŚRÓDBŁONKOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA	Technetu (99mTc) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA01	techneto(99mTc)dizofenina	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA02	techneto(99mTc)etyfenina	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA03	techneto(99mTc)lidofenina	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA04	techneto(99mTc)mebrofenina	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DA05	techneto(99mTc)galtyfenina	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB	Technet (99mTc), cząstki i koloidy	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB01	nanokoloid z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB02	mikrokoloid z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB03	milimikrosfery z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB04	cyna koloidalna z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB05	siarka koloidalna z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB06	renu siarczek koloidalny z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DB07	technetu (99mTc) fitynian	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DX	Inne radiofarmaceutyki stosowane w diagnostyce wątroby i układu siateczkowo-śróbłonkowego	WHO Anatomical Therapeutic Chemical classification
0‑L	V09DX01	kwas tauroselcholowy z selenem (75Se)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09E	UKŁAD ODDECHOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA	Wziewne preparaty zawierające technet (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA01	kwas pentety z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA02	technetu (99mTc) technegaz	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EA03	nanokoloid z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EB	Technet (99mTc), cząstki do wstrzyknięć	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EB01	makrosalb z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EB02	mikrosfery z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX	Inne radiofarmaceutyki stosowane w diagnostyce układu oddechowego	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX01	krypton (81mKr) gaz	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX02	ksenon (127Xe) gaz	WHO Anatomical Therapeutic Chemical classification
0‑L	V09EX03	ksenon (133Xe) gaz	WHO Anatomical Therapeutic Chemical classification
0‑L	V09F	TARCZYCA	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX	Różne radiofarmaceutyki stosowane w diagnostyce tarczycy	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX01	sodu nadtechnecjan (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX02	sodu jodek (123I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX03	sodu jodek (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09FX04	sodu jodek (124I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09G	UKŁAD SERCOWO-NACZYNIOWY	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA	Technetu (99mTc) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA01	techneto(99mTc)sestamibi	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA02	techneto(99mTc)tetrofosmina	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA03	techneto(99mTc)teboroksym	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA04	albumina ludzka z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA05	techneto(99mTc)furyfosmina	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA06	komórki znakowane technetu (99mTc) koloidem cynawym	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GA07	techneto(99mTc)apcytyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GB	Jodu (125I) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GB01	fibrynogen z jodem (125I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GB02	albumina ludzka z jodem (125I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX	Inne radiofarmaceutyki stosowane w diagnostyce układu sercowo-naczyniowego	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX01	talu (201Tl) chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX02	imcyromab z indem (111In)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX03	komórki znakowane chromianem (51Cr)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX04	rubidu (82Rb) chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	V09GX05	amoniak (13N)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09H	WYKRYWANIE STANÓW ZAPALNYCH I ZAKAŻEŃ	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA	Technetu (99mTc) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA01	immunoglobulina ludzka z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA02	komórki znakowane techneto(99mTc)eksametazymem	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA03	przeciwciało przeciw granulocytom znakowane technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HA04	sulesomab z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HB	Indu (111In) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HB01	komórki znakowane indu (111In) oksynianem	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HB02	komórki znakowane indu (111In) tropolonianem	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HX	Inne radiofarmaceutyki stosowane w celu wykrycia stanów zapalnych i zakażeń	WHO Anatomical Therapeutic Chemical classification
0‑L	V09HX01	galu (67Ga) cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	V09I	DIAGNOSTYKA NOWOTWORÓW	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA	Technetu (99mTc) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA01	przeciwciało przeciw CEA znakowane technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA02	przeciwciało przeciw komórkom czerniaka znakowane technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA03	technetu (99mTc) sukcymer pięciowalentny	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA04	wotumumab z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA05	techneto(99mTc)depreotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA06	arcytumomab z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA07	techneto(99mTc)tektrotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA08	techneto(99mTc)etarfolatyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA09	tylmanocept z technetem (99mTc)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IA10	technet (99mTc)chlorek trofolastatu	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB	Indu (111In) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB01	indu (111In) pentetreotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB02	pendetydosatumomab z indem (111In)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB03	przeciwciało przeciw komórkom raka jajnika znakowane indem (111In)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IB04	pendetydokapromab z indem (111In)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX	Inne radiofarmaceutyki stosowane w diagnostyce nowotworów	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX01	Jobenguan (123I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX02	Jobenguan (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX03	przeciwciało monoklonalne CC49 znakowane jodem (125I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX04	fludeoksyglukoza (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX05	fluorodopa (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX06	sodu fluorek (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX07	fluorocholina (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX08	fluoroetylocholina (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX09	galu (68Ga) edotreotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX10	fluoroetylo-L- tyrozyna (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX11	fluoroestradiol (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX12	flucyklowina (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX13	metionina (11C)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX14	gozetotyd galu (68Ga)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX15	dotatat miedzi (64Cu)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX16	piflufolastat (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09IX17	PSMA-1007 (18F)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09X	INNE RADIOFARMACEUTYKI DIAGNOSTYCZNE	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA	Jodu (131I) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA01	norcholesterol z jodem (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA02	jodocholesterol (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XA03	albumina ludzka z jodem (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX	Różne radiofarmaceutyki diagnostyczne	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX01	cyjanokobalamina (57Co)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX02	cyjanokobalamina (58Co)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX03	norcholesterol z selenem (75Se)	WHO Anatomical Therapeutic Chemical classification
0‑L	V09XX04	żelaza(III) (59Fe) cytrynian	WHO Anatomical Therapeutic Chemical classification
0‑L	V10	RADIOFARMACEUTYKI STOSOWANE W LECZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	V10A	LEKI PRZECIWZAPALNE	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA	Itru (90Y) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA01	itru (90Y) cytrynian koloidalny	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA02	itr (Y90) z żelaza wodorotlenkiem koloidalnym	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AA03	itru (90Y) krzemian koloidalny	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX	Inne przeciwzapalne radiofarmaceutyki	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX01	chromu fosforan (32P) koloidalny	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX02	hydroksyapatyt koloidalny z samarem (153Sm)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX03	dysproz (165Dy) koloidalny	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX04	erbu (169Er) cytrynian koloidalny	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX05	renu (186Re) siarczek koloidalny	WHO Anatomical Therapeutic Chemical classification
0‑L	V10AX06	złoto (198Au) koloidalne	WHO Anatomical Therapeutic Chemical classification
0‑L	V10B	ŁAGODZENIE DOLEGLIWOŚCI BÓLOWYCH (LEKI GROMADZĄCE SIĘ W KOŚCIACH)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX	Różne radiofarmaceutyki stosowane w łagodzeniu bólu	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX01	strontu (89Sr) chlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX02	samaru (153Sm) leksydronam	WHO Anatomical Therapeutic Chemical classification
0‑L	V10BX03	kwas etydro z renem (186Re)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10X	INNE RADIOFARMACEUTYKI STOSOWANE W LECZENIU	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA	Jodu (131I) związki	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA01	sodu jodek (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA02	jobenguan (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA03	jod (131I) omburtamab	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XA53	tozytumomab/tozytumomab z jodem (131I)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX	Różne radiofarmaceutyki stosowane w leczeniu	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX01	sodu fosforan (32P)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX02	ibrytumomab tiuksetan (90Y)	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX03	radu (223Ra) dichlorek	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX04	lutetu (117Lu) oksodotreotyd	WHO Anatomical Therapeutic Chemical classification
0‑L	V10XX05	tetraksetan wipiwotydu lutetu (177Lu)	WHO Anatomical Therapeutic Chemical classification
0‑L	V20	OPATRUNKI CHIRURGICZNE	WHO Anatomical Therapeutic Chemical classification

Legenda: Typ L=liść, S=specjalizowalny, A=abstrakcyjny, D=odrzucony. NullFlavour powinien występować w atrybucie @nullFlavour, a nie w @code.